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Chapter 1 
 
Reductive Deoxygenation of Alcohols – Catalytic 
Methods beyond Barton McCombie Deoxygenation 
 
 
 
 
This chapter was submitted to the European Journal of Organic Chemistry as Microreview. 
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1 Reductive Deoxygenation of Alcohols – Catalytic Methods 
beyond Barton McCombie Deoxygenation 
 
The deoxygenation is an extensively studied field in organic chemistry and over the last 
decades many methods like the Barton McCombie deoxygenation or the deoxygenation 
with alkali metals in liquid ammonia were established. Within this review we discuss 
different strategies for the chemoselective catalytic deoxygenation of alcohols with special 
attention to their scope and limitations. The deoxygenation of derivatives of alcohols and 
their direct deoxygenation as step-economic alternative are covered with current examples. 
Catalytic methods can serve as convenient and economic alternatives for established 
methods in the reduction of carbon oxygen single bonds. 
 
1.1 Introduction 
The deoxygenation of alcohols is an important and rather broad area of research in 
modern organic chemistry. The scope includes the conversion of organic feedstock to 
biofuel just as the removal of hydroxyl groups in the synthesis of natural products. While 
for the production of biofuel only non-selective methods are used to convert a mixture of 
carbohydrates derived from natural resources,
1-4
 organic chemists need chemoselective 
methods for the synthesis of specific molecules. Specific deoxygenation methods should be 
applicable to various substrates and tolerate a variety of functional groups.  
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Figure 1.1. Reaction pathways for the deoxygenation of alcohols. 
Taking a closer look at the principles of deoxygenation, several pathways should be 
considered (Figure 1.1). Most methods for the deoxygenation of alcohols employ a two-
step procedure. A commonly used two-step deoxygenation of alcohols is the elimination 
followed by hydrogenation of the resulting carbon-carbon double bond. This principle of 
dehydration and hydrogenation is the most important method for the conversion of 
biomass-derived carbohydrates into alkanes.
5
 Another possibility is the conversion of the 
hydroxyl group into a suitable leaving group, which is removed in the second step. The 
conversion to a halide followed by dehalogenation is a widely used strategy.
6,7
 Also, the 
conversion to ethers or esters is very common with O-thiocarbonyls as typical derivatives. 
They can be reduced by electron transfer using alkali metals in the so called “dissolving 
metal reduction”, or with stannanes in the Barton-McCombie-Deoxygenation.8,9 The use of 
stannanes as hydride source for the deoxygenation entails disadvantages as they are toxic 
and hardly to remove from the reaction mixture. Therefore stannanes cannot be used in the 
synthesis of pharmaceuticals. Several improvements like the catalytic use of stannanes or 
the use of other hydride sources like silanes have been made.
10
 However, undesired radical 
side reactions and the two step procedure render this approach still disadvantageous. The 
direct deoxygenation and the use of catalysts are far more desirable. 
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The aim of this review is to give the reader an overview of catalytic deoxygenation 
methods, show their substrate scope and the tolerated functional groups. We only discuss 
catalytic deoxygenation methods for alcohols or their derivatives, with typical examples, as 
a comprehensive coverage would exceed the scope of this review. Moreover, we exclude 
the known catalytic Barton McCombie deoxygenation, because it was already reviewed 
extensively.
10
 These catalytic methods may serve synthetic organic chemists as tools for 
the selective removal of hydroxyl groups and disclose alternatives for the established 
methods, like the Barton McCombie reaction. 
 
1.2 Deoxygenations employing a two-step procedure 
1.2.1 Deoxygenation of alcohol derivatives (ethers, esters) 
The removal of a hydroxyl group under mild reaction conditions is challenging, because 
of the high C-O bond strength, which can be diminished by the conversion of the alcohol 
into an appropriate derivative, like an ether or ester. In this first part we discuss catalytic 
deoxygenation methods for such substrates. 
 
1.2.1.1 Transition metal catalysts for the deoxygenation of ethers and esters 
Palladium catalyzed deoxygenations 
Palladium is one of the most powerful catalysts for the deoxygenation of phenolic 
hydroxyl groups. The most convenient catalytic approach is the transfer hydrogenation 
with palladium on charcoal (Pd/C), which is an easy to handle and active reducing system. 
Before this reductive cleavage can be applied, the hydroxyl group must be converted into a 
suitable leaving group. Very typical is the transformation into the corresponding aryl 
sulfonates
11-13
, like triflates, tosylates or mesylates. But also isourea derivatives
14,15
, 
thiocarbamates
15
, aryl ethers and heteroaromatic ethers
16,17
 were successfully reduced by 
Pd/C with hydrogen (Figure 1.2). Undesired side reactions, like the reduction of 
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carbon-carbon double bonds, benzyl ethers, nitro groups and chloro arenes, are limiting 
this method to substrates without reducible functional groups. 
 
Figure 1.2. Substrates for the deoxygenation by palladium on charcoal catalyzed transfer hydrogenation. 
Another mild reducing system was described by Sajiki et al., using Pd/C in combination 
with Mg/MeOH/NH4OAc
18
 or Et2NH/MeOH/H2
19
, for the reduction of aryl triflates and 
mesylates (Scheme 1.1). They describe a mechanism involving a single electron transfer 
from the ammonium/amine to the aromatic system followed by the cleavage 
of 
-
OTf/
-
OMs.
20
 
 
Scheme 1.1. Reductive deoxygenation of aryl triflates and mesylates using Pd/C as catalyst. 
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Cacchi et al. described a chemoselective homogeneous reduction system using 
Pd(OAc)2, a phosphine ligand and ammonium formate as hydrogen donor. This method 
tolerates the presence of carbon‒carbon double bonds, nitro groups and ketones in the 
substrate.
21
 Not only a chemoselective deoxygenation is possible, also the deoxygenation 
of highly sterically hindered phenyl triflates, using PdCl2(PPh3)2 with dppp (1,3-
bis(diphenylphosphino)propane) as bidentate ligand, was achieved (Scheme 1.2).
22
 
 
Scheme 1.2. Chemoselective deoxygenation of hindered phenols using homogeneous palladium catalysis.
22
 
A method, invented by Lipshutz et al., tolerates reducible functional groups, like chloro 
and bromo groups or olefins, during deoxygenation of perfluoroalkyl sulfonates (OTf, 
ONf).
23
 Pd(PPh3)4 as homogeneous catalyst, was found to be most effective in combination 
with Me2NH•BH3, as reductant, and K2CO3 in acetonitrile. The presence of potassium 
carbonate as base was essential in the reduction of substrates containing an olefin; 
otherwise the hydroboration of the olefin occurred. 
An interesting application of this palladium catalyzed deoxygenation is the cleavage 
from a solid support. With perfluoroalkylsulfonyl esters as the linker to the resin, the 
cleavage can be performed by palladium catalyzed deoxygenation.
24-26
 
 
Scheme 1.3. Perflouroalkylsulfonates as linker to a solid phase cleavable by palladium catalyzed 
deoxygenation.
24-26
 
Closely associated to the deoxygenation of phenolic hydroxyl groups is the 
deoxygenation of enols, which proceeds effectively with vinyl triflates and homogeneous 
palladium catalysis using Pd(OAc)2 in combination with dppp (1,3-bis(diphenyl-
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phosphino)propane) or dppf (1,3-bis(diphenylphosphino)ferrocene) as ligand and Et3SiH 
as hydride source.
27
 This procedure was found to deoxygenate even stabilized triflates 
while other reducible functional groups like esters, aldehydes, nitro or bromo groups and 
olefins were unaffected (Scheme 1.4). A similar method with Pd(PPh3)4, NaBH4 and NEt3 
was used to deoxygenate vinyl triflates of nucleotides.
28
 
 
Scheme 1.4. Aryl and vinyl triflates deoxygenated by homogeneous palladium catalysis.
27
 
Beside phenolic hydroxyl groups also allyl alcohols can be deoxygenated catalytically 
with palladium.
29-31
 Their alkoxyalkyl ethers (methoxymethyl MOM or ethoxyethyl EE) 
can be deoxygenated selectively in the presence of other ethers, shown exemplary in the 
synthesis of lavendulol (Scheme 1.5).
32
 The ethoxy ethyl ether of the allyl alcohol was 
removed selectively. 
 
Scheme 1.5. Chemoselective deoxygenation of allyl alcohol in the synthesis of lavendulol.
32
 
This reduction proceeds via a -allyl-palladium intermediate by hydride transfer. The 
deoxygenation method was also successfully applied in the synthesis of desoxyribose 
derivatives of pyrimidine nucleosides.
33
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Nickel catalyzed deoxygenations 
Nickel is becoming more popular in recent years as a cheap and more available 
alternative for palladium catalysts.
34
 Nickel(0) has d
10
 configuration that is often found to 
be highly active in catalysis. And, like palladium, it is used as catalyst for carbon-carbon 
bond coupling reactions.
35,36
 
Already 1975, Lonsky et al. reported the use of Raney nickel for the deoxygenation of 
potassium aryl sulfates.
37
 Later, the use of Raney nickel as catalyst for the transfer 
hydrogenation of aryl and vinyl perfluoroalkyl sulfonates was compared with palladium 
and PtO2 catalysts and a very high potential of this catalyst for the deoxygenation was 
found.
38
 However, the substrates and the reductants for the deoxygenation with nickel are 
similar to the substrates for deoxygenations with palladium. Sasaki et al. have shown the 
deoxygenation of aryl triflates
39
 and mesylates
40
 with NiBr2(PPh3)3/dppp catalyst, zinc as 
reductant and methanol as hydrogen donor. Another commonly used homogeneous catalyst 
for the deoxygenation is Ni(cod)2; it was used for the effective hydrogenolysis of alkyl aryl 
ethers and benzyl ethers using hydrogen,
41,42
 but this is a very unselective protocol. More 
interesting is the use of a different reductant resulting in enhanced chemoselectivity. With 
silane hydride as reductant, alkoxy aryl ethers and, more easily, aryl pivaloates are 
effectually deoxygenated without reduction of olefins (Scheme 1.6).
43
 
 
Scheme 1.6. Homogeneous catalyst for the chemoselective deoxygenation of aryl ethers and esters.
43
 
Nickel on graphite was found to have several advantages like lower costs and higher 
thermal conductivity, which is important for microwave assisted reactions, and compable 
with nickel on charcoal.
44
 In combination with Me2NH•BH3 as reducing agent and PPh3, 
K2CO3 in DMF, it catalyzes the deoxygenation of aryl tosylates and mesylates in high 
yields, while benzyl protecting groups and conjugated carbon-carbon double bonds were 
not removed (Scheme 1.7).
45
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Scheme 1.7. Deoxygenation of aryl tosylates and mesylates catalyzed by Ni/Cg.
45
 
 
Rhodium and Ruthenium catalyzed deoxygenations 
While palladium and nickel catalysts are used for Caryl‒O cleavage, rhodium, by 
contrast, is mostly used for deoxygenations of allylic and benzylic alcohols. The well-
known Wilkinson catalyst, RhCl(PPh3)3, catalyzes the deoxygenation of allylic and 
benzylic alcohols (Scheme 1.8). However, the use of ,‒unsaturated esters as substrates 
is essential, otherwise no deoxygenation was observed.
46
 
 
Scheme 1.8. Deoxygenation of allylic and benzylic alcohols with Wilkinson´s catalyst.
46
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Rh(cod)(cot) catalyzes the deoxygenation of allyl acetates with HCO2H and NEt3.
47
 
Furthermore, RhH2(PPh3)4 with ammonium formate was used for the deoxygenation of 
allyl and propargyl carboxylates and carbonates.
48
 Due to the -allyl ruthenium complex 
that is formed during this reaction a shift of the double bond can occur (Scheme 1.9). 
 
Scheme 1.9. Rhodium catalyzed deoxygenation of allyl carbonates.
48
 
Rhodium(I), like palladium(II) and nickel(II), were found suitable homogeneous 
catalyst for deoxygenation, their d
8
 configuration makes an oxidative addition of C‒O 
bonds to the metal center via a d
6
 octahedral intermediate possible. Van de Boom et al. 
studied the tendency for the C‒O insertion of these three catalysts. For their model system 
they could demonstrated insertion into C(sp
2)‒O bonds for the nucleophilic rhodium(I) 
catalyst while electrophilic palladium(II) and nickel(II) preferably inserted into C(sp
3)‒O 
bonds (Scheme 1.10).
49
 Nevertheless, all deoxygenations with palladium and nickel 
catalyst led to the cleavage of the Caryl‒O and not the Calkyl‒O bond. Consequently, the 
observed tendency of insertion of the C‒O bond seems to be dependent on the model 
system, and may not be involved in the deoxygenation mechanism. 
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Scheme 1.10. Model system for the study of C-O activation by transition metal catalysts.
49
 
 
 
1.2.1.2 Electrochemical deoxygenation 
Using electrons as reductant is a very elegant possibility for reductive deoxygenation of 
alcohols. Such electroreductive deoxygenations of alcohols can be achieved after 
conversion into the corresponding phosphates or phosphinates. In 1979, Shono et al. 
reported the deoxygenation of aryl diethylphosphates in a divided cell, equipped with a 
platinum anode and lead cathode, with a cathode potential of -2.6 to -2.7 V vs. SCE. They 
could apply this method successfully in the synthesis of olivetol.
50
 A similar 
electroreductive deoxygenation was applied for the deoxygenation of diphenylphosphinate 
esters of aliphatic alcohols. The mechanism of this deoxygenation consists of an initial 
single electron transfer followed by decomposition of the resulting radical anion into the 
diphenylphosphonic acid and the alkyl radical (Scheme 1.11).
51
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Scheme 1.11. Electrochemical deoxygenation of diethylphosphates and diphenylphosphinates.
50,51
 
Ohmori et al. demonstrated the possibility of one-step electroreductive deoxygenation 
without initial transformation by so-called “double electrolysis”. They used phosphines, 
which undergo initially anodic oxidation, to form a phosphonium ion with the alcohol. The 
phosphonium ion intermediates are subsequently reduced to the phosphinoxide and the 
deoxygenation product (Scheme 1.12).
52
 
 
Scheme 1.12. Direct electroreductive deoxygenation via “double electrolysis”. 52 
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1.2.1.3 Thiol-catalyzed radical-chain redox decomposition 
A very interesting catalytic deoxygenation is the so called thiol catalyzed radical-chain 
redox decomposition. With this method methoxymethyl ethers of secondary and tertiary 
aliphatic alcohols can be deoxygenated. Dang et al. reported the use of tri-tert-
butoxysilanethiol (TBST) as polarity-reversal catalyst for the deoxygenation of several 
secondary and tertiary alcohols even in more complex systems (Scheme 1.13).
53,54
 2,2-Di-
tertbutylperoxybutane (DBPB) was used as initiator for the radical chain mechanism. 
 
Scheme 1.13. Thiol catalyzed radical-chain redox decomposition.
53,54
 
The polarity reversal catalyst enables this radical chain reaction by replacing the 
unfavored hydrogen abstraction of the nucleophilic radical R
•
 from ROCH2OMe (Scheme 
1.14, Equation 1) by a stepwise hydrogen transfer (Scheme 1.14, Equation 3,4). This 
stepwise hydrogen transfer is more favored due to polar effects.
55
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Scheme 1.14. Mechanism of the thiol catalyzed radical-chain redox decomposition.
53-55
 
 
1.2.2 Deoxygenation of alcohols via elimination-hydrogenation sequence 
Dehydration followed by hydrogenation is a classical two-step procedure for the 
deoxygenation of alcohols. Both, the elimination of hydroxyl groups (dehydration) and the 
hydrogenation of carbon-carbon double bonds are well studied reactions and excellent 
reviews exist.
56-63
 We therefore will only discuss very few selected examples.  
 
Scheme 1.15. Atom-economic two-step deoxygenation of alcohols employing a dehydration-hydrogenation 
sequence. 
In theory, the generation of waste can be limited to water when catalytic reactions are 
used, while only hydrogen is needed as reactant (Scheme 1.15). Hence, this method is 
desirable for industrial applications and frequently employed for the synthesis of platform 
chemicals or biofuel from carbohydrates derived from biomass.
1-4 
The catalysts for the 
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industrial hydrodeoxygenation (HDO), i.e. CoMo/-Al2O3 and NiMo/-Al2O3, remove 
hydroxyl groups unselectively from biomass derived carbohydrates.
64-66
 But also the 
selective conversion of biomass derived platform chemicals by dehydration-hydrogenation 
is possible. Leitner et al. showed the conversion of 4-(2-tetrahydrofuryl)-2-butanol 
(THFA) into 1-octanol (1-OL) and 1,1-dioctylether (DOE) employing a ruthenium 
hydrogenation catalyst under acidic conditions(Scheme 1.16).
67
 
 
Scheme 1.16. Selective HDO of 4-(2-tetrahydrofuryl)-2-butanol (THFA) with Ru/C in ionic liquid. 
For chemoselective organic synthesis the catalytic processes must be chosen with care, 
as the acidic conditions for the dehydrogenation as well as the catalytic hydrogenation can 
cause undesirable side reactions. The acidic conditions for the dehydration can lead to the 
generation of ethers or the cleavage of acid sensitive protecting groups. Hydrogenation is 
problematic, if other reducible functional groups are present in the molecule, but choosing 
the appropriate conditions these problems can be solved. 
The dehydration is usually achieved under acidic conditions, i.e. with para-
toluenesuflonic acid, but also solid acid catalysts, like heteropoly acids, or acid ion 
exchange resins (Amberlyst-18, Nafion-H), and basic catalysts can be applied.
68,69
 For the 
hydrogenation of carbon-carbon double bonds a variety of catalyst is available, including 
palladium, nickel, ruthenium, iridium, rhenium and platinum metal catalysts.
70
 Palladium, 
as for the deoxygenation of ethers and esters, is the outstanding catalyst for the 
hydrogenation of carbon-carbon double bonds. Either homogenous or heterogeneous 
catalysts can be used, but the functional groups within the molecule have to be 
considered.
71,72
 For example, the deoxygenation with Pd/C under hydrogen atmosphere is 
not applicable for molecules containing benzyl or allyl ether moieties. Therefore, either the 
catalyst or the hydrogen source must be changed. Using the palladium catalyst Pd/C(en), 
poisoned with ethylenediamine, carbon-carbon double bonds can be hydrogenated 
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selectively while benzylethers, Cbz protection groups and TBDMS ethers are 
unaffected.
73,74
 With 1,4-cyclohexydiene as hydrogen-source, even Pd/C can be used for 
the hydrogenation of carbon-carbon double bonds without the cleavage of benzylethers.
75
 
 
Scheme 1.17. Chemoselective hydrogenation of carbon-carbon double bonds with transfer hydrogenation 
catalysts. 
A metal-free hydrogenation method for non-polarized multiple bond employs diimide 
as hydrogen source. As diimide is very unstable, it has to be generated in situ from 
hydrazine hydrate or its derivatives.
76
 For example riboflavin catalysts are able to oxidize 
hydrazine catalytically to diimide in the presence of air-oxygen and promote the 
chemoselective reduction of non-polarized carbon-carbon double bonds (Scheme 1.18).
77
 
 
Scheme 1.18. Reduction of nonpolarized carbon-carbon double bonds with organocatalytically generated 
diimide. 
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1.3 Direct reductive deoxygenation of alcohols 
1.3.1 Direct deoxygenation with hydrogenation catalysts 
In the second part of this review we discuss direct deoxygenation methods of alcohols. 
Being a one-step procedure the direct deoxygenation saves time, chemicals and 
consequently money and is therefore of great interest. While in the first part the C-O bonds 
of the alcohols were activated by derivatization for the catalytic cleavage, the catalyst has 
to achieve this activation for the direct deoxygenation. Indeed, the hydrogenation catalysts, 
mentioned in the first part, are able to deoxygenate phenols as the study of Frost et al. 
demonstrates.
78
 They studied the deoxygenation of polyhydroxybenzenes (Scheme 1.19), 
derived from glucose, by hydrogenation with supported rhenium, platinum and palladium 
catalysts. But these special substrates cannot serve as general examples for the 
chemoselective deoxygenation of phenols with these catalysts. 
 
Scheme 1.19. Direct deoxygenation of polyhydroxybenzenes.
78
 
Raney nickel and Raney cobalt in refluxing 2-propanol were applied for the direct 
deoxygenation of aliphatic alcohols substituted in , , ,  or  position with an aromatic 
ring (Scheme 1.20). Raney nickel gave very high yields in short reaction times of a few 
hours while Raney cobalt suffered from low conversions even after 24 hours.
79
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Scheme 1.20. Direct deoxygenation of aliphatic alcohols catalyzed by Raney nickel or cobalt.
79
 
The ruthenium catalyst [{Cp*Ru(CO)2}2(µ-H)]
+
OTf
-
 was found to deoxygenate 
terminal diols partially by hydrogenation (Scheme 1.21). The secondary alcohol was 
removed selectively due to the higher stability of the carbenium ion intermediate.
80
 Other 
ruthenium and iridium catalysts have been investigated to catalyze this reaction.
81,82
  
 
Scheme 1.21. Partial direct deoxygenation of a terminal diol using a ruthenium catalyst.
80
 
The hydrido cobalt complex HCo(CN)5
-3
 was identified as catalyst for the 
deoxygenation of allyl alcohols.
83
 The complex is formed in situ from cobalt(II)chloride 
and potassium cyanide under hydrogen atmosphere. In a first study the hydridopentacyano-
cobaltate anion was found to deoxygenate allyl alcohols by hydrogenation of the C-C 
double bond followed by an elimination of the hydroxyl group. This leads to the overall 
deoxygenation of the allylic alcohol, but a 1,2-shift of the double bond occurs, dependent 
on the ratio of cyanide to cobalt, and yields a mixture of products (Scheme 1.22). 
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Scheme 1.22. Direct deoxygenation of allyl alcohols with in situ formed HCo(CN)5
-3
.
83
 
Lee et al. used the hydridopentacyanocobaltate anion HCo(CN)5
-3 
for the deoxygenation 
of allyl alcohols. Their improved protocol deoxygenates allyl alcohols directly by 
1,2-reduction applying -cyclodextrin as phase transfer catalyst.84 No hydrogenation and 
no shift of the double bond was observed and catalytic deoxygenation of several allylic 
alcohols was accomplished in high yields at room temperature (Scheme 1.23). 
 
Scheme 1.23. Direct catalytic deoxygenation of allyl alcohols by in situ formed HCo(CN)5
-3
.
84
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1.3.2 (Lewis) Acid catalyzed direct deoxygenations 
1.3.2.1 Direct deoxygenation by activation of the C-O bonds with Lewis acids 
Lewis acids are known to activate C-O bonds for the deoxygenation with a hydride 
source.
85
 They are used in stoichiometric amounts and reveal selectivity for alcohols 
following the trend tertiary > secondary >> primary. Gevorgyan et al. demonstrated 
convincingly that the use of B(C6F5)3 in catalytical amounts and HSiEt3 as hydrid source 
changes this order of reactivity completely to primary >> secondary > tertiary.
86
 Even the 
chemoselective deoxygenation of a primary alcohol in the presence of a secondary alcohol 
is possible (Scheme 1.24).
87
 
 
Scheme 1.24. Chemoselective deoxygenation of a primary alcohol in the presence of a secondary alcohol.
87
 
Indium(III) catalysts are used for carbon-carbon bond formations and as Lewis 
acids.
88,89
 In combination with silanes as a hydride source trivalent indium halides are good 
catalysts for the mild deoxygenation of secondary, tertiary and benzylic alcohols. 
Baba et al. studied the deoxygenation of ketones using InCl3 (5 mol%) and Me2SiClH and 
discovered that their protocol was applicable for alcohols.
90
 Later they refined this protocol 
for the direct catalytic deoxygenation of alcohols. The use of an InCl3 catalyst in 
dichloroethane with Ph2SiClH as hydride source gave the best results for the 
deoxygenation of secondary, tertiary and benzylic alcohols.
91
 The mechanism involves an 
initial formation of the silylether followed by the deoxygenation by hydride transfer. 
Without catalyst the reaction yields the silylether. 
 
Scheme 1.25. Indium(III) chloride catalyzed direct deoxygenation.
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Recent examples also demonstrate the acid catalyzed chemoselective deoxygenation of 
allylic and propargylic alcohols with silane as reductant. The heteropolyacid 
H3[PW12O40]×nH2O deoxygenates allylic and propargylic alcohols under mild conditions 
in high yields with Et3SiH as reducing agent (Scheme 1.26).
92
 
 
Scheme 1.26. Direct deoxygenation of propargylic and allylic alcohols with the heteropolyacid catalyst 
H3[PW12O40]×nH2O.
92
 
The Lewis acids Ca(NTf2)2 and Bi(OTf)3 deoxygenate propargylic alcohols with Et3SiH 
as hydride source. The Ca(NTf2)2 catalyzed reaction was enhanced by Bu4NPF6 as 
additive,
93
 while the deoxygenation catalyzed by Bi(OTf)3 was performed in the ionic 
liquid [BMIM][BF4].
94
 The latter study explored several Lewis acids and the 
bismute(II)triflate gave the best results. Furthermore, not only propargylic also allylic and 
benzylic alcohols were deoxygenated successfully.  
Molybdenum hexacarbonyl, known for the cleavage of C-S bonds, was also applied in 
the catalytic deoxygenation of alcohols. In combination with Lawesson´s reagent, normally 
used for the conversion of carbonyl compounds into thiocarbonyls, Mo(CO)6 deoxygenates 
heterocyclic halo-benzyl alcohols in high yields (Scheme 1.27).
95
 
 
Scheme 1.27. Molybdenum hexacarbonyl catalyzed deoxygenation of heterocyclic halo-benzyl alcohols.
95
  
 
Reductive Deoxygenation of Alcohols – Catalytic Methods beyond Barton McCombie Deoxygenation 
 
23 
1.3.2.2 Radical deoxygenation catalyzed by low-valent titanium 
Low-valent titanium is long known for the activation of C-O bonds, not only in 
McMurry reactions, but also for the deoxygenation of benzylic and allylic alcohols.
96
 In 
1980, Sato et al. described the catalytic deoxygenation of allyl and benzyl alcohols and 
allyl ethers. They used LiAlH4 as reducing agent with catalytic amounts of TiCl4 or 
titanocene dichloride, Cp2TiCl2.
97
 Recently, Dieguez studied the mechanism of the 
deoxygenations of benzylic and allylic alcohols, diols and carbonyl compounds with 
Nugent´s Reagent, Cp2TiCl.
98
 The C-O bond is cleaved homolytically by single electron 
transfer, SET, from Cp2TiCl and generates a radical. This radical can either react with a 
hydrogen donor under hydrogen abstraction, giving overall deoxygantion, or recombine 
with a second radical. In the case of 1,2-diols the recombination of the radical intermediate 
leads to the generation of a double bond (Scheme 1.28). 
 
Scheme 1.28. Deoxygenation of benzylic alcohols with Cp2TiCl2 as catalyst.
 97
 
Deoxygenation of allyl alcohols sometimes gave a mixture of products with different 
positions of the double bond. Depending on the stability of the generated radical 
intermediate, the double bond shifts to generate the most stable radical (Scheme 1.29).  
 
Scheme 1.29. Mechanism of the deoxygenation of allylic alcohols with Cp2TiCl.
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1.3.2.3 Iodine/HI catalyzed deoxygenations 
The deoxygenation of alcohols using refluxing hydriodic acid and red phosphorous was 
invented by Kiliani et al. 140 years ago, is still used for industrial applications and was 
reinvestigated as catalytic reduction.
99
 The mechanism of this reduction consists of two 
steps, first the hydroxyl group is converted into the corresponding alkyl iodide that is 
subsequently reduced by redox comproportionation with hydriodic acid (Scheme 1.30). 
While the nucleophilic substitution as the first step is widely accepted, the second step is 
controversially discussed in literature.
100-102
 Already in 1939, Miescher et al. described the 
regeneration of HI from iodine by red phosphorous and the possibility of using iodine or 
iodide instead of hydriodic acid.
103
 
 
Scheme 1.30. Mechanism of the deoxygenation of alcohols with hydriodic acid. 
Robinson et al. studied the deoxygenation of polyols, i.e. D-sorbitol, with hydriodic 
acid and the recycling of the acid for industrial application (Scheme 1.31). They 
regenerated hydriodic acid either by chemical reduction with H3PO3 or 
electrochemically.
104,105
 But the harsh conditions of these methods are still problematic for 
the use in organic synthesis. 
 
Scheme 1.31. Deoxygenation of D-sorbitol with catalytic amounts of hydriodic acid.
 104
 
König et al. described the use of red phosphorous and catalytic amounts of aqueous HI 
in a biphasic reaction media for the reduction of benzylic alcohols (Scheme 1.32).
106
 The 
cleavage of methyl ethers or dehalogenation reactions were not observed with this protocol 
in contrast to the classic method. 
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Scheme 1.32. Direct deoxygenation of benzylic alcohols with hydriodic acid and red phosphorous.
106
 
Another possibility is the in situ generation of HI from another iodide source. Milne et 
al. used sodium iodide in combination with phosphorous acid as stoichiometric reductant. 
Under these conditions -hydroxyphenylacetic acids could be deoxygenated successfully. 
Furthermore, bromo substituents and ethers were tolerated (Scheme 1.33).
107,108
 Using 
hypophosphorous acid and catalytic amounts of iodine in acetic acid Gordon et al. could 
deoxygenate benzhydrols without the cleavage of chloro and bromo substituents.
102,109
 
 
Scheme 1.33. In situ generation of HI from sodium iodide and phosphorous acid for the deoxygenation of 
-hydroxyphenylacetic acids. 107,108 
Sen et al. also used HI in catalytic amounts for the deoxygenation of biomass derived 
fructose to generate 5-methylfurfural MF.
110
 They applied a hydrogenation catalyst and 
hydrogen for the regeneration of HI from iodine. The reaction could not be achieved 
without hydriodic acid and provides another good opportunity for the catalytic use and the 
regeneration of hydriodic acid. 
 
Scheme 1.34. Generation of MF from fructose with catalytic amounts of HI.
110
 
Reductive Deoxygenation of Alcohols – Catalytic Methods beyond Barton McCombie Deoxygenation 
 
26 
1.4 Conclusion 
The Barton McCombie deoxygenation has been studied and developed extensively over 
more than 35 years. It is the first method that comes to most chemists mind thinking about 
the chemoselective and mild removal of a hydroxyl group. In this review we have provided 
a short overview of catalytic alternatives for this method, including their scope and 
limitations.  
For the deoxygenation of aryl alcohols the currently best methods employ a two-step 
procedure transferring the alcohol first into an appropriate ester or ether that can be 
reductively cleaved catalytically with a palladium or nickel catalyst. The deoxygenation of 
alkyl hydroxyl groups is more versatile; depending on the substrate even the direct 
deoxygenation is possible. Mostly activated alkyl alcohols, like benzyl, allyl or propargyl 
alcohols, are preferred for the direct deoxygenation. This substrates can stabilize a radical 
or ionic intermediate by delocalization via the neighbouring -system, thus the C-O bond 
is cleaved more easily. But also without this activation, the direct deoxygenation is 
possible by activation of C-O bond with an appropriate Lewis acid. In the case of the 
radical chain deoxygenation an external reductant is not even needed, as the MOM ether 
serves as internal reducing agent. 
The direct deoxygenation will be the preferred method when more catalytic procedures 
with improved chemoselectivity will become available. The increasing use of biomass 
derived compounds instead of fossil carbon for chemical synthesis will set a strong 
demand for efficient, selective and catalytic defunctionalization methods.  
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Chapter 2 
 
Reduction of benzylic alcohols and α-hydroxycarbonyl 
compounds by hydriodic acid in a biphasic reaction 
medium 
 
 
 
This chapter was written in collaboration with Michael Dobmeier and published in the “Beilstein Journel of 
Organic Chemistry”: Dobmeier, M.; Herrmann, J. M.; Lenoir, D.; König, B. Beilstein Journal of Organic 
Chemistry 2012, 8, 330. Michael Dobmeier and Josef Herrmann contributed equally to the written part of this 
chapter. Table entries based on experiments performed by Josef Herrmann are marked with *. The alcohols 
1-(4-methoxyphenyl)-2-phenylpropan-1-ol, 2-methyl-1-(thiophen-3-yl)propan-1-ol, 4-methyl-2-phenyl-
pentan-2-ol, 3-methyl-1-phenylbutan-1-ol, (E)-6-methyl-1-phenylhept-4-en-3-ol, 6,6-dimethyl-2-phenylhept-
4-yn-3-ol, ethyl 3-(4-chlorophenyl)-3-hydroxybutanoate were synthesized by Josef Herrmann. Radical 
capture experiments with TEMPO were performed by Josef Herrmann. 
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2 Reduction of benzylic alcohols and α-hydroxycarbonyl 
compounds by hydriodic acid in a biphasic reaction medium 
2.1 Introduction 
The reduction of hydroxyl groups is a typical and important step in the synthesis of 
complex natural products or drugs.
1-4
 Functional group tolerance during this reduction step 
is essential since various other groups are usually present. A number of synthetic 
procedures have been developed, which allow selective reduction, but only a few one-step 
transformations are known using either titanium-(III)
5-8
 or different metal-complexes.
9-13
 
Most procedures require a sequence of steps, e.g. the conversion of hydroxyl groups into a 
chloride or bromide substituent and subsequent catalytic reduction with H2/Pt or the 
conversion into a tosylate and reduction with LiAlH4. The most commonly applied method 
is the Barton-McCombie reaction,
14
 due to its versatility and its very high functional group 
tolerance.
15-18
 Although very general, the reaction has some drawbacks: the involved 
organo tin hydrides are costly, highly toxic
19-21
 and often difficult to separate from the 
reaction products. Furthermore, secondary alcohols give best results, while others may 
react less efficient.  
We have reinvestigated the long known reduction of benzylic alcohols and -hydroxy 
carbonyl compounds by hydriodic acid.
22-32
 First described by Kiliani more than 140 years 
ago for the reduction of gluconic acid to hydrocarbons,
33
 the method has been reported for 
a variety of alcohols, but typically proceeds in aqueous solution and requires an excess of 
HI or strong mineral acids like phosphoric or sulfuric acid.
34-36
 
We describe a biphasic reaction medium consisting of toluene and aqueous hydriodic 
acid. The phase separation allows milder reaction conditions compared to the classic 
Kiliani protocol and is more applicable to organic synthesis. 
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2.2 Results and Discussion 
2.2.1 Deoxygenation of benzylic alcohols 
Initial investigations focused on simple benzylic alcohols (Table 2.1, entry 1-3), which 
were converted in high to quantitative yields into the corresponding alkanes. Carbonyl 
groups or amides in benzylic position (Table 2.1, entries 4 and 6) and aromatic hydroxyl 
groups, (Table 2.2, entry 7) or aromatic ethers (Table 2.1, entry 5) are not affected. 
Moreover, heterocycles like thiophene (Table 2.1, entry 7) were stable under these 
conditions whereas furans (Table 2.1, entry 8) were decomposed due to ring opening. 
Benzylic alcohols were converted in good to high yields to alkanes with increasing 
reactivity in the order primary (2 h) < secondary (0.5-1 h) < tertiary alcohol (15 – 30 min); 
carbonyl groups and ethers are tolerated. Diethyl tartrate is converted into diethyl succinate 
under the reaction condition (Table 2.1, entry 12), but some of the material is lost due to 
ester hydrolysis. 
Table 2.1. Reduction of benzylic alcohols to corresponding alkanes.  
Entry Alcohol Product
a
 Yield [%] 
1 
 
 
70
b 
2 
 
 
96 
3 
 
 
100 
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4 
 
 
80 
5* 
 
 
92 
6 
 
 
82 
7* 
 
 
62
c 
8  decomposition  
9* 
 
 
74
c 
10* 
 
 
49
c 
11 
 
 
78 
12 
  
65 
a 
All products are known compounds described in the literature. Identity has been proven by proton 
NMR and mass analysis, which match literature data. 
 b
 The corresponding iodo compound was 
identified as byproduct; 
c
 the corresponding elimination product was obtained as byproduct. 
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2.2.2 Deoxygenation of allylic and propargylic alcohols 
Allylic alcohols are completely consumed, but the corresponding alkenes could not be 
isolated as pure product (Table 2.2). Mixtures of eliminiation and deoxygenation products, 
in some cases also rearangement of the deoxygenated product into the higher substitued, 
thermodynamical more stable, alkene occurred. Propargylic alcohols (Table 2.2, entry 3,4) 
showed elimination or decomposed. In the case of flavin (Table 2.2, entry 6), three 
hydroxyl groups were reduced and one was converted into an iodo substituent. 
 
Table 2.2. Alcohols showing incomplete or unselective reaction with hydriodic acid and red 
phosphorous (3.0 eq. HI, 0.4 eq. Pred). 
Entry Alcohol Product Yield [%] 
1* 
 
mixture of several 
products 
- 
2* 
 mixture of several 
products 
- 
3 
 
 
Traces 
4* 
 
Decomposition - 
5 
 
Decomposition - 
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6 
 
 
21 
7 
 
no conversion - 
 
 
2.2.3 Conversion of aliphatic alcohols without -system in -position 
Others alcohols than benzylic or  to carbonyl groups were not converted into the 
corresponding alkane and the reaction stopped at the iodo alkanes (Table 2.3). The 
reactivity follows the order of primary < secondary < tertiary alcohols, as expected for an 
SN 1 reaction. The reduction potential of the non-benzylic iodo alkanes is not sufficient for 
reduction by hydriodic acid. 
Table 2.3. Alcohols yielding alkyl iodides with hydriodic acid and red phosphorous
a
 
Entry Alcohol Product Yield [%] 
1 
 
 
98
 
2 
  
83
b
 
3* 
  
81
c 
a
 3 eq. HI, 0.6 eq. Pred; 8 h; 
b
 single isomer; 
c 
20 h; products were analyzed by gas chromatography; 
chlorobenzene was used as internal standard. 
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2.2.4 Mechanism of the deoxygenation with hydriodic acid 
The mechanism of reduction by hydriodic acid consists of two steps (Scheme 2.1): The 
nucleophilic substitution of the hydroxyl group by iodide and the subsequent reduction of 
the alkyl iodide by hydriodic acid. The iodine, generated in the second step, is recycled by 
reduction with red phosphorous regenerating hydriodic acid. 
 
Scheme 2.1. Mechanism of the alcohol reduction and recycling of iodine 
The mechanistic details of the redox comproportionation of alkyl iodides and H–I are 
controversially discussed in the literature.
37-39
 However, the required benzylic or 
-carbonyl position for the redox comproportionation indicates an intermediate with 
mesomeric stabilization by the adjacent -system. In a trapping experiment, using HI 
without phosphorous, diphenylcarbinol as substrate and TEMPO as trapping agent for 
radical intermediates, the TEMPO adduct of diphenylcarbinol was detected by mass 
analysis (Scheme 2.2). 
 
Scheme 2.2. Radical capture experiments with diphenylcarbinol and TEMPO. 
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This indicates a radical mechanism of the redox comproportionation. We suggest a 
stepwise reduction by single electron transfer (SET) accompanied by the oxidation of I
-
 to 
I2. The iodine, generated in the second step, is recycled by reduction with red phosphorous, 
regenerating hydriodic acid. Admittedly, the above-mentioned TEMPO adduct could also 
be generated by nucleophilic substitution of the alkyl iodide with reduced TEMPO. At 
least this would be another proof for the first reaction step (Scheme 2.3). 
 
Scheme 2.3. Possible reaction pathways for the generation of the TEMPO adduct. 
 
2.2.5 Deoxygenation with catalytic amounts of hydriodic acid 
According to the redox equations of the reaction between iodine and red phosphorous, 
each mol of red phosphorous is able to reduce at least 1.5 mol of iodine. 
3 I2 + 2 P + 6 H2O → 6 HI + 2 H3PO3 
5 I2 + 2 P + 8 H2O → 10 HI + 2 H3PO4 
Catalytic amounts of hydriodic acid are therefore sufficient for the reduction of the 
hydroxy group, when excess red phosphorous is added as terminal reducing agent (Table 
2.4, entry 1, 3-6). However, depending on the amount of added hydriodic acid the 
elimination of water may occur as an alternative reaction pathway (Table 2.4, entry 2). Low 
concentration of HI favors the elimination of water, while higher HI concentrations lead to 
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deoxygenation (Table 2.4, entry 1). But for substrates without a methyl, methylene of methine 
group in -position (Table 2.4, entry 4 - 6), even low concentration of HI were sufficient for 
deoxygenation. In these cases dehydration could not take place as alternative reaction pathway. 
 
Table 2.4. Reduction of alcohols with catalytic amounts of hydriodic acid. 
Entry Alcohol Product Yield [%] 
1* 
  
74
a 
2* 
  
67
b 
3* 
  
82
a 
4 
 
 
92
b
 
5 
  
98
b
 
6 
  
74
b
 
a
 0.6 eq. HI, 0.4 eq. Pred; 
b 
0.1 eq. HI, 0.7 eq. Pred. 
 
  
Reduction of benzylic alcohols and α-hydroxycarbonyl compounds by hydriodic acid in a biphasic 
reaction medium 
 
41 
2.3 Conclusions 
Toluene and aqueous hydriodic acid are a suitable biphasic reaction mixture for the 
reduction of a range of benzylic alcohols. The two-phase system makes the Kiliani 
protocol easier applicable to organic synthesis, as organic substrates and products dissolve 
in the organic phase and are separated from the mineral acids. The procedure allows the 
use of catalytic amounts of hydriodic acid and red phosphorous as the terminal reductant. 
In the case of alcohols having no activation by adjacent benzylic or carbonyl groups the 
reaction stops at the corresponding alkyl iodide. A quantitative mass efficiency analysis
40
 
of the reaction in comparison to tosylation/LAH, Ti(III)-mediated and Barton-McCombie 
reduction revealed a better atom economy and mass efficiency.  
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2.4 Experimental 
General: All reagents and solvents used were of analytical grade, purchased from 
commercial sources and used without further purification. Unless stated otherwise, 
purification and drying of the solvents used was performed according to accepted general 
procedures. All reactions were performed under an inert atmosphere of N2 by using 
standard Schlenk techniques, if not otherwise stated. TLC analyses were performed on 
silica-gel-coated alumina plates (F254 silica gel, layer thickness 0.2 mm). Visualization 
was achieved by UV light at 254 nm/366 nm or through staining with ninhydrin dissolved 
in EtOH. For preparative column chromatography, silica gels (70–230 mesh and 230–400 
mesh) were used. For chromatography commercially available solvents of standard quality 
were used without further purification. 
 
Representative experimental procedure: The alcohol (1 mmol, 1 eq.) is dissolved in 4 
mL of toluene. Red phosphorus (0.4 mmol), followed by concentrated hydriodic acid 
(57 wt.-%; 3.0 mmol, 3 eq.) is added and the reaction mixture is heated to 127 °C for the 
stated time, allowed to cool to room temperature and quenched with Na2S2O3 (10 mL; 
10 wt.-% ) solution. The aqueous phase is extracted with dichloromethane (3 x 10 mL), the 
combined organic phases are dried over MgSO4, filtered and the solvent is removed. The 
crude product is purified by chromatography and spectroscopically characterized.  
For catalytic reactions of 1 mmol of the respective alcohol the following amounts of 
hydriodic acid and P(red) were used: (a) 0.6 mmol HI / 0.4 mmol P(red), (b) 0.2 mmol HI / 
0.6 mmol P(red), (c) 0.1 mmol HI / 0.7 mmol P(red). 
 
E-6-Methyl-1-phenylhept-4-en-3-ol: The reaction was carried out under dry nitrogen 
atmosphere using standard Schlenk techniques. To a slurry of Mg powder (0.67 g, 28 
mmol) in dry THF (4 mL), 2 mL of a solution of 2-phenyl-1-bromethane (3.0 mL, 28 
mmol) in dry THF (10 mL) were added. The Grignard reaction was initiated by addition of 
iodine and sonication for several minutes. When the exothermic reaction had started the 
rest of the 2-phenyl-1-bromethane solution was added through a septum via syringe over 
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15 minutes. After addition the reaction solution was heated to reflux for 1 hour to complete 
the reaction. The reaction solution was allowed to cool to room temperature before 4-
methyl-2-pentenal (2.3 mL, 20 mmol) was added dropwise. To complete the reaction the 
solution was again heated to reflux for 1 hour. The reaction was quenched by addition of 
HCl (2 M, 25 mL). The aqueous phase was extracted with diethyl ether (3 × 15 mL). The 
combined organic phases were washed with saturated NaHCO3 (15 mL), H2O (2 × 10 mL) 
and dried with MgSO4. The solvent was removed with a rotary evaporator. The crude 
product was purified by flash chromatography (PE/EtOAc 4:1, Rf = 0.32, staining with 
vanillin solution gave a blue spot). E-6-Methyl-1-phenylhept-4-en-3-ol was isolated as 
yellow oil in 74 % yield (3.05 g, 14.9 mmol). 
1
H NMR (300 MHz, CDCl3) δ 7.33 – 7.14 
(m, 5H), 5.63 (ddd, J = 15.5, 6.4, 0.7 Hz, 1H), 5.44 (ddd, J = 15.5, 7.0, 1.2 Hz, 1H), 4.13 – 
4.01 (m, 1H), 2.79 – 2.59 (m, 2H), 2.39 – 2.21 (m, 1H), 1.97 – 1.72 (m, 2H), 1.58 (d, J = 
2.7 Hz, 0.3H), 1.46 (d, J = 1.8 Hz, 1H), 1.00 (d, J = 6.8 Hz, 6H). 
13
C NMR (75 MHz, 
CDCl3) δ 139.6, 129.7, 128.5, 128.4, 125.8, 72.6, 38.8, 31.8, 30.7, 22.4, 21.3. EI-MS: m/z 
(%) = 91.1 (100) [C7H7]
+
, 161.1 (81) [M–C3H7]
+
, 186.1 (5) [M-H2O]
+
, 204.2 [M]
+∙
. HR-
MS: calcd. for C14H20O [M]
+∙
 204.1514; found 204.1511. 
 
E- 1-Phenylhex-4-en-3-ol: The reaction was carried out under dry nitrogen atmosphere 
using standard Schlenk techniques. A solution (1 mL) of 2-phenyl-1-bromethane (1.35 mL, 
10.0 mmol) in dry THF (10 mL) was added to Mg-powder (0.25 g, 10 mmol). The 
Grignard reaction was initiated by addition of iodine and sonication for several minutes. 
When the exothermic reaction had started the rest of the 2-phenyl-1-bromethane solution 
was added through a septum via syringe over 15 minutes. After addition the reaction 
solution was heated to reflux for 1 hour to complete the reaction. The reaction solution was 
allowed to cool to room temperature before crotonaldehyde (0.74 mL, 9.0 mmol) was 
added dropwise. To complete the reaction the solution was again heated to reflux for 2.5 
hours. The reaction was quenched by addition of HCl (2 M, 10 mL). The aqueous phase 
was extracted with diethyl ether (2 × 15 mL). The combined organic phases were washed 
with saturated NaHCO3 (5 mL), H2O (2 × 5 mL) and dried with MgSO4. The solvent was 
removed with a rotary evaporator. E-1-Phenylhex-4-en-3-ol was obtained in 96 % yield 
(1.53 g, 8.69 mmol). Analytical data were identical with the literature.
41
 
1
H NMR (300 
MHz, CDCl3) δ 7.34 – 7.06 (m, 5H), 5.63 (dq, J = 15.3, 6.2 Hz, 1H), 5.48 (ddd, J = 15.3, 
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7.0, 1.4 Hz, 1H), 4.02 (q, J = 6.7 Hz, 1H), 2.73 – 2.56 (m, 2H), 1.67 (dd, J = 6.3, 0.7 Hz, 
3H) , 1.52 (s, 0.3H), 1.40 (s, 0.7H). EI-MS: m/z (%) = 71.1 (100) [C4H7O]
+
, 91.1 (67) 
[C7H7]
+
, 105.1 (19) [M– C4H7O]
+
, 176.1 (50) [M]
+∙
. 
 
1-(4-Methoxyphenyl)-2-phenylpropan-1-ol: The reaction was carried out under dry 
nitrogen atmosphere using standard Schlenk techniques. 1 mL of a solution of 4-bromo-1-
methoxy-benzene (0.62 mL, 5.0 mmol) in dry THF (10 mL) was added to Mg-powder 
(0.12 g, 5.0 mmol). The Grignard reaction was initiated by addition of iodine and 
sonication for several minutes. When the exothermic reaction had started the rest of the 4-
bromo-1-methoxy-benzene solution was added through a septum via syringe over 15 
minutes. After addition the reaction solution was heated to reflux for 1 hour to complete 
the reaction. The reaction solution was allowed to cool to room temperature before 2-
phenylpropionaldehyde (0.60 mL, 4.5 mmol) was added dropwise. To complete the 
reaction the solution was again heated to reflux for 2 hour. The reaction was quenched by 
addition of HCl (2 M, 5 mL). The aqueous phase was extracted with diethyl ether 
(2 × 5 mL). The combined organic phases were washed with saturated NaHCO3 (3 mL), 
H2O (2 × 2.5 mL) and dried with MgSO4. The solvent was removed with a rotary 
evaporator. The crude product was purified by flash chromatography (PE/EtOAc 4:1, Rf = 
0.3, staining with vanillin solution gave a blue spot). 1-(4-Methoxyphenyl)-2-
phenylpropan-1-ol was isolated as yellow oil in 57 % yield (0.62 g, 2.6 mmol). Analytical 
data are identical with literature.
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1
H NMR (300 MHz, CDCl3) δ 7.45 – 7.05 (m, 7H), 6.85 
– 6.74 (m, 2H), 4.76 (d, J = 6.1 Hz, 1H), 3.78 (s, 3H), 3.09 (p, J = 6.9 Hz, 1H), 1.34 (d, J = 
7.0 Hz, 3H). EI-MS: m/z (%) = 137.1 (53) [M–C8H9]
+
, 224.1 (2) [M-H2O]
+
, 242.1 (1) 
[M]
+∙
. 
 
6,6-Dimethyl-2-phenylhept-4-yn-3-ol: The reaction was carried out under dry nitrogen 
atmosphere using standard Schlenk techniques. The solution of 3,3-dimethyl-1-butyne 
(0.62 mL, 5 mmol) in dry THF (10 mL) was cooled to –78 °C. n-BuLi (1.6 M in hexane, 
3.5 mL, 5.6 mmol) was added dropwise through a septum via syringe. The reaction 
mixture was allowed to warm to room temperature before the solution of 2-
propionaldehyde (0.68 mL, 5 mmol) in dry THF (5 mL) was added dropwise through a 
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septum via syringe. This solution was stirred for 4.5 hours. The reaction was stopped by 
addition of H2O (10 mL). The aqueous phase was extracted with diethyl ether (3 × 15 mL) 
and the combined organic layers were dried with MgSO4. The solvent was removed with a 
rotary evaporator. The crude product was purified by flash chromatography (PE/EtOAc 
4:1, Rf = 0.42, staining with vanillin solution gave a blue spot). 6,6-dimethyl-2-phenylhept-
4-yn-3-ol was isolated as colorless oil in 46 % yield (0.50 g, 2.3 mmol). 
1
H NMR (300 
MHz, CDCl3) δ 7.40 – 7.19 (m, 5H), 4.44 (dd, J = 7.4, 5.4 Hz, 1H), 3.03 (dd, J = 7.1, 5.4 
Hz, 1H), 1.67 (d, J = 5.4 Hz, 1H), 1.64 (d, J = 7.4 Hz, 1H), 1.39 (d, J = 7.1 Hz, 3H), 1.17 
(s, 9H). 
13
C NMR (75 MHz, CDCl3) δ 141.9, 128.8, 128.2, 127.0, 95.5, 78.1, 67.8, 67.5, 
55.0, 46.1, 31.0, 30.0, 16.3. EI-MS: m/z (%) = 57.1 (36) [C4H9]
+
, 99.1 (100), 105.1 (20) 
[C8H10]
+
, 216.2 (7) [M]
+∙
. 
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Chapter 3 
 
Synthesis of novel natural products isolated from 
butchers broom 
 
 
The compounds ruscozepine A and B were isolated from Rusci rhizoma in the working group of Prof. Dr. 
Jörg Heilmann at the University of Regensburg by Martej Barbič. The synthetic approach was performed by 
Josef Herrmann. Pharmaceutical testing was performed by Monika Untergehrer and Gabriele Brunner, 
coworkers of Prof. Dr. Jörg Heilmann. 
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3 Synthesis of novel natural products isolated from butchers 
broom 
3.1 Benzoxepines isolated from butchers broom 
Ruscus aculeatus L. (Figure 3.2), also known as butchers broom, is a low evergreen 
shrub native to South- and West-Central Europe, Asia Minor, Northern Africa and 
Caucasus. The use of the plant for medical applications is long known, ancient Greek 
physicians applied it as laxative or diuretic and in Europe it was added to wine as diuretic 
to remove kidney stones.
1
 In a study on the in vitro active compounds of the Rusci 
rhizoma, the novel phenyl-1-benzoxepinols ruscozepine A 1a and ruscozepine B 1b 
(Figure 3.1) were isolated from the methanolic extract of the Rusci rhizoma.
2
  
 
Figure 3.1. Phenyl-1-benzoxepinols isolated from the Rusci rhizoma. 
The plant and its constituents are of special interest as the Rusci rhizoma extract is 
already used for the preparation of commercially available drugs.
3
 Main application of the 
Rusci rhizoma preparations is the treatment of varicose veins and hemorrhoids, but the 
anti-inflammatory and vasoconstrictive activity is also of interest in recent studies, e.g. for 
the treatment of venous insufficiency.
4,5
 Furthermore, a clinical trial indicated that the use 
of Rusci rhizoma extract may prevent diabetic retinopathy.
6
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Figure 3.2., A: Illustration of Ruscus aculeatus L., B: Ruscus aculeatus plant, C: Ruscus aculeatus twig, D: 
Rusci rhizoma.
7
 
All these effects are mostly ascribed to the steroidal saponins and ruscinogens (Figure 
3.3) being the main constituents of the Rusci rhizoma extract. However, nothing is known 
about the influence on the pharmacological effects of the newly found ruscozepines. Due 
to the limited availability of these substances by isolation a synthetic approach is needed to 
provide enough material for pharmacological testing. 
 
Figure 3.3. Constituents of Rusci rhizoma isolated besides ruscozepine A and B.
2
 
A B 
C D 
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3.2 Synthesis of the ruscozepines and analogous benzoxepines 
The syntheses of the desired benzoxepines follows a known synthetic pathway,
8
 which 
was improved for the ruscozepines. The carbon-carbon double bond of the 2,3-dihydro-
benzo[b]oxepins 1 is generated by a reduction and elimination sequence from the ,-
unsaturated ester of the 3-aryl-benzo[b]oxepin-5(2H)-ones 2. The 7-membered ring is 
closed by Friedel-Crafts acylation of the compounds 3, which are generated by coupling of 
a phenol derivative 4 with an allyl bromide 5. For the synthesis of the benzoxepines 
containing methoxy ether beside a phenol hydroxyl group, it was essential to apply an 
appropriate protection group strategy. 
 
 
Scheme 3.1. Retro synthetic analysis of the 2,3-dihydrobenzo[b]oxepins. 
 
In addition to the two isolated benzoxepines further analogous substances were 
synthesized (Figure 3.4). The planned synthesis of a benzazepine analog was not possible 
with the established synthetic protocol of the benzoxepines. The synthesized compounds 
differ in the substitution pattern of the aromatic rings and the functional groups present in 
the molecule and should help to broaden the knowledge of the pharmacological effects of 
this substance class.  
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Figure 3.4. Synthesized compounds. 
Aim of the study was the synthesis of the novel isolated phenyl-1-benzoxepinols 
ruscozepine A 1a and ruscozepine B 1b to elucidate their pharmacological effects and their 
role in the overall activity of the Rusci rhizoma extract. The synthesis was inevitable due to 
the limited availability of these compounds by isolation. In addition to the isolated 
substances further analogs were synthesized to broaden the knowledge on the 
pharmacological effects of this substance class. 
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3.2.1 Ruscozepine A, B and analogous benzoxepines 
The Syntheses of the isolated ruscozepines A 1a and B 1b and the related benzoxepines 
1c and 1d are shown in Scheme 3.2. The 11 steps proceeded with yields ranging from 
moderate to very good and provided the desired benzoxepines 1a-d in overall yields from 
1.5 % to 3.1 %, which means an average yield of 68 % to 73 % per step. A detailed 
description of the synthetic approach including encountered difficulties is provided in the 
following chapter. 
 
Scheme 3.2. Syntheses of ruscozepine A and B and analogous benzoxepines. 
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3.2.1.1 Synthesis of the 4-bromo-but-2-enoic acid esters 5a and 5c 
In a first attempt benzyl was used as protection group for the aromatic hydroxyl groups 
as it was considered to be stable towards the conditions throughout the whole synthesis. 
Unfortunately, the benzyl group turned out is to be unstable during the allylic bromination. 
This reaction not only brominates in allylic, but also in benzylic position (Scheme 3.3). As 
a similar method is already used for the cleavage of benzyl groups using NBS in CCl4 and 
additional CsCO3 as base,
9,10
 it is not appropriate for the synthesis of the 4-bromo-but-2-
enoic acid esters. 
 
Scheme 3.3. Side reaction of the radical bromination. 
Consequently, benzoyl was chosen as alternative protection group, which is stable for 
the first part of the synthesis. The benzoyl protection of the commercial available 
acetophenones 6a/c proceeded with excellent yields.
11
 The following Reformatsky reaction 
of ethylbromo acetate with the benzoyl protected acetophenone derivatives 7a/c was 
accelerated in an ultrasonic bath and afforded the corresponding alcohols 8a/c in high 
yields (Scheme 3.4).
12
  
 
Scheme 3.4. Reformatsky reaction with commercial available zinc powder accelerated by sonication. 
The Reformatsky reaction, being the classical reaction for the synthesis of -hydroxy 
esters, proceeds via a nucleophilic addition of an organo zinc reagent to a ketone or 
aldehyde. The advantage of the Reformatsky reaction, in contrast to the Grignard 
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approach, is the toleration of esters, which would be attacked by Grignard reagents. In 
typical procedures activated zinc is prepared by reduction of zinc(II) chloride with 
potassium.
13-16
 Using such a procedure,
15
 only a unsatisfactory yield of 43 % was obtained. 
Therefore a simpler and faster procedure, accelerated by ultrasound, was chosen that could 
even be performed with commercially available zinc powder activated with catalytic 
amounts of iodine. 
The alcohols 8a/c were dehydrated with catalytic amounts of p-toluenesulfonic acid by 
continuous azeotropic removal of water in a Dean-Stark-apparatus.
17
 Allylic bromination 
of the compounds 9a/c with N-bromosuccinimide and dibenzoylperoxide as radical starter 
gave the 4-bromo-but-2-enoic acid esters 5a/c in good yields (Scheme 3.5).
18
 
 
Scheme 3.5. Synthesis of ethyl 4-bromobut-2-enoate derivatives. 
 
3.2.1.2 Synthesis of selectively protected phenol derivatives 
The phenol derivatives were protected with benzyl groups, to guarantee the 
regioselective coupling with the allyl bromides 5a/c.
11
 The protection of resorcinol 12 with 
one equivalent of benzyl bromide gave the mono-protected resorcinol 13 in 32 % yield in a 
1:1:1 mixture with the double- und unprotected resorcinol, which could be easily separated 
by flash chromatography (Scheme 3.6). 
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Scheme 3.6. Synthesis of 3-(benzyloxy)phenol. 
The selectively protected phenyl derivative 4b was generated by a two-step procedure 
starting from vanillin 13. The selective benzyl protection of 2-methoxybenzene-1,4-diol 
would not have been possible to our knowledge. First, the hydroxyl group was protected 
with benzyl bromide followed by conversion of the aldehyde 14 to the hydroxyl group by a 
Dakin reaction using boric acid and hydrogen peroxide (Scheme 3.7).
19,20
 
 
Scheme 3.7. Synthesis of 4-(benzyloxy)-3-methoxyphenol. 
 
3.2.1.3 Intramolecular Friedel-Crafts acylation 
For the synthesis of the 4-phenoxy-3-phenylbut-2-enoic acids 10a-d the 4-bromo-but-2-
enoic acid esters 5a/c were coupled with the phenol derivatives 4a/b under standard 
conditions for the nucleophilic substitution. With potassium carbonate as base and 
additional potassium iodide in refluxing acetone, the ethyl 4-phenoxy-3-phenylbut-2-
enoates 3a-d could be obtained in moderate yields from 42 % to 64 % (Scheme 3.8). The 
replacement of the base or the solvent with cesium carbonate or DMF, respectively, did not 
show any improvement of the yields. 
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Scheme 3.8. Nucleophilic substitution of the 4-bromo-but-2-enoic acid esters 5a/c with the phenol 
derivatives 4a/b. 
One possible explanation for these moderate yields might be the debromination of the 
4-bromo-but-2-enoic acid esters 5 by single electron transfer (SET) reduction (Scheme 
3.9).
21
 This theory is supported by the successful isolation of a significant amount of the 
debrominated ,-unsaturated esters 9. The phenyl derivatives 4a/b, being structurally 
related to hydroquinone, might serve as electron donors in this debromination reaction.
22
  
 
Scheme 3.9. Possible mechanism for the debromination of the allyl bromides 5a/c by SET.
21,22
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Saponification of the esters 3a-d was performed with lithium hydroxide in a THF/water 
solvent mixture at 50 °C. Under these conditions both, the ethyl and benzoyl esters were 
cleaved. Afterwards, the phenol hydroxyl group was protected with benzyl bromide and 
potassium carbonate in refluxing acetone. The benzyl ether formation of the hydroxyl 
group was accompanied by the simultaneous formation of the benzyl ester of the acid. 
Hence, this ester has to be cleaved subsequently by saponification. These steps of 
deprotection and protection could have been avoided if the benzyl group could have been 
used from the beginning of the synthesis. The 4-phenoxy-3-phenylbut-2-enoic acids 10a-d 
could be isolated by crystallization from ethyl acetate in 36 % to 50 % yield over three 
steps (Scheme 3.10). 
 
Scheme 3.10. Synthesis of the 4-phenoxy-3-phenylbut-2-enoic acids 10a-d. 
The 7-membered ring of the 3-phenyl-benzo[b]oxepin-5(2H)-ones 2a-d was formed by 
intramolecular Friedel-Crafts acylation of the 4-phenoxy-3-phenylbut-2-enoic acids 10a-d. 
Unfortunately, all attempts to perform this reaction under standard conditions failed. 
Applying polyphosphoric acid (PPA),
23-25
 activation as acid chloride, with thionyl chloride 
(either in excess or stoichiometric with DMAP as catalyst) or oxalyl chloride,
26-28
 followed 
by AlCl3 or the use of Sc(OTf)3 Lewis acid in catalytic amounts,
29-31
 did not yield the 
desired 3-phenyl-benzo[b]oxepin-5(2H)-one 2b (Scheme 3.11). 
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Scheme 3.11. Unsuccessful attempts for the intramolecular Friedel-Crafts acylation. 
All of these procedures involve harsh acidic conditions, either Brønsted or Lewis acids 
are employed or released during the reaction. These strong acids are frequently used for the 
cleavage of ether groups and may lead to the cleavage of one or more of the ether groups in 
4-(4-(benzyloxy)-3-methoxyphenoxy)-3-(4-(benzyloxy)phenyl)but-2-enoic acid 10b.
32,33
 
Consequently, a milder procedure for the Friedel-Crafts acylation invented by Kangani et 
al. was employed, activating the carboxylic acid with cyanuric chloride and pyridine 
(Scheme 3.12).
34
 These reagents avoid the excessive release of HCl in combination with 
AlCl3 and thus serve as mild alternative for the classical procedures.
35,36
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Scheme 3.12. Mild procedure for the Friedel-Crafts acylation invented by Kangani et al. employing cyanuric 
chloride.
34
 
 
Thus, the 3-phenyl-benzo[b]oxepin-5(2H)-ones 2a-d were obtained in 50 to 65 % yield. 
Moreover, no problems concerning the regioselectivity could be observed (Scheme 3.13). 
 
Scheme 3.13. Synthesis of the 3-phenyl-benzo[b]oxepin-5(2H)-ones 2a-d. 
 
  
Synthesis of novel natural products isolated from butchers broom 
 
63 
3.2.1.4 Reduction of the 3-phenyl-benzo[b]oxepin-5(2H)-ones 2a-d yielding the 
desired 3-phenyl-2,3-dihydrobenzo[b]oxepins 1a-d 
The final three steps of the synthesis include the reduction of the carbon-carbon double 
bond of the ,-unsaturated ketone 2a-d and the simultaneous cleavage of the benzyl 
protection groups with hydrogen and palladium on charcoal, the reduction of the ketone 11 
to the alcohol 15 and the subsequent elimination of this hydroxyl group (Scheme 3.14). 
 
Scheme 3.14. Reduction and dehydration sequence yielding the 3-phenyl-2,3-dihydrobenzo[b]oxepins 1a-d. 
 
The reduction of the carbon-carbon double bond and the deprotection of the benzyl 
ethers in one step turned out to be problematic, because the complete reduction of the 
-unsaturated ketones 2a/c occurred as side reaction yielding the 3-phenyl-2,3,4,5-
tetrahydrobenzo[b]oxepins 16a/c (Scheme 3.15). High catalyst loading with 25 wt.-% of 
Pd/C and low hydrogen pressure could reduce this side reaction. The 3,4-dihydro-
benzo[b]oxepin-5(2H)-ones 11a-d could be isolated in 58 to 85 % yield. 
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Scheme 3.15. Transfer hydrogenation of the 3-phenyl-benzo[b]oxepin-5(2H)-ones 2a-d with Pd/C and 
hydrogen. 
The following reduction of the ketone using sodium borohydride gave the 2,3-dihydro-
benzo[b]oxepins 1a-d as final products in about 40 % yield. The alcohols 15a-d 
corresponding to the ketones 11a-d could not be isolated, as the elimination to the desired 
product occurred by basic as well as acidic workup. 
 
Scheme 3.16. Synthesis of the 2,3-dihydrobenzo[b]oxepins 1a-d. 
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3.2.2 Synthesis of 8-methoxy-2,3-dihydrobenzo[b]oxepin-7-ol 
8-Methoxy-2,3-dihydrobenzo[b]oxepin-7-ol 1e was synthesized via an analogous 
synthesis (Scheme 3.17), starting with the coupling of 4-(benzyloxy)-3-methoxyphenol 4b 
with 4-bromo-butanoic acid ethyl ester under standard SN reaction conditions. The closure 
of the 7-membered ring gave only a poor yield of 15 %, even the increase of temperature 
or reaction time couldn´t solve this problem. This poor yield of the ring closure might be 
ascribed to the higher rotational freedom of the 4-(4-(benzyloxy)-3-methoxy-
phenoxy)butanoic acid 18 compared to the 4-phenoxy-3-phenylbut-2-enoic acids 10a-d 
containing an E-configured carbon-carbon double bond. The following steps were 
performed similarly to the synthesis of previous benzoxepines. 
 
 
Scheme 3.17. Synthesis of 8-methoxy-2,3-dihydrobenzo[b]oxepin-7-ol 1e. 
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3.2.3 Nitrogen analog of ruscozepines - benzazepine 
In addition to the benzoxepines the synthetic protocol was applied for the synthesis of a 
benzazepine 26 (Scheme 3.18), a nitrogen analog of the ruscozepines. Therefore the phenol 
derivative for the coupling with the allyl bromide was replaced by the aniline 21. A tosyl 
group was used for the protection of the aniline to avoid the formation of an amide. The 
synthesis proceeded well till the Friedel-Crafts acylation step. The tosyl group was not 
stable towards the reaction conditions and was cleaved, resulting in the formation of the 
5-memebered -lactam 27. Even the use of a milder Lewis acid, i.e. indium(III) chloride 
that is known not to cleave the tosyl protection group,
37
 did not avoid the formation of the 
lactam. For synthesis of the benzazepine a complete change of the synthetic plan would 
have been required exceeding the time frame of the project. 
 
Scheme 3.18. Unsuccessful synthesis of the benzazepine 26. 
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3.3 Pharmacology 
3.3.1 Rhizoma extract of Ruscus aculeatus L. 
Ruscus aculeatus L. is long known for its medical use. In present times the alcoholic 
extract of the Rusci rhizoma is mostly used for the treatment of chronic venous 
insufficiency (CVI) and hemorrhoids. As the anti-inflammatory activity of the extract is 
mostly subscribed to the saponins and ruscogenin,
38
 the aim of this study was to elucidate 
the pharmacological effects of the ruscozepines A and B and if they contribute to the anti-
inflammatory activity of the Rusci rhizoma extract. Therefore, the effect of the 
ruscozepines on the TNF--induced expression of ICAM-1 (intercellular adhesion 
molecule), besides cytotoxicity and antioxidant activity, was investigated. The 
pharmacological testing was done by the working group of Pharmaceutical Biology of 
Prof. Dr. Jörg Heilmann at the University of Regensburg. 
 
3.3.2 MTT viability assay - cytotoxicity 
The cytotoxicity of ruscozepine B was measured with the MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) viability assay with HMEC-1 (human micro-
vascular endothelial cells) that are used for the ICAM-1 expression inhibition assay. 
Ruscozepine B 1b had no effect on the viability of HMEC-1 in the concentration range of 
1-100 µM (Figure 3.5). 
Synthesis of novel natural products isolated from butchers broom 
 
68 
 
Figure 3.5. MTT viability assay after 24 h of ruscozepine B on HMEC #2-4; n=3; mean±SD. 
 
3.3.3 ICAM-1 expression inhibition assay – anti-inflammatory activity 
The ICAM-1 expression inhibition assay was used for the determination of the anti-
inflammatory activity of ruscozepine B 1b. For this assay, a HMEC-1 cell culture is treated 
with TNF- (tumor necrosis factor) to induce ICAM-1 expression via the NF-B (nuclear 
factor kappa-light-chain-enhancer of activated B-cells) signal transduction pathway (Figure 
3.6). The expression of ICAM-1 is a good indicator for the degree of inflammation in the 
endothelial cells and is determined by a fluorescence labeled antibody. An anti-
inflammatory compound leads to a decrease of the TNF- induced ICAM-1 expression, 
indicated by a reduced fluorescence compared with a control. 
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Figure 3.6. Simplified signal transduction pathway of the TNF- induced ICAM-1 expression. 
Ruscozepine B 1b shows no significant inhibition of the ICAM-1 expression in the 
concentrations 1, 50 and 75 µM (Figure 3.7). The inhibition of 23 % at a concentration of 
10 µM is not clear and might either be an outlier or an effect of the concentration or 
solubility. 
 
Figure 3.7. Inhibition of TNF-α induced ICAM-1-expression of ruscozepine B 1b after 24 h; Parthenolide 
(5µM) is used as positive control; HMEC#2-10; n=3 in duplicates; mean±SD. 
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3.3.4 ORAC-Fluorescein assay – antioxidant activity 
Antioxidants, especially phenolic antioxidants, are supposed to exhibit anti-
inflammatory activity by the down regulation of the TNF- expression by blocking the 
LPS (lipopolysaccharide) induced TNF- production and the decrease of ROS (reactive 
oxygen species) in the cell, respectively.
39-41
 Furthermore, a direct radical scavenging 
activity of various phenolics is discussed by a reaction with the ROS. Consequently, the 
antioxidant activity of the synthesized benzoxepines is of great interest and was measured 
with an ORAC-Fluorescein assay (oxygen radical absorbance capacity).
42,43
 Therefore a 
fluorescent probe, containing fluorescein, is treated with an antioxidant to measure the 
decrease of the fluorescein decay (Figure 3.9), induced by addition of AAPH (2,2´-azobis-
(2-methylpropionamide)-dihydrochloride, Figure 3.8). The antioxidant activity is 
referenced to Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, water-
soluble derivative of vitamin E) equivalents, TEAC (trolox equivalent antioxidant 
capacity). 
 
Figure 3.8. Radical generation reaction from AAPH; the water-soluble vitamin E derivative trolox. 
 
Figure 3.9. Fluorescence curves of compounds 1a-e, 16a and Trolox (concentration 5 µM, each) for the 
ORAC-assay. 
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Both isolated compounds, ruscozepine A 1a and ruscozepine B 1b, showed a high 
antioxidant activity of 3.7±0.2 and 4.2±0.3 TEAC (concentration range 1-5 µM), 
respectively (Table 3.1). These TEAC values are comparable with strong antioxidants like 
ferulic acid (4.5±0.2 TEAC, concentration range 0.4-1.3 µM) and p-coumaric acid (4.5±0.2 
TEAC, concentration range 0.4-1.0 µM).
42
 The analogous 2,3-dihydrobenzo[b]oxepins 
1c/d have also shown a good antioxidant activity, but the additional methoxy substitution 
of the second aromatic ring seems to decrease the activity. The big influence of the second 
aromatic ring becomes clear looking at the TEAC value of compound 1e, where this 
second aromatic ring is not present. The TEAC value is lowered by 1.8 Trolox units 
compared to ruscozepine 1b. Surprisingly, the compounds 16a/c, having no carbon-carbon 
double bond that was expected to increase the TEAC value by being involved in the radical 
capture mechanism, show a 0.8/1.2 higher TEAC value compared with 1a/c. Consequently, 
the antioxidant activity of the ruscozepines is mostly caused by the phenolic rings and 
influenced by the different substitution patterns.  
 
Table 3.1. TEAC values of the compounds 1a-e and 16a in the concentration range of 1-5 µM. 
compound TEAC ± SD 
1a 
 
3.7 ± 0.2 
1b 
 
4.2 ±0.3 
1c 
 
3.2 ± 0.1 
1d 
 
3.2 ± 0.2 
1e 
 
2.4 ± 0.2 
16a 
 
4.5 ± 0.2 
16c 
 
4.4 ± 0.3 
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3.4 Conclusion 
We developed the racemic synthesis of novel phenyl-1-benzoxepinols ruscozepine A 1a 
and ruscozepine B 1b, analogous benzoxepines 1c-e and the 3-phenyl-2,3,4,5-tetrahydro-
benzo[b]oxepins 16a/c. For the crucial step, the formation of the 7-membered ring by 
Friedel-Crafts acylation, a mild procedure using cyanuric chloride for the activation of the 
carboxylic acid had to be applied, while standard methods for the Friedel-Crafts acylation 
failed, because of the harsh acidic conditions. Unfortunately, the synthetic protocol could 
not be applied for the synthesis of an analogous benzazepine. 
Pharmacological testing of ruscozepine B 1b did not show an effect on the TNF- 
induced expression of ICAM-1 on human microvascular endothelial cells (HMEC-1). 
Moreover, no cytotoxicity on the HMEC-1 could be detected in a MTT viability assay. 
However, the ORAC-Fluorescein assay revealed a high antioxidant activity for the 
compounds 1a-d and 16a/c that could influence the anti-inflammatory activity via a 
decreasing level of ROS in the cell, which play an important role in cell signaling, 
including inflammation. 
Consequently, the anti-inflammatory effect of the Rusci rhizoma extract might at least 
partly be ascribed to the novel found phenyl-1-benzoxepinols. The overall activity might 
be a cooperative effect of the Rusci rhizoma constituents, as the amount of the 
ruscozepines in the Rusci rhizoma extract is very low these compounds will only 
contribute a minor part of the pharmacological activity. Further investigations are needed 
to provide clear evidence for the exact pharmacological effects of these compounds. 
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3.5 Experimental 
3.5.1 Preparation of compounds 
General: Commercial reagents and starting materials were purchased from Acros 
Organics, Alpha-Aesar, Eurorad, Fluka, Merck or Sigma-Aldrich and used without further 
purification. 1,4-Dioxane was dried with sodium and stored over 4 Å molecular sieves 
according to common procedures.
44
 Acetone, dichloromethane, dichloroethane and 
dimethylformamide were dried by storage over molecular sieves for at least 24 hours. Zinc 
dust was activated according to reports of Cava et al..
45
 Flash column chromatography was 
performed on Merck silica gel (Si 60 40-63 μm) either manually or on a Biotage® 
 solera™ flash purification system. T C was performed on aluminum plates coated with 
Merck silica gel (60 F254, thickness 0.2 mm), compounds were detected by UV-light ( = 
254 nm) and staining with common vanillin or ninhydrin staining-solutions. Melting points 
were measured on a SRS melting point apparatus (MPA100 Opti Melt) and are 
uncorrected. NMR spectra were recorded on Bruker Avance 300 (
1
H 300.13 MHz, 
13
C 
75.47 MHz, T = 300 K), Bruker Avance 400 (
1
H 400.13 MHz, 
13
C 100.61 MHz, T = 300 
K), Bruker Avance 600 (
1
H 600.13 MHz, 
13
C 150.92 MHz, T = 300 K) and Bruker Avance 
III 600 Kryo (
1
H 600.25 MHz, 
13
C 150.95 MHz, T = 300 K) instruments. Chemical shifts 
are reported in  [ppm] relative to external standards and coupling constants J are given in 
Hz. Abbreviations for the multiplet signals: s = singlet, d = doublet, t = triplet, q = quartet, 
, qunit = quintet, m = multiplet, bs = broad singlet, dd = double doublet, dt = doublet of 
triplets. The relative number of protons was determined by integration. Error of reported 
values: chemical shift 0.01 ppm (
1
H NMR) and 0.1 ppm (
13
C NMR), coupling constant 0.1 
Hz. The solvents used for the measurements are reported for each spectrum. IR spectra 
were recorded with a Bio-Rad FT-IR-FTS 155 spectrometer and UV/Vis spectra with a 
Cary BIO 50 UV/Vis/NIR spectrometer (Varian). Mass spectra were recorded on Finnigan 
MAT95 (EI-MS), Agilent Q-TOF 6540 UHD (ESI-MS, APCI-MS), Finnigan MAT SSQ 
710 A (EI-MS, CI-MS) or ThermoQuest Finnigan TSQ 7000 (ES-MS, APCI-MS) 
spectrometer. 
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4-Acetylphenyl benzoate (7a) 
NEt3 (3.8 mL, 28 mmol) was added to a solution of p-hydroxyacetophenone 6a (3.40 g, 
25.0 mmol) in THF (200 mL). The stirring solution was cooled with an ice-water bath 
while benzoyl chloride (3.1 mL, 27 mmol) was added via syringe over 30 minutes. After 2 
hours the cooling bath was removed and the solution stirred at room temperature for 
additional 2 hours. The reaction solution was evaporated and the residue dissolved in 
dichloromethane (150 mL). The organic layer was washed with 1 N HCl (50 mL), saturated 
sodium chloride solution (50 mL) and water (50 mL). Afterwards the organic layer was 
dried with MgSO4 before the solvent was removed under reduced pressure. The product, 4-
acetylphenyl benzoate 7a, was obtained as pale white solid in 96 % yield (5.80 g, 24.1 
mmol). 
1
H NMR (300 MHz, CDCl3):  = 8.21 (dt, J = 8.5, 1.6 Hz, 2H), 8.09 – 8.03 (m, 
2H), 7.70 – 7.63 (m, 1H), 7.58 – 7.49 (m, 2H), 7.37 – 7.30 (m, 2H), 2.63 (s, 3H) ppm. 
13
C NMR (75 MHz, CDCl3): δ = 197.0, 154.7, 134.8, 134.0, 130.3, 130.0, 129.1, 128.7, 
122.0, 26.7 ppm. EI-MS: m/z (%) = 77.1 (69), 105.0 (100), 240.1 (11) [M]
+•
. HR-MS: 
calcd. for C15H12O3 [M]
+•
 240.0786; found 240.0792. (Ref. 
46
) 
 
4-Acetyl-2-methoxyphenyl benzoate (7c) 
NEt3 (14.7 mL, 105 mmol) was added to a solution of acetovanillone 6c (16.6 g, 100 
mmol) in THF (700 mL). The stirring solution was cooled with an ice-water bath while 
benzoyl chloride (12.1 mL, 105 mmol) was added via syringe over 30 minutes. After 2 
hours the cooling bath was removed and the solution stirred at room temperature for 
additional 2 hours. The reaction solution was evaporated and the residue dissolved in 
dichloromethane (500 mL). The organic layer was washed with 1 N HCl (100 mL), 
saturated sodium chloride solution (150 mL) and water (150 mL). Afterwards the organic 
layer was dried with MgSO4 before the solvent was removed under reduced pressure. 4-
Acetyl-2-methoxyphenyl benzoate 7c was obtained as pale white solid in 99 % yield (27.3 
g, 99 mmol). 
1
H NMR (300 MHz, CDCl3):  = 8.22 (dt, J = 8.5, 1.7 Hz, 2H), 7.69 – 7.58 
(m, 3H), 7.57 – 7.48 (m, 2H), 7.25 (d, J = 8.1 Hz, 1H), 3.88 (s, 3H), 2.63 (s, 3H) ppm. 13C 
NMR (75 MHz, CDCl3):  = 197.0, 164.3, 151.7, 144.1, 136.0, 133.8, 130.4, 129.0, 128.6, 
123.0, 122.0, 111.5, 56.1, 26.6 ppm. (Ref. 
47,48
)  
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4-(4-Ethoxy-2-hydroxy-4-oxobutan-2-yl)phenyl benzoate (8a) 
The reaction was performed under inert nitrogen atmosphere using standard Schlenk 
techniques. 4-Acetylphenyl benzoate 7a (5.13 g, 21.4 mmol) and ethylbromoacetate (2.8 
mL, 26 mmol) were dissolved in dry dioxane (45 mL) and zinc dust (2.52 g, 38.5 mmol) 
was added. Stirring of the solution was stopped before iodine (0.28 g, 1.1 mmol) was 
added. The reaction solution was then sonicated for 3 hours. Afterwards the reaction 
mixture was cooled with an ice-water bath and quenched adding 1 N HCl (50 mL). To 
remove remaining iodine from the organic layer, potassium iodide (0.4 g) was added. The 
aqueous layer was extracted with dichloromethane (3×100 mL). The combined organic 
layers were dried with MgSO4 and the solvent was removed under reduced pressure. The 
crude product was purified by flash chromatography (PE/EtOAc 4:1, Rf 0.22). 4-(4-
Ethoxy-2-hydroxy-4-oxobutan-2-yl)phenyl benzoate 8a was obtained as white crystalline 
needles in 98 % yield (6.88 g, 20.9 mmol). Mp 72 – 76 °C. 1H NMR (300 MHz, CDCl3):  
= 8.26 – 8.15 (m, 2H), 7.69 – 7.59 (m, 1H), 7.58 – 7.46 (m, 4H), 7.23 – 7.15 (m, 2H), 4.47 
(s, 1H), 4.09 (q, J = 7.1 Hz, 2H), 2.98 (d, J = 15.9 Hz, 1H), 2.80 (d, J = 15.9 Hz, 1H), 1.56 
(s, 3H), 1.17 (t, J = 7.1 Hz, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 172.7, 165.2, 149.8, 
144.5, 133.7, 133.6, 130.2, 129.6, 128.6, 125.8, 121.4, 72.6, 60.9, 46.4, 30.7, 14.0 ppm. 
FT-IR:  (cm-1) = 707, 1024, 1062, 1171, 1205, 1244, 1267, 1708, 1731, 2903, 2959, 2984, 
3071, 3543. ESI-MS: m/z (%) = 311.0 (18), 329.0 (36) [M+H]
+
, 346.1 (100) [M+NH4]
+
, 
370.1 (92) [M+H+MeCN]
+
, 388.1 (32). HR-MS: calcd. for C19H20NaO5 [M+Na]
+
 
351.1203; found 351.1205.  
 
4-(4-Ethoxy-2-hydroxy-4-oxobutan-2-yl)-2-methoxyphenyl benzoate (8c) 
The reaction was performed under inert nitrogen atmosphere using standard Schlenk 
techniques. 4-Acetyl-2-methoxyphenyl benzoate 7c (27.3 g, 100 mmol) and 
ethylbromoacetate (13.3 mL, 120 mmol) were dissolved in dry dioxane (250 mL) and zinc 
dust (11.8 g, 180 mmol) was added. Stirring of the solution was stopped before iodine 
(1.27 g, 5.00 mmol) was added. The reaction solution was then sonicated for 20 hours. 
Afterwards the reaction mixture was cooled with an ice-water bath and quenched adding 
1 N HCl (300 mL). To remove remaining iodine from the organic layer, potassium iodide 
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(1.5 g) was added. The aqueous layer was extracted with dichloromethane (3×250 mL). 
The combined organic layers were dried with MgSO4 and the solvent was removed under 
reduced pressure. 4-(4-Ethoxy-2-hydroxy-4-oxobutan-2-yl)-2-methoxyphenyl benzoate 8c 
was obtained as yellowish white solid in 98 % yield (35.2 g, 98.0 mmol). The crude 
product was used without further purification. Mp 95 – 101 °C. 1H NMR (300 MHz, 
CDCl3):  = 8.24 – 8.17 (m, 2H), 7.67 – 7.59 (m, 1H), 7.55 – 7.45 (m, 2H), 7.24 (d, J = 2.1 
Hz, 1H), 7.10 (d, J = 8.3 Hz, 1H), 6.96 (dd, J = 8.3, 2.1 Hz, 1H), 4.53 (s, 1H), 4.11 (q, J = 
7.1 Hz, 2H), 3.84 (s, 3H), 2.99 (d, J = 15.9 Hz, 1H), 2.80 (d, J = 15.9 Hz, 1H), 1.56 (s, 
3H), 1.19 (t, J = 7.1 Hz, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 172.8, 164.8, 151.1, 
146.1, 138.7, 133.5, 130.3, 129.5, 128.5, 122.5, 116.7, 109.4, 72.8, 60.9, 56.0, 46.3, 30.8, 
14.1 ppm. FT-IR:  (cm-1) = 708, 1022, 1065, 1172, 1268, 1714, 2968, 2986, 3080, 3508. 
ESI-MS: m/z (%) = 341.1 (35) [M+H-H2O]
+
, 376.2 (100) [M+NH4]
+
. HR-MS: calcd. for 
C20H26NO6 [M+NH4]
+
 376.1755; found 376.1752. 
 
4-(4-Ethoxy-4-oxobut-2-en-2-yl)phenyl benzoate (9a) 
4-(4-Ethoxy-2-hydroxy-4-oxobutan-2-yl)phenyl benzoate 8a (6.9 g, 21 mmol), toluene 
(40 mL) and p-toluenesulfonic acid (0.20 g, 1.1 mmol) were placed in a Dean-Stark 
apparatus and heated to reflux for 4 hours. The solvent was removed under reduced 
pressure and the crude product purified by flash chromatography (PE/EtOAc 4:1 Rf 0.4). 4-
(4-Ethoxy-4-oxobut-2-en-2-yl)phenyl benzoate 9a was obtained as white crystals in 84 % 
yield (5.46 g, 17.6 mmol). Mp 77 – 80 °C. 1H NMR (300 MHz, CDCl3):  = 8.27 – 8.15 
(m, 2H), 7.69 – 7.61 (m, 1H), 7.60 – 7.47 (m, 4H), 7.24 (dt, J = 9.5, 2.6 Hz, 2H), 6.15 (q, J 
= 1.2 Hz, 1H), 4.23 (q, J = 7.1 Hz, 2H), 2.59 (d, J = 1.3 Hz, 3H), 1.33 (t, J = 7.1 Hz, 3H) 
ppm. 
13
C NMR (75 MHz, CDCl3):  = 166.8, 165.0, 154.5, 151.5, 139.9, 133.8, 130.2, 
129.3, 128.6, 127.6, 121.8, 117.4, 59.9, 18.0, 14.4 ppm. FT-IR:  (cm-1) = 717, 1164, 1211, 
1252, 1703, 1726, 2903, 2961, 2989, 3073. ESI-MS: m/z (%) = 328.0 (100) [M+NH4]
+
, 
356.1 (40), 369.1 (33) [M+NH4+MeCN]
+
, 638.2 (70) [2M+NH4]
+
. HR-MS: calcd. for 
C19H18O4 [M+H]
+
 311.1278; found 311.1280. 
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4-(4-Ethoxy-4-oxobut-2-en-2-yl)-2-methoxyphenyl benzoate (9c) 
4-(4-Ethoxy-2-hydroxy-4-oxobutan-2-yl)-2-methoxyphenyl benzoate 8c (34.8 g, 97.2 
mmol), toluene (200 mL) and p-toluenesulfonic acid (0.95 g, 5.0 mmol) were placed in a 
Dean-Stark apparatus and heated to reflux for 4 hours. The solvent was removed under 
reduced pressure and the crude product purified by flash chromatography (PE/EtOAc 4:1, 
Rf 0.3). 4-(4-Ethoxy-4-oxobut-2-en-2-yl)-2-methoxyphenyl benzoate 9c was obtained as 
pale white solid in 78 % yield (26.4 g, 77.6 mmol). Mp 88 – 91 °C. 1H NMR (300 MHz, 
CDCl3):  = 8.29 – 8.15 (m, 2H), 7.71 – 7.60 (m, 1H), 7.57 – 7.45 (m, 2H), 7.19 – 7.07 (m, 
3H), 6.14 (q, J = 1.2 Hz, 1H), 4.23 (q, J = 7.1 Hz, 2H), 3.85 (s, 3H), 2.59 (d, J = 1.3 Hz, 
3H), 1.33 (t, J = 7.1 Hz, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 166.8, 164.7, 154.9, 
151.2, 141.3, 140.6, 133.6, 130.4, 129.2, 128.6, 122.9, 119.0, 117.4, 110.6, 60.0, 56.0, 
18.2, 14.4 ppm. FT-IR:  (cm-1) = 707, 1155, 1235, 1262, 1709, 1741, 2980, 3061. EI-MS: 
m/z (%) = 77.1 (26) [C6H5]
+•
, 84.0 (35), 105.1 (100) [PhCO]
+
, 340.3 (9) [M]
+•
. HR-MS: 
calcd. for C20H20O5 [M]
+•
 340.1311; found 340.1312. 
 
4-(1-Bromo-4-ethoxy-4-oxobut-2-en-2-yl)phenyl benzoate (5a) 
The reaction was performed under inert nitrogen atmosphere using standard Schlenk 
techniques. Dibenzoyl peroxide was dried on vacuum for 2 hours prior to use. 4-(4-
Ethoxy-4-oxobut-2-en-2-yl)phenyl benzoate 9a (3.81 g, 12.3 mmol) was dissolved in dry 
tetrachloromethane (40 mL). This solution was degassed using the freeze-pump-thaw 
technique before NBS (2.58 g, 14.5 mmol) was added. The reaction mixture was then 
heated to reflux and when refluxing started the radical starter dibenzoyl peroxide (0.13 g, 
0.53 mmol) was added. Heating was continued for 24 hours. After the reaction mixture has 
cooled down to room temperature, the succinimide was filtered off. The solvent was 
removed under reduced pressure and the crude product purified by flash chromatography 
(PE/EtOAc 4:1, Rf 0.34). 4-(1-Bromo-4-ethoxy-4-oxobut-2-en-2-yl)phenyl benzoate 5a 
was obtained as white solid in 80 % yield (3.81 g, 9.82 mmol). Mp 90 – 95 °C. 1H NMR 
(300 MHz, CDCl3):  = 8.25 – 8.16 (m, 2H), 7.70 – 7.59 (m, 3H), 7.58 – 7.48 (m, 2H), 
7.33 – 7.23 (m, 2H), 6.23 (s, 1H), 4.98 (s, 2H), 4.27 (q, J = 7.2 Hz, 2H), 1.35 (t, J = 7.1 Hz, 
3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 165.5, 164.9, 152.3, 152.1, 136.1, 133.8, 130.3, 
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129.2, 128.7, 127.9, 122.2, 120.0, 60.6, 26.4, 14.2 ppm. FT-IR:  (cm-1) = 540, 709, 1166, 
1269, 1715, 2902, 2939, 2978, 3072. EI-MS: m/z (%) = 77.1 (22) [C6H5]
+•
, 84.0 (35), 
105.1 (100) [PhCO]
+
, 388.1 (2) [M]
+•
. HR-MS: calcd. for C19H17BrO4 [M]
+•
 388.0310; 
found 388.0315. 
 
4-(1-Bromo-4-ethoxy-4-oxobut-2-en-2-yl)-2-methoxyphenyl benzoate (5c) 
The reaction was performed under inert nitrogen atmosphere using standard Schlenk 
techniques. Dibenzoyl peroxide was dried on vacuum for 2 hours prior to use. 4-(4-
Ethoxy-4-oxobut-2-en-2-yl)-2-methoxyphenyl benzoate 9c (24.0 g, 70.5 mmol) was 
dissolved in dry tetrachloromethane (250 mL). This solution was degassed using the 
freeze-pump-thaw technique before NBS (13.9 g, 78.3 mmol) was added. The reaction 
mixture was then heated to reflux and when refluxing started the radical starter dibenzoyl 
peroxide (0.59 g, 2.5 mmol) was added. Heating was continued for 48 hours. After the 
reaction mixture has cooled down to room temperature, the succinimide was filtered off. 
The solvent was removed under reduced pressure and the crude product purified by flash 
chromatography (PE/EtOAc 4:1, Rf 0.32). 4-(1-Bromo-4-ethoxy-4-oxobut-2-en-2-yl)-2-
methoxyphenyl benzoate 5c was obtained as pale white solid in 82 % yield (24.2g, 61.5 
mmol). Mp 84 – 93 °C. 1H NMR (400 MHz, CDCl3):  = 8.24 – 8.15 (m, 2H), 7.70 – 7.59 
(m, 1H), 7.57 – 7.45 (m,2H), 7.19 (s, 3H), 6.21 (s, 1H), 4.96 (s, 2H), 4.28 (q, 7.1 Hz, 2H), 
3.86 (s, 3H), 1.35 (t, 7.1 Hz, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 165.5, 164.6, 
152.7, 151.5, 141.2, 137.6, 133.7, 130.4, 129.1, 128.6, 123.2, 120.1, 119.3, 110.9, 60.7, 
56.1, 26.7, 14.3 ppm. FT-IR:  (cm-1) = 669, 708, 1162, 1247, 1710, 1742, 2981, 3074. EI-
MS: m/z (%) = 77.1 (13) [C6H5]
+•
, 105.1 (100) [PhCO]
+
, 418.2 (4) [M]
+•
. HR-MS: calcd. 
for C20H19BrO5 [M]
+•
 418.0416; found 418.0418. 
 
3-(Benzyloxy)phenol (4a) 
Benzylbromide (120 mmol, 14.2 mL) was added over 15 minutes to a slurry of 
resorcinol (10.0 mmol, 1.10 g) and K2CO3 (20.0 mmol, 2.76 g) in acetone (18 mL). The 
slurry was heated to 60 °C for 4 hours. After completion of the reaction potassium 
carbonate was filtered off and washed with EtOAc. The organic layer was washed with 
HCl (1 N, 2×10 mL) and brine (10 mL). Afterward the organic layer was dried with 
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anhydrous MgSO4 before the solvent was removed under reduced pressure with a rotary 
evaporator. The crude product was purified by flash chromatography (PE/EtOAc 4:1, Rf = 
0.26). 3-(Benzyloxy)phenol 4a was isolated as pale white solid in 32 % yield (7.68 g, 38.4 
mmol). 
1
H NMR (400 MHz, CDCl3):  = 7.46 – 7.29 (m, 5H), 7.14 (t, J = 8.2 Hz, 1H), 
6.57 (dd, J = 8.3, 2.1 Hz, 1H), 6.49 (t, J = 2.3 Hz, 1H), 6.44 (dd, J = 7.9, 2.1 Hz, 1H), 5.04 
(s, 2H) ppm. ESI-MS: m/z (%) = 91.1 (100), 200.1 (27.4) [M
+∙
]. (Ref. 
49
) 
 
4-(Benzyloxy)-3-methoxybenzaldehyde (14) 
Vanillin 13 (3.8 g, 25 mmol) was dissolved in acetone (45 mL) and potassium carbonate 
(6.9 g, 50 mmol) and benzyl bromide (4.45 mL, 37.5 mmol) were added. This slurry was 
heated to 60 °C for 2 hours. Potassium carbonate was filtered off and washed with EtOAc 
(100 mL). The organic phase was washed with 1 N HCl (50 mL), brine (40 mL) and dried 
with MgSO4. The solvent was removed under reduced pressure. 4-(Benzyloxy)-3-
methoxybenzaldehyde 14 was obtained in 92 % yield. 
1
H NMR (300 MHz, CDCl3):  = 
9.84 (s, 1H), 7.51 – 7.28 (m, 9H), 6.99 (d, J = 8.2 Hz, 1H), 5.25 (s, 2H), 4.50 (s, 1H), 3.95 
(s, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 191.0, 153.6, 150.1, 136.0, 128.8, 128.2, 
127.2, 126.6, 112.4, 109.3, 70.9, 56.1, 33.6 ppm. ESI-MS: m/z (%) = 91.0 (100), 242.1 
(38) [M]
+•
. (Ref. 
50
) 
 
4-(Benzyloxy)-3-methoxyphenol (4b) 
A solution of 4-(benzyloxy)-3-methoxybenzaldehyde 14 in THF (20 mL) was added to 
the slurry of boric acid (7.02 g, 114 mmol), 30 % aqueous H2O2 (7.5 mL, ), H2SO4 (3.2 
mL) and THF (65 mL). This slurry was stirred for 5 hours at room temperature. The 
mixture was neutralized with sat. NaHCO3 solution (150 mL) and extracted with EtOAc 
(3×80 mL). The combined organic phases were dried with MgSO4 and the solvent removed 
under reduced pressure. The crude product was purified by flash chromatography 
(PE/EtOAc 3:1). 4-(Benzyloxy)-3-methoxyphenol 4b was obtained as brownish solid in 59 
% yield. 
1
H NMR (300 MHz, CDCl3):  = 7.45 – 7.28 (m, 6H), 6.73 (d, J = 8.6 Hz, 1H), 
6.47 (d, J = 2.8 Hz, 1H), 6.26 (dd, J = 8.6, 2.8 Hz, 1H), 5.06 (s, 2H), 4.67 (d, J = 1.6 Hz, 
1H), 3.84 (s, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 150.7, 142.2, 137.5, 128.5, 127.8, 
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127.5, 127.0, 116.2, 105.9, 100.8, 72.3, 55.9 ppm. ESI-MS: m/z (%) = 91.1 (100), 139.1 
(91), 230.1 (46) [M]
+•
. HR-MS: calcd. for C14H14O3 [M]
+
 230.0943; found 230.0945. (Ref. 
50
) 
 
4-(1-(3-(Benzyloxy)phenoxy)-4-ethoxy-4-oxobut-2-en-2-yl)phenyl benzoate (3a) 
3-(Benzyloxy)phenol 4a (4.0 g, 20 mmol) and 4-(1-bromo-4-ethoxy-4-oxobut-2-en-2-
yl)phenyl benzoate 5a (7.8 g, 20 mmol) were dissolved in dry acetone (90 mL) before 
K2CO3 (13.8 g, 100 mmol) and KI (0.16 g, 0.10 mmol) were added. The stirring reaction 
mixture was heated to 60 °C for 8 hours. Subsequently, H2O (75 mL) was added and 
extracted with Et2O (3×100 mL). The combined organic phases were washed with brine 
(25 mL) and dried with MgSO4. The solvent was removed under reduced pressure. The 
crude product was purified by flash chromatography on Biotage®  solera™ flash 
purification system (PE/EtOAc 4:1, Rf 0.36). 4-(1-(3-(Benzyloxy)phenoxy)-4-ethoxy-4-
oxobut-2-en-2-yl)phenyl benzoate 3a was obtained as slight yellow viscose oil in 64 % 
yield (6.52 g, 12.8 mmol). 
1
H NMR (300 MHz, CDCl3):  = 8.26 – 8.16 (m, 2H), 7.70 – 
7.61 (m, 1H), 7.60 – 7.49 (m, 4H), 7.47 – 7.31 (m, 5H), 7.26 – 7.21 (m, 2H), 7.20 – 7.12 
(m, 1H), 6.62 – 6.53 (m, 3H), 6.27 (s, 1H), 5.57 (d, J = 0.4 Hz, 2H), 5.02 (s, 2H), 4.25 (q, J 
= 7.1 Hz, 2H), 1.32 (t, J = 7.1 Hz, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 165.8, 165.0, 
160.0, 159.6, 152.8, 151.7, 137.0, 136.0, 133.8, 130.2, 129.9, 129.3, 128.7, 128.6, 127.9, 
127.5, 121.7, 120.5, 107.8, 107.4, 102.1, 70.0, 64.1, 60.6, 14.3 ppm. FT-IR:  (cm-1) = 695, 
1025, 1169, 1266, 1590, 1695, 1726, 2933, 2985, 3036, 3063. ESI-MS: m/z (%) = 282.3 
(100), 509.2 (93) [M+H]
+
, 526.2 (69) [M+NH4]
+
, 531.2 (84) [M+Na]
+
. HR-MS: calcd. for 
C32H29O6 [M+H]
+
 509.1959; found 509.1962. 
 
 
4-(1-(4-(Benzyloxy)-3-methoxyphenoxy)-4-ethoxy-4-oxobut-2-en-2-yl)phenyl benzoate (3b) 
4-(Benzyloxy)-3-methoxyphenol 4b (1.15 g, 5.0 mmol) and 4-(1-bromo-4-ethoxy-4-
oxobut-2-en-2-yl)phenyl benzoate 5a (1.94 g, 5.0 mmol) were dissolved in dry acetone (20 
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mL) before K2CO3 (3.46 g, 25.0 mmol) and KI (0.08 g, 0.5 mmol) were added. The stirring 
reaction mixture was heated to 60 °C for 5 hours. Subsequently, H2O (15 mL) was added 
and extracted with EtOAc (3×15 mL). The combined organic phases were washed with 
brine (10 mL) and dried with MgSO4. The solvent was removed under reduced pressure. 
The crude product was purified by flash chromatography (PE/EtOAc 4:1, Rf 0.2). 4-(1-(4-
(Benzyloxy)-3-methoxyphenoxy)-4-ethoxy-4-oxobut-2-en-2-yl)phenyl benzoate 3b was 
obtained as gum-like oil in 52 % yield (1.73 g, 2.60 mmol). 
1
H NMR (600 MHz, CDCl3):  
= 8.21 (dd, J = 8.3, 1.2 Hz, 2H), 7.67 – 7.63 (m, 1H), 7.58 – 7.55 (m, 2H), 7.52 (t, J = 7.8 
Hz, 2H), 7.42 (d, J = 7.5 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 7.29 (t, J = 7.3 Hz, 1H), 7.25 – 
7.22 (m, 2H), 6.77 (dd, J = 8.8, 2.6 Hz, 1H), 6.49 (d, J = 2.8 Hz, 1H), 6.40 (dd, J = 8.8, 2.8 
Hz, 1H), 6.26 (s, 1H), 5.53 (s, 2H), 5.07 (s, 2H), 4.23 (q, J = 7.1 Hz, 2H), 3.81 (s, 3H), 
1.32 (t, J = 7.1 Hz, 3H) ppm. 
13
C NMR (151 MHz, CDCl3):  = 165.8, 164.9, 153.5, 152.9, 
151.7, 150.7, 142.7, 137.5, 136.0, 133.7, 130.2, 129.3, 128.6, 128.5, 128.4, 127.7, 127.4, 
121.7, 120.4, 115.5, 104.7, 101.4, 72.0, 64.4, 60.5, 55.9, 14.2 ppm. FT-IR:  (cm-1) = 794, 
1023, 1157, 1506, 1708, 1735, 2937, 2979, 3066. ESI-MS: m/z (%) = 539.1 (100) [M+H]
+
, 
556.1 (74) [M+NH4]
+
. HR-MS: calcd. for C33H31O7 [M+H]
+
 539.2064; found 539.2063. 
 
 
4-(1-(3-(Benzyloxy)phenoxy)-4-ethoxy-4-oxobut-2-en-2-yl)-2-methoxyphenyl benzoate (3c) 
3-(Benzyloxy)phenol 4a (1.53 g, 7.65 mmol) and 4-(1-bromo-4-ethoxy-4-oxobut-2-en-
2-yl)-2-methoxyphenyl benzoate 5c (3.2 g, 7.7 mmol) were dissolved in dry acetone (50 
mL) before K2CO3 (5.3 g, 39 mmol) and KI (0.12 g, 0.77 mmol) were added. The stirring 
reaction mixture was heated to 60 °C for 8 hours. Subsequently, H2O (50 mL) was added 
and extracted with Et2O (3×100 mL). The combined organic phases were washed with 
brine (25 mL) and dried with MgSO4. The solvent was removed under reduced pressure. 
The crude product was purified by flash chromatography on Biotage®  solera™ flash 
purification system (PE/EtOAc 4:1, Rf 0.3). 4-(1-(3-(Benzyloxy)phenoxy)-4-ethoxy-4-
oxobut-2-en-2-yl)-2-methoxyphenyl benzoate 3c was obtained in 58 % yield (2.40 g, 4.46 
mmol). 
1
H NMR (300 MHz, CDCl3):  = 8.26 – 8.18 (m, 2H), 7.68 – 7.60 (m, 1H), 7.56 – 
7.48 (m, 2H), 7.46 – 7.31 (m, 5H), 7.18 – 7.09 (m, 4H), 6.62 – 6.54 (m, 3H), 6.27 (s, 1H), 
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5.55 (s, 2H), 5.02 (s, 2H), 4.25 (q, J = 7.1 Hz, 2H), 3.79 (s, J = 8.2 Hz, 3H), 1.32 (dd, J = 
9.2, 5.1 Hz, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 165.8, 164.6, 160.0, 159.6, 153.0, 
151.1, 140.8, 137.4, 137.0, 133.6, 130.4, 129.9, 129.2, 128.6, 128.0, 127.6, 122.9, 120.7, 
120.0, 111.5, 107.8, 107.3, 102.1, 70.0, 64.3, 60.7, 56.0, 14.3 ppm. FT-IR:  (cm-1) = 706, 
1022, 1146, 1251, 1590, 1708, 1741, 2873, 2937, 2980, 3031, 3062. ESI-MS: m/z (%) = 
282.3 (50), 539.2 (100) [M+H]
+
, 556.2 (90) [M+NH4]
+
, 561.2 (100) [M+Na]
+
. HR-MS: 
calcd. for C33H31O7 [M+H]
+
 539.2064; found 539.2068. 
 
4-(1-(3-(Benzyloxy)-4-methoxyphenoxy)-4-ethoxy-4-oxobut-2-en-
2-yl)-2-methoxyphenyl benzoate (3d) 
4-(Benzyloxy)-3-methoxyphenol 4b (4.60 g, 20.0 mmol) and 4-(1-bromo-4-ethoxy-4-
oxobut-2-en-2-yl)-2-methoxyphenyl benzoate 5c (8.36 g, 20.0 mmol) were dissolved in 
dry acetone (100 mL) before K2CO3 (13.1 g, 100 mmol) and KI (0.32 g, 2.0 mmol) were 
added. The stirring reaction mixture was heated to 60 °C for 18 hours. Subsequently, H2O 
(50 mL) was added and extracted with EtOAc (3×100 mL). The combined organic phases 
were washed with brine (50 mL) and dried with MgSO4. The solvent was removed under 
reduced pressure. The crude product was purified by flash chromatography on a Biotage® 
 solera™ flash purification system (PE/EtOAc 4:1, Rf 0.22). 4-(1-(3-(Benzyloxy)-4-
methoxyphenoxy)-4-ethoxy-4-oxobut-2-en-2-yl)-2-methoxyphenyl benzoate 3d was 
obtained as yellow oil in 42 % yield (4.69 g, 8.46 mmol). 
1
H NMR (300 MHz, CDCl3):  = 
8.26 – 8.18 (m, 2H), 7.69 – 7.60 (m, 1H), 7.56 – 7.47 (m, 2H), 7.46 – 7.40 (m, 2H), 7.39 – 
7.32 (m, 2H), 7.32 – 7.28 (m, 1H), 7.16 – 7.10 (m, 3H), 6.78 (d, J = 8.7 Hz, 1H), 6.51 (d, J 
= 2.8 Hz, 1H), 6.41 (dd, J = 8.7, 2.8 Hz, 1H), 6.26 (s, 1H), 5.51 (s, 2H), 5.07 (s, 2H), 4.24 
(q, J = 7.1 Hz, 2H), 3.82 (s, 3H), 3.79 (s, 3H), 1.32 (t, J = 7.1 Hz, 3H) ppm. 
13
C NMR (75 
MHz, CDCl3):  = 165.8, 164.6, 153.5, 153.2, 151.2, 150.7, 142.7, 140.9, 137.5, 137.5, 
133.7, 130.4, 129.2, 128.6, 128.5, 127.8, 127.4, 122.9, 120.6, 120.0, 115.4, 111.5, 104.7, 
101.4, 72.0, 64.7, 60.6, 56.0, 55.9, 14.3 ppm. FT-IR:  (cm-1) = 706, 1025, 1161, 1452, 
1510, 1600, 1625, 1704, 1728, 2904, 2939, 2985, 3085. ESI-MS: m/z (%) = 568.2 (6) 
[M]
+•
, 569.2 (99) [M+H]
+
, 586.2 (39) [M+NH4]
+
, 591.2 (100) [M+Na]
+
. HR-MS: calcd. for 
C34H32O8 [M]
+•
 568.2097; found 568.2090. 
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Benzyl 4-(4-(benzyloxy)-3-methoxyphenoxy)-3-(4-(benzyloxy)phenyl)but-2-enoate 
4-(1-(4-(Benzyloxy)-3-methoxyphenoxy)-4-ethoxy-4-oxobut-2-en-2-yl)phenyl benzoate 
(4.4 g, 8.1 mmol) was dissolved in THF/H2O (3:1, 80 mL) and cooled with an ice-water-
bath before LiOH (2.0 g, 82 mmol) was added. This slurry was stirred at 0 °C for 1 hour 
and heated to 50 °C for 24 hours. Afterwards the reaction mixture was acidified with 1 N 
HCl to pH 1 - 2 and extracted with EtOAc (3 × 100 mL). The combined organic phases 
were dried with MgSO4 and the solvent was removed under reduced pressure. The residue 
was used without further purification in the subsequent reaction. 4-(4-(Benzyloxy)-3-
methoxyphenoxy)-3-(4-hydroxyphenyl)but-2-enoic acid was recrystallized from 
PE/EtOAc (1:1). 
1
H NMR (300 MHz, DMSO-d6):  = 7.49 – 7.27 (m, 7H), 6.89 (d, J = 8.8 
Hz, 1H), 6.78 (d, J = 8.7 Hz, 2H), 6.55 (d, J = 2.7 Hz, 1H), 6.41 (dd, J = 8.7, 2.7 Hz, 1H), 
6.18 (s, 1H), 5.48 (s, 2H), 4.97 (s, 2H), 3.71 (s, 3H) ppm. 
13
C NMR (75 MHz, DMSO):  = 
167.1, 158.7, 153.1, 151.6, 150.0, 141.9, 137.4, 128.5, 128.2, 127.6, 118.0, 115.2, 114.9, 
104.4, 100.9, 70.7, 63.1, 55.4 ppm. 
4-(4-(Benzyloxy)-3-methoxyphenoxy)-3-(4-hydroxyphenyl)but-2-enoic acid (4.05 g, 
8.10 mmol) was dissolved in acetone (40 mL). Benzyl bromide (2.3 mL, 19.4 mmol), 
K2CO3 (2.24 g, 16.2 mmol) and KI (0.13 g, 0.8 mmol) were added to the stirring solution 
before heating was initiated. The reaction mixture was heated to 60 °C for 24 h. After 
K2CO3 was filtered off, H2O (20 mL) was added. The mixture was extracted with EtOAc 
(3×50 mL). The combined organic phases were washed with brine (20 mL) and dried with 
MgSO4. The crude product was purified by flash chromatography (PE/EtOAc 5:1). Benzyl 
4-(4-(benzyloxy)-3-methoxyphenoxy)-3-(4-(benzyloxy)phenyl)but-2-enoate was obtained 
as colorless oil in 79 % yield (3.78 g, 6.45 mmol). 
1
H NMR (300 MHz, CDCl3):  = 7.52 – 
7.27 (m, 17H), 6.96 (d, J = 8.9 Hz, 2H), 6.75 (d, J = 8.8 Hz, 1H), 6.49 (d, J = 2.8 Hz, 1H), 
6.37 (dd, J = 8.8, 2.8 Hz, 1H), 6.28 (s, 1H), 5.51 (s, 2H), 5.20 (s, 2H), 5.08 (s, 2H), 5.07 (s, 
2H), 3.78 (s, J = 3.5 Hz, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 166.0, 160.0, 153.8, 
153.7, 150.8, 142.8, 137.7, 136.7, 136.0, 130.8, 128.9, 128.8, 128.7, 128.6, 128.4, 128.2, 
127.9, 127.6, 127.5, 118.1, 115.6, 114.9, 104.9, 101.5, 72.1, 70.2, 66.4, 64.4, 56.0 ppm. 
FT-IR:  (cm-1) = 695, 734, 794, 829, 1015, 1149, 1508, 1600, 1707, 2875, 2936, 3033, 
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3062. ESI-MS: m/z (%) = 586.2 (15) [M]
+•
, 587.2 (100) [M+H]
+
, 1195.5 (74) [2M+Na]
+
. 
HR-MS: calcd. for C38H35O6 [M+H]
+
 587.2428; found 587.2429. 
 
 
Benzyl 4-(3-(benzyloxy)phenoxy)-3-(4-(benzyloxy)phenyl)but-2-enoate 
4-(1-(3-(Benzyloxy)phenoxy)-4-ethoxy-4-oxobut-2-en-2-yl)phenyl benzoate (1.2 g, 2.5 
mmol) was dissolved in THF/H2O (3:1, 30 mL) and cooled with an ice-water-bath before 
LiOH (0.60 g, 25 mmol) was added. This slurry was stirred at 0 °C for 1 hour and heated 
to 50 °C for 18 hours. The completion of the reaction was monitored by TLC. Afterwards 
the reaction mixture was acidified with 1 N HCl to pH 1 - 2 and extracted with EtOAc 
(3×50 mL). The combined organic phases were dried with MgSO4 and the solvent was 
removed under reduced pressure. The residue was used without further purification in the 
subsequent reaction and dissolved in acetone (15 mL). Benzyl bromide (0.57 mL, 4.8 
mmol), K2CO3 (0.55 g, 4.0 mmol) and KI (0.03 g, 0.2 mmol) were added to the stirring 
solution before heating was initiated. The reaction mixture was heated to 60 °C for 20 h. 
After K2CO3 was filtered off, H2O (10 mL) was added. The mixture was extracted with 
EtOAc (3 × 20 mL). The combined organic phases were washed with brine (10 mL) and 
dried with MgSO4. The crude product was purified by flash chromatography (PE/EtOAc 
4:1, Rf 0.34). Benzyl 4-(3-(benzyloxy)phenoxy)-3-(4-(benzyloxy)phenyl)but-2-enoate was 
obtained as colorless oil in 73 % yield (1.02 g, 1.83 mmol). 
1
H NMR (300 MHz, CDCl3):  
= 7.52 – 7.28 (m, 17H), 7.20 – 7.11 (m, 1H), 7.00 – 6.91 (m, 2H), 6.62 – 6.52 (m, 2H), 
6.29 (s, 1H), 5.55 (s, 2H), 5.21 (s, J = 5.5 Hz, 2H), 5.08 (s, 2H), 5.00 (s, 2H) ppm. FT-
IR: (cm-1) = 694, 733, 829, 1015, 1144, 1248, 1599, 1707, 2872, 2934, 3032, 3061. ESI-
MS: m/z (%) = 557.2 (98) [M+H]
+
, 1135.4 (74) [2M+Na]
+
. HR-MS: calcd. for C37H33O5 
[M+H]
+
 557.2323; found 557.2327. 
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Benzyl 3-(4-(benzyloxy)-3-methoxyphenyl)-4-(3-(benzyloxy)phenoxy)but-2-enoate 
4-(1-(3-(Benzyloxy)phenoxy)-4-ethoxy-4-oxobut-2-en-2-yl)-2-methoxyphenyl benzoate 
(2.40 g, 4.46 mmol) was dissolved in THF/H2O (3:1, 50 mL) and cooled with an ice-water-
bath before LiOH (1.07 g, 44.6 mmol) was added. This slurry was stirred at 0 °C for 1 hour 
and heated to 50 °C for 20 hours. The completion of the reaction was monitored by TLC. 
Afterwards the reaction mixture was acidified with 1 N HCl to pH 1 - 2 and extracted with 
EtOAc (3 × 75 mL). The combined organic phases were dried with MgSO4 and the solvent 
was removed under reduced pressure. The residue was used without further purification in 
the subsequent reaction and dissolved in acetone (50 mL). Benzyl bromide (1.85 mL, 15.6 
mmol), K2CO3 (1.2 g, 9.0 mmol) and KI (0.07 g, 0.44 mmol) were added to the stirring 
solution before heating was initiated. The reaction mixture was heated to 60 °C for 24 h. 
After K2CO3 was filtered off, H2O (20 mL) was added. The mixture was extracted with 
EtOAc (3 × 50 mL). The combined organic phases were washed with brine (20 mL) and 
dried with MgSO4. The crude product was purified by flash chromatography on a 
Biotage®  solera™ flash purification system (PE/EtOAc 4:1, Rf 0.23). Benzyl 3-(4-
(benzyloxy)-3-methoxyphenyl)-4-(3-(benzyloxy)phenoxy)but-2-enoate was obtained as 
yellow oil in 84 % yield (2.20 g, 3.75 mmol). 
1
H NMR (300 MHz, CDCl3):  = 7.47 – 7.28 
(m, 15H), 7.18 – 7.11 (m, 1H), 7.04 (td, J = 4.5, 2.1 Hz, 2H), 6.84 (d, J = 9.0 Hz, 1H), 6.61 
– 6.50 (m, 3H), 6.28 (s, 1H), 5.53 (s, 2H), 5.20 (s, 2H), 5.17 (s, 2H), 5.00 (s, 2H), 3.85 (s, 
3H) ppm. FT-IR:  (cm-1) = 695, 734, 1023, 1140, 1254, 1453, 1513, 1593, 1708, 2870, 
2933, 3032, 3065. ESI-MS: m/z (%) = 587.2 (100) [M+H]
+
, 604.3 (14) [M+NH4]
+
, 1195.5 
(52) [2M+Na]
+
. HR-MS: calcd. for C38H35O6 [M+H]
+
 587.2428; found 587.2430. 
 
 
Benzyl 3-(4-(benzyloxy)-3-methoxyphenyl)-4-(3-(benzyloxy)-4-
methoxyphenoxy)but-2-enoate 
4-(1-(3-(Benzyloxy)-4-methoxyphenoxy)-4-ethoxy-4-oxobut-2-en-2-yl)-2-methoxy-
phenyl benzoate (2.75 g, 5.00 mmol) was dissolved in THF/H2O (3:1, 50 mL) and cooled 
with an ice-water-bath before LiOH (1.20 g, 50.0 mmol) was added. This slurry was stirred 
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at 0 °C for 1 hour and heated to 45 °C for 48 hours. The completion of the reaction was 
monitored by TLC. Afterwards, the reaction mixture was acidified with 1 N HCl to pH 
1 - 2 and extracted with EtOAc (4 × 50 mL). The combined organic phases were dried with 
MgSO4 and the solvent was removed under reduced pressure. The residue was used 
without further purification in the subsequent reaction and dissolved in acetone (50 mL). 
Benzyl bromide (1.90 mL, 15.6 mmol), K2CO3 (1.38 g, 10.0 mmol) and KI (0.08 g, 0.50 
mmol) were added to the stirring solution before heating was initiated. The reaction 
mixture was heated to 60 °C for 20 h. After K2CO3 was filtered off, 1 N HCl (50 mL) was 
added. The mixture was extracted with EtOAc (3 × 75 mL). The combined organic phases 
were washed with H2O (50 mL) and dried with MgSO4. The crude product was purified by 
flash chromatography on a Biotage®  solera™ flash purification system (PE/EtOAc 4:1, 
Rf 0.13). Benzyl 3-(4-(benzyloxy)-3-methoxyphenyl)-4-(3-(benzyloxy)-4-methoxy-
phenoxy)but-2-enoate was obtained as yellow oil in 78 % yield (2.39 g, 3.87 mmol). 
1
H 
NMR (300 MHz, CDCl3):  = 7.46 – 7.28 (m, 15H), 7.08 – 7.02 (m, 2H), 6.85 (d, J = 9.0 
Hz, 1H), 6.75 (d, J = 8.8 Hz, 1H), 6.48 (d, J = 2.8 Hz, 1H), 6.37 (dd, J = 8.8, 2.8 Hz, 1H), 
6.27 (s, 1H), 5.49 (s, 2H), 5.20 (s, 2H), 5.17 (s, 2H), 5.07 (s, 2H), 3.86 (s, 3H), 3.78 (s, 3H) 
ppm. 
13
C NMR (75 MHz, CDCl3):  = 165.8, 153.8, 153.6, 150.6, 149.5, 149.3, 142.7, 
137.5, 136.7, 135.8, 131.2, 128.6, 128.5, 128.4, 128.4, 128.1, 128.0, 127.8, 127.6, 127.4, 
127.3, 120.3, 118.3, 115.4, 113.2, 110.7, 104.7, 101.3, 72.0, 70.8, 66.4, 64.4, 56.1, 55.9 
ppm. FT-IR:  (cm-1) = 695, 734, 1015, 1139, 1452, 1507, 1597, 1708, 2874, 2937, 3032, 
3063. ESI-MS: m/z (%) = 282.3 (36), 616.2 (21) [M]
+•
, 617.3 (100) [M+H]
+
, 634.3 (27) 
[M+NH4]
+
. HR-MS: calcd. for C39H37O7 [M+H]
+
 617.2534; found 617.2526. 
 
 
4-(3-(Benzyloxy)phenoxy)-3-(4-(benzyloxy)phenyl)but-2-enoic acid (10a) 
Benzyl 4-(3-(benzyloxy)phenoxy)-3-(4-(benzyloxy)phenyl)but-2-enoate (1.4 g, 2.5 
mmol) was dissolved in THF/H2O (3:1, 30 mL) and cooled with an ice-water-bath before 
LiOH (1.3 g, 55 mmol) was added. This slurry was stirred at 0 °C for 1 hour and additional 
24 hours at 45 °C. Afterwards the reaction mixture was acidified with 1 N HCl to pH 1 - 2 
and extracted with EtOAc (3×40 mL). The combined organic phases were dried with 
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MgSO4 and the solvent was removed under reduced pressure. The residue was 
recrystallized from PE/EtOAc (1:2). 4-(3-(Benzyloxy)phenoxy)-3-(4-
(benzyloxy)phenyl)but-2-enoic acid 10a was obtained as white crystalline solid in 61 % 
yield (0.71 g, 1.5 mmol). Mp 131 – 133 °C. 1H NMR (300 MHz, CDCl3):  = 7.52 – 7.28 
(m, 12H), 7.16 (t, J = 8.3 Hz, 1H), 6.97 (d, J = 8.8 Hz, 2H), 6.63 – 6.51 (m, 3H), 6.25 (s, 
1H), 5.55 (s, 2H), 5.09 (s, 2H), 5.01 (s, 2H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 160.2, 
160.0, 159.6, 156.0, 136.9, 136.6, 130.4, 129.9, 129.0, 128.7, 128.6, 128.2, 128.0, 127.5, 
117.2, 114.8, 107.8, 107.4, 102.1, 70.1, 70.0, 63.9 ppm. FT-IR:  (cm-1) = 505, 697, 741, 
998, 1172, 1593, 1687, 1738, 2873, 3033. ESI-MS: m/z (%) = 449.2 (41), 467.2 (100) 
[M+H]
+
. HR-MS: calcd. for C30H27O5 [M+H]
+
 467.1853; found 467.1856. 
 
 
4-(4-(Benzyloxy)-3-methoxyphenoxy)-3-(4-(benzyloxy)phenyl)but-2-enoic acid (10b) 
Benzyl 4-(4-(benzyloxy)-3-methoxyphenoxy)-3-(4-(benzyloxy)phenyl)but-2-enoate 
(3.2 g, 5.5 mmol) was dissolved in THF/H2O (3:1, 60 mL) and cooled with an ice-water-
bath before LiOH (1.3 g, 55 mmol) was added. This slurry was stirred at 0 °C for 1 hour 
and additional 15 hours at 50 °C. Afterwards the reaction mixture was acidified with 1 N 
HCl to pH 1 - 2 and extracted with EtOAc (3×75 mL). The combined organic phases were 
dried with MgSO4 and the solvent was removed under reduced pressure. The residue was 
recrystallized from PE/EtOAc (1:1). 4-(4-(Benzyloxy)-3-methoxyphenoxy)-3-(4-
(benzyloxy)phenyl)but-2-enoic acid 10b was obtained as white crystalline solid in 63 % 
yield (1.77 g, 3.57 mmol). Mp 135 - 138 °C. 
1
H NMR (300 MHz, CDCl3):  = 7.49 (d, J = 
8.8 Hz, 2H), 7.45 – 7.29 (m, 10H), 6.98 (d, J = 8.9 Hz, 2H), 6.77 (d, J = 8.8 Hz, 1H), 6.48 
(d, J = 2.8 Hz, 1H), 6.39 (dd, J = 8.7, 2.8 Hz, 1H), 6.25 (s, 1H), 5.51 (s, 2H), 5.09 (s, 2H), 
5.07 (s, 2H), 3.79 (s, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 160.2, 156.1, 153.4, 
150.6, 142.7, 137.5, 136.5, 130.4, 129.0, 128.7, 128.5, 128.2, 127.8, 127.5, 127.4, 117.2, 
115.2, 114.8, 104.6, 101.4, 71.9, 70.1, 64.2, 55.9 ppm. FT-IR:  (cm-1) = 695, 746, 999, 
1178, 1510, 1595, 1673, 1738, 2875, 2946, 3032. ESI-MS: m/z (%) = 496.2 (9) [M]
+•
, 
497.2 (100) [M+H]
+
. HR-MS: calcd. for C31H29O6 [M+H]
+
 497.1959; found 497.1961. 
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3-(4-(Benzyloxy)-3-methoxyphenyl)-4-(3-(benzyloxy)phenoxy)but-2-enoic acid (10c) 
Benzyl 3-(4-(benzyloxy)-3-methoxyphenyl)-4-(3-(benzyloxy)phenoxy)but-2-enoate 
(2.00 g, 3.41 mmol) was dissolved in THF/H2O (3:1, 60 mL) and cooled with an ice-water-
bath before LiOH (0.41 g, 17 mmol) was added. This slurry was stirred at 0 °C for 1 hour 
and additional 20 hours at 50 °C. Afterwards the reaction mixture was acidified with 1 N 
HCl to pH 1 - 2 and extracted with EtOAc (3×30 mL). The combined organic phases were 
dried with MgSO4 and the solvent was removed under reduced pressure. The residue was 
recrystallized from EtOAc (15 mL) covered with a layer of hexane. 3-(4-(Benzyloxy)-3-
methoxyphenyl)-4-(3-(benzyloxy)phenoxy)but-2-enoic acid 10c was obtained as white 
crystalline solid in 62 % yield (1.05 g, 2.12 mmol). Mp 118 – 120 °C. 1H NMR (300 MHz, 
CDCl3):  = 7.47 – 7.30 (m, 10H), 7.15 (t, J = 8.2 Hz, 1H), 7.08 – 7.02 (m, 2H), 6.86 (d, J 
= 9.0 Hz, 1H), 6.62 – 6.50 (m, 3H), 6.24 (s, 1H), 5.52 (s, 2H), 5.18 (s, 2H), 5.00 (s, 2H), 
3.86 (s, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 170.3, 160.0, 159.6, 155.9, 149.7, 
149.3, 136.9, 136.7, 130.9, 129.9, 128.6, 128.6, 128.0, 128.0, 127.5, 127.3, 120.6, 117.5, 
113.2, 110.9, 107.8, 107.4, 102.2, 70.9, 70.0, 64.0, 56.1 ppm. FT-IR:  (cm-1) = 681, 743, 
1020, 1146, 1590, 1686, 1738, 2874, 2941, 3030. ESI-MS: m/z (%) = 496.2 (2) [M]
+•
, 
497.2 (100) [M+H]
+
. HR-MS: calcd. for C31H29O6 [M+H]
+
 497.1959; found 497.1963. 
 
 
3-(4-(Benzyloxy)-3-methoxyphenyl)-4-(3-(benzyloxy)-4-
methoxyphenoxy)but-2-enoic acid (10d) 
Benzyl 3-(4-(benzyloxy)-3-methoxyphenyl)-4-(3-(benzyloxy)-4-methoxyphenoxy)but-
2-enoate (2.35 g, 3.80 mmol) was dissolved in THF/H2O (3:1, 55 mL) and cooled with an 
ice-water-bath before LiOH (0.46 g, 20 mmol) was added. This slurry was stirred at 0 °C 
for 1 hour and additional 20 hours at 40 °C. Afterwards the reaction mixture was acidified 
with 1 N HCl to pH 1 - 2 and extracted with EtOAc (3×50 mL). The combined organic 
phases were dried with MgSO4 and the solvent was removed under reduced pressure. The 
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residue was recrystallized from EtOAc covered with a layer of hexane. 3-(4-(Benzyloxy)-
3-methoxyphenyl)-4-(3-(benzyloxy)-4-methoxyphenoxy)but-2-enoic acid 10d was 
obtained as white crystalline solid in 57 % yield (1.14 g, 2.17 mmol). Mp 104 – 106 °C. 1H 
NMR (300 MHz, CDCl3):  = 7.47 – 7.27 (m, 11H), 7.09 – 7.02 (m, 2H), 6.87 (d, J = 8.9 
Hz, 1H), 6.77 (d, J = 8.7 Hz, 1H), 6.48 (d, J = 2.8 Hz, 1H), 6.38 (dd, J = 8.7, 2.8 Hz, 1H), 
6.24 (s, J = 7.0 Hz, 1H), 5.48 (s, 2H), 5.19 (s, 2H), 5.07 (s, 2H), 3.87 (s, 3H), 3.79 (s, J = 
4.8 Hz, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 170.5, 156.0, 153.5, 150.7, 149.7, 
149.3, 142.8, 137.5, 136.7, 131.0, 128.7, 128.5, 128.0, 127.8, 127.4, 127.3, 120.6, 117.4, 
115.3, 113.2, 110.8, 104.7, 101.4, 72.0, 70.8, 64.4, 56.1, 55.9 ppm. FT-IR:  (cm-1) = 698, 
745, 1001, 1141, 1194, 1510, 1593, 1682, 1738, 2875, 2936, 3031. ESI-MS: m/z (%) = 
526.2 (6) [M]
+•
, 527.2 (100) [M+H]
+
, 544.2 (24) [M+NH4]
+
. HR-MS: calcd. for C32H31O7 
[MH]
+
 527.2064; found 527.2064. 
 
8-(Benzyloxy)-3-(4-(benzyloxy)phenyl)benzo[b]oxepin-5(2H)-one (2a) 
4-(3-(Benzyloxy)phenoxy)-3-(4-(benzyloxy)phenyl)but-2-enoic acid 10a (0.23 g, 0.50 
mmol) was dissolved in dry dichloromethane (10 mL). The solution was cooled with an 
ice-water-bath before pyridine (40 L, 0.50 mmol) and cyanuric chloride (0.15 g, 0.80 
mmol) were added. The reaction mixture was stirred at 0 °C for 0.5 hours, the cooling bath 
was then removed and the mixture stirred for additional 3 hours at room temperature. After 
cooling to -60 °C, AlCl3 (80 mg, 0.60 mmol) was added in three portions. The mixture was 
allowed to warm slowly up to 0 °C over a period of 4 hours, before the reaction was 
quenched by adding ice/H2O (5 mL). Phase separation could be enhanced by the addition 
of saturated NaHCO3 solution (5 mL). The aqueous phase was exctracted with 
dichloromethane (3×10 mL). The combined organic phases were dried with MgSO4 and 
the solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography on a Biotage® Isolera™ flash purification system (PE/EtOAc 3:1, Rf 
0.28). 8-(Benzyloxy)-3-(4-(benzyloxy)phenyl)benzo[b]oxepin-5(2H)-one 2a was obtained 
as slightly yellow solid in 64 % yield (144 mg, 0.32 mmol). Mp 146 – 148 °C. 1H NMR 
(300 MHz, CDCl3):  = 8.09 (d, J = 9.0 Hz, 1H), 7.53 – 7.47 (m, 2H), 7.45 – 7.31 (m, 
11H), 7.07 – 6.99 (m, 2H), 6.81 (dd, J = 9.0, 2.5 Hz, 1H), 6.66 (s, 1H), 6.64 (d, J = 2.5 Hz, 
1H), 5.12 (s, 4H), 5.08 (s, 2H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 187.5, 164.0, 162.3, 
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160.2, 150.0, 136.4, 136.0, 133.5, 130.8, 130.2, 128.7, 128.6, 128.3, 128.2, 127.5, 127.5, 
121.5, 115.4, 111.6, 105.0, 71.7, 70.3, 70.1 ppm. FT-IR:  (cm-1) = 697, 827, 999, 1243, 
1599, 1730, 2871, 2917, 2932, 3033, 3063. ESI-MS: m/z (%) = 449.2 (100) [M+H]
+
, 919.3 
(100) [2M+Na]
+
. HR-MS: calcd. for C30H25O4 [M+H]
+
 449.1747; found 449.1746. 
 
7-(Benzyloxy)-3-(4-hydroxyphenyl)-8-methoxybenzo[b]oxepin-5(2H)-one (2b) 
4-(4-(Benzyloxy)-3-methoxyphenoxy)-3-(4-(benzyloxy)phenyl)but-2-enoic acid 10b 
(0.50 g, 1.0 mmol) was dissolved in dry dichloromethane (20 mL). The solution was 
cooled with an ice-water-bath before pyridine (80 L, 1.0 mmol) and cyanuric chloride 
(0.30 g, 1.6 mmol) were added. The reaction mixture was stirred at 0 °C for 0.5 hours, the 
cooling bath was then removed and the mixture stirred for additional 2 hours at room 
temperature. After cooling to -60 °C, AlCl3 (0.16 g, 1.2 mmol) was added in three portions. 
The mixture was allowed to warm slowly up to -20 °C over a period of 2 hours, before the 
cooling bath was removed. The reaction mixture was stirred at room temperature for 2 
hours and then quenched by adding H2O (5 mL). The aqueous phase was extracted with 
dichloromethane (3 × 10 mL). The combined organic phases were dried with MgSO4 and 
the solvent was removed under reduced pressure. The crude product was purified by 
recrystallization from PE/EtOAc (1:2). 7-(Benzyloxy)-3-(4-hydroxyphenyl)-8-
methoxybenzo[b]oxepin-5(2H)-one 2b was obtained as slightly yellow crystals in 48 % 
yield (0.22 g, 0.46 mmol). Mp 137 – 142 °C. 1H NMR (300 MHz, CDCl3):  = 7.66 (s, 
1H), 7.52 – 7.30 (m, 12H), 7.06 – 6.99 (m, 2H), 6.65 (s, 1H), 6.58 (s, 1H), 5.16 (s, 2H), 
5.12 (s, 2H), 5.05 (s, 2H), 3.92 (s, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 187.2, 160.3, 
156.9, 155.4, 150.2, 144.7, 136.8, 136.6, 130.8, 130.4, 128.8, 128.7, 128.5, 128.3, 128.1, 
127.8, 127.6, 120.0, 115.4, 113.9, 103.2, 72.0, 71.2, 70.2, 56.4 ppm. FT-IR:  (cm-1) = 695, 
735, 830, 1001, 1220, 1450, 1605, 1691, 2937, 3032, 3061. ESI-MS: m/z (%) = 479.2 
(100) [M+H]
+
. HR-MS: calcd. for C31H27O5 [M+H]
+
 479.1853; found 479.1849. 
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8-(Benzyloxy)-3-(4-(benzyloxy)-3-methoxyphenyl)benzo[b]oxepin-5(2H)-one (2c) 
3-(4-(Benzyloxy)-3-methoxyphenyl)-4-(3-(benzyloxy)phenoxy)but-2-enoic acid 10c 
(0.25 g, 0.50 mmol) was dissolved in dry dichloromethane (10 mL). The solution was 
cooled with an ice-water-bath before pyridine (40 L, 0.50 mmol) and cyanuric chloride 
(0.15 g, 0.80 mmol) were added. The reaction mixture was stirred at 0 °C for 0.5 hours, the 
cooling bath was then removed and the mixture stirred for additional 4 hours at room 
temperature. After cooling to -60 °C, AlCl3 (80 mg, 0.60 mmol) was added in three 
portions. The mixture was allowed to warm slowly up to -10 °C over a period of 3 hours, 
before the cooling bath was removed. The reaction mixture was stirred at room 
temperature for 2 hours and then quenched by adding H2O (5 mL). Phase separation could 
be enhanced by the addition of saturated NaHCO3 solution (5 mL). The aqueous phase was 
extracted with dichloromethane (3×10 mL). The combined organic phases were dried with 
MgSO4 and the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography on a Biotage®  solera™ flash purification system 
(PE/EtOAc 3:1, Rf 0.28). 8-(Benzyloxy)-3-(4-(benzyloxy)-3-methoxyphenyl)-
benzo[b]oxepin-5(2H)-one 2c was obtained as pale white solid in 67 % yield (161 mg, 0.34 
mmol). Mp 142 – 146 °C. 1H NMR (300 MHz, CDCl3):  = 8.10 (d, J = 9.0 Hz, 1H), 7.48 
– 7.31 (m, 10H), 7.06 (dd, J = 7.2, 1.9 Hz, 2H), 6.95 – 6.89 (m, 1H), 6.81 (dd, J = 9.0, 2.5 
Hz, 1H), 6.67 (s, 1H), 6.63 (d, J = 2.5 Hz, 1H), 5.21 (s, 2H), 5.12 (s, 2H), 5.06 (s, 2H), 
3.94 (s, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 187.6, 164.2, 162.5, 150.4, 150.0, 
149.9, 136.7, 136.1, 133.6, 131.0, 130.8, 128.9, 128.8, 128.5, 128.2, 127.7, 127.3, 121.5, 
120.0, 113.6, 111.8, 110.3, 105.1, 71.8, 71.0, 70.5, 56.3 ppm. FT-IR:  (cm-1) = 697, 735, 
1023, 1145, 1248, 1514, 1593, 1738, 2875, 2935, 3031, 3063. ESI-MS: m/z (%) = 280.3 
(10), 479.2 (100) [M+H]
+
. HR-MS: calcd. for C31H27O5 [M+H]
+
 479.1853; found 
479.1849. 
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7-(Benzyloxy)-3-(4-(benzyloxy)-3-methoxyphenyl)-8-
methoxybenzo[b]oxepin-5(2H)-one (2d) 
3-(4-(Benzyloxy)-3-methoxyphenyl)-4-(3-(benzyloxy)-4-methoxyphenoxy)but-2-enoic 
acid 10d (0.26 g, 0.50 mmol) was dissolved in dry dichloromethane (10 mL). The solution 
was cooled with an ice-water-bath before pyridine (40 L, 0.50 mmol) and cyanuric 
chloride (0.15 g, 0.80 mmol) were added. The reaction mixture was stirred at 0 °C for 0.5 
hours, the cooling bath was then removed and the mixture stirred for additional 4 hours at 
room temperature. After cooling to -60 °C, AlCl3 (80 mg, 0.60 mmol) was added in three 
portions. The mixture was allowed to warm slowly up to -10 °C over a period of 3 hours, 
before the cooling bath was removed. The reaction mixture was stirred at room 
temperature for 1 hour and then quenched by adding H2O (5 mL). The aqueous phase was 
extracted with dichloromethane (3×10 mL). The combined organic phases were dried with 
MgSO4 and the solvent was removed under reduced pressure. The crude product was 
purified by flash chromatography on a Biotage®  solera™ flash purification system 
(PE/EtOAc 2:1, Rf 0.32). 7-(Benzyloxy)-3-(4-(benzyloxy)-3-methoxyphenyl)-8-
methoxybenzo[b]oxepin-5(2H)-one 2d was obtained as pale white solid in 53 % yield (135 
mg, 0.27 mmol). Mp 82 – 85 °C. 1H NMR (300 MHz, CDCl3):  = 7.66 (s, 1H), 7.52 – 
7.28 (m, 10H), 7.10 – 7.03 (m, 2H), 6.92 (d, J = 8.9 Hz, 1H), 6.66 (s, 1H), 6.57 (s, 1H), 
5.21 (s, 2H), 5.16 (s, 2H), 5.05 (s, 2H), 3.94 (s, 3H), 3.92 (s, 3H) ppm. 
13
C NMR (75 MHz, 
CDCl3):  = 187.1, 156.8, 155.4, 150.2, 149.8, 149.7, 144.6, 136.7, 136.6, 130.8, 130.7, 
128.7, 128.6, 128.0, 127.7, 127.2, 119.9, 119.8, 113.7, 113.5, 110.2, 103.0, 71.9, 71.1, 
70.9, 56.3, 56.2 ppm. FT-IR:  (cm-1) = 695, 736, 1006, 1140, 1206, 1505, 1596, 1738, 
2341, 2359, 2871, 2939, 3033, 3063. ESI-MS: m/z (%) = 509.2 (100) [M+H]
+
, 567.2 (5) 
[M+NH4+MeCN]
+
, 1039.4 (9) [2M+Na]
+
. HR-MS: calcd. for C32H29O6 [M+H]
+
 509.1959; 
found 509.1957. 
 
8-Hydroxy-3-(4-hydroxyphenyl)-3,4-dihydrobenzo[b]oxepin-5(2H)-one (11a) 
8-(Benzyloxy)-3-(4-(benzyloxy)phenyl)benzo[b]oxepin-5(2H)-one 2a (0.14 g, 0.32 
mmol) was dissolved in EtOAc/MeOH (2:1, 35 mL) and Pd/C (35 mg) was added. The 
reaction mixture was placed in flask equipped with a hydrogen filled balloon and stirred 
for 6 hours under a H2 atmosphere. The mixture was filtered through celite and the solvent 
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removed under reduced pressure. The crude product was purified by flash chromatography 
on a Biotage®  solera™ flash purification system (PE/EtOAc 2:1, Rf 0.14). 8-Hydroxy-3-
(4-hydroxyphenyl)-3,4-dihydrobenzo[b]oxepin-5(2H)-one 11a was isolated in 58 % yield 
(50 mg, 0.11 mmol). 
1
H NMR (300 MHz, MeOD):  = 7.67 (d, J = 8.7 Hz, 1H), 7.22 – 
7.13 (m, 2H), 6.77 – 6.69 (m, 2H), 6.56 (dd, J = 8.7, 2.3 Hz, 1H), 6.48 (d, J = 2.3 Hz, 1H), 
4.35 (dd, J = 12.2, 6.3 Hz, 1H), 4.19 (dd, J = 12.2, 6.9 Hz, 1H), 3.56 – 3.43 (m, 1H), 3.08 
(dd, J = 12.6, 7.7 Hz, 1H), 3.00 (dd, J = 12.6, 6.9 Hz, 1H) ppm. 
13
C NMR (75 MHz, 
MeOD):  = 200.2, 167.2, 164.8, 157.6, 134.5, 132.3, 129.5, 122.0, 116.5, 112.1, 107.5, 
80.6, 45.1 ppm. FT-IR:  (cm-1) = 532, 737, 830, 1020, 1111, 1160, 1244, 1448, 1515, 
1596, 1648, 2853, 2924, 3026, 3293. APCI-MS: m/z (%) = 271.1 (100) [M+H]
+
. HR-MS: 
calcd. for C16H15O4 [M+H]
+
 271.0965; found 271.0969. 
 
3-(4-Hydroxyphenyl)-2,3,4,5-tetrahydrobenzo[b]oxepin-8-ol (16a) 
8-(Benzyloxy)-3-(4-(benzyloxy)phenyl)benzo[b]oxepin-5(2H)-one 2a (54 mg, 0.12 
mmol) was dissolved in EtOAc/MeOH (2:1, 35 mL) and Pd/C (14 mg) was added. The 
reaction mixture was placed in an autoclave under 5 bar H2 pressure and stirred for 6 
hours. The mixture was filtered through celite and the solvent removed under reduced 
pressure. The crude product was purified by flash chromatography on a Biotage® 
 solera™ flash purification system (PE/EtOAc 2:1, Rf 0.32). 3-(4-Hydroxyphenyl)-2,3,4,5-
tetrahydrobenzo[b]oxepin-8-ol 16a was isolated in 50 % yield (18 mg, 0.07 mmol) (in 
addition 8-hydroxy-3-(4-hydroxyphenyl)-3,4-dihydrobenzo[b]oxepin-5(2H)-one 11a was 
isolated in 28 % yield (9 mg, 0.03 mmol)). 
1
H NMR (600 MHz, MeOD):  = 7.01 – 6.98 
(m, 2H, H-2´/6´), 6.94 (d, J = 8.0 Hz, 1H, H-6), 6.72 – 6.67 (m, 2H, H-3´/5´), 6.43 (dd, J = 
8.0, 2.5 Hz, 1H, H-7), 6.42 (d, J = 2.4 Hz, 1H, H-9), 4.21 (ddd, J = 12.0, 3.6, 1.7 Hz, 1H, 
H-2A), 3.55 (dd, J = 11.9, 10.5 Hz, 1H, H-2B), 3.03 (tt, J = 11.0, 3.5 Hz, 1H, H-3), 2.83 (t, 
J = 12.7 Hz, 1H, H-5B), 2.69 (ddd, J = 14.4, 6.3, 1.6 Hz, 1H, H-5A), 2.08 – 1.98 (m, 1H, 
H-4A), 1.65 (td, J = 13.5, 1.8 Hz, 1H, H-4B) ppm. 
13
C NMR (151 MHz, MeOD):  = 
162.1 (C-10), 157.8 (C-8), 157.1 (C-4´), 135.1 (C-1´), 131.7 (C-6), 129.4 (C-2´/6´), 127.7 
(C-11), 116.3 (C-3´/5´), 111.5 (C-7), 109.0 (C-9), 79.2 (C-2), 49.9 (C-3), 35.5 (C-4), 33.2 
(C-5) ppm. FT-IR:  (cm-1) = 830, 1006, 1114, 1153, 1234, 1361, 1448, 1514, 1615, 2927, 
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3375. EI-MS: m/z (%) = 107.1 (19), 123.1 (21), 149.1 (100), 256.1 (24) [M]
+•
. HR-MS: 
calcd. for C16H16O3 [M]
+•
 256.1099; found 256.1097. 
 
7-Hydroxy-3-(4-hydroxyphenyl)-8-methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one (11b) 
7-(Benzyloxy)-3-(4-hydroxyphenyl)-8-methoxybenzo[b]oxepin-5(2H)-one 2b (0.20 g, 
0.42 mmol) was dissolved in MeOH/EtOAc (1:1, 20 mL) and Pd/C (0.05 g) was added. 
The reaction mixture was placed in an autoclave under 20 bar H2 pressure and stirred for 
10 hours. The mixture was filtered through celite and the solvent removed under reduced 
pressure. 7-Hydroxy-3-(4-hydroxyphenyl)-8-methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-
one 11b was obtained as colorless oil in 85 % yield (0.11 g, 0.37 mmol). 
1
H NMR (600 
MHz, MeOD):  = 7.20 (s, J = 4.6 Hz, 1H), 7.18 – 7.13 (m, 2H), 6.76 – 6.72 (m, 2H), 6.71 
(s, 1H), 4.33 (dd, J = 12.1, 6.6 Hz, 1H), 4.17 (dd, J = 12.1, 7.2 Hz, 1H), 3.90 (s, J = 5.2 Hz, 
3H), 3.50 – 3.44 (m, 1H), 3.12 (dd, J = 12.9, 8.2 Hz, 1H), 3.00 (dd, J = 12.9, 6.0 Hz, 1H) 
ppm. 
13
C NMR (151 MHz, MeOD):  = 200.4, 159.8, 157.6, 154.6, 143.6, 134.4, 129.4, 
122.2, 116.5, 114.5, 104.8, 80.8, 56.6, 49.7, 44.9 ppm. FT-IR:  (cm-1) = 532, 834, 1209, 
1267, 1445, 1515, 1613, 1699, 2963, 3087, 3216. ESI-MS: m/z (%) = 272.6 (35), 301.0 
(100) [M+H]
+
, 318.0 (60) [M+NH4]
+
, 342.0 (50) [M+H+MeCN]
+
. HR-MS: calcd. for 
C17H17O5 [M+H]
+
 301.1071; found 301.1070. 
 
8-Hydroxy-3-(4-hydroxy-3-methoxyphenyl)-3,4-dihydrobenzo[b]oxepin-5(2H)-one (11c) 
8-(Benzyloxy)-3-(4-(benzyloxy)-3-methoxyphenyl)benzo[b]oxepin-5(2H)-one 2c (0.15 
g, 0.31 mmol) was dissolved in EtOAc/MeOH (2:1, 30 mL) and Pd/C (38 mg) was added. 
The reaction mixture was placed in flask equipped with a hydrogen filled balloon and 
stirred for 5 hours under a H2 atmosphere. The mixture was filtered through celite and the 
solvent removed under reduced pressure. The crude product was purified by flash 
chromatography on a Biotage®  solera™ flash purification system (PE/Et2O 0:1, Rf 0.48). 
8-Hydroxy-3-(4-hydroxy-3-methoxyphenyl)-3,4-dihydrobenzo[b]oxepin-5(2H)-one 11c 
was isolated in 67 % yield (63 mg, 0.21 mmol). 
1
H NMR (300 MHz, MeOD):  = 7.68 (d, 
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J = 8.7 Hz, 1H), 6.94 (d, J = 1.8 Hz, 1H), 6.79 (dd, J = 8.2, 1.8 Hz, 1H), 6.74 (d, J = 8.1 
Hz, 1H), 6.57 (dd, J = 8.7, 2.3 Hz, 1H), 6.49 (d, J = 2.3 Hz, 1H), 4.37 (dd, J = 12.2, 6.4 Hz, 
1H), 4.19 (dd, J = 12.2, 7.1 Hz, 1H), 3.84 (s, 3H), 3.58 – 3.43 (m, 1H), 3.15 – 2.99 (m, 2H) 
ppm. 
13
C NMR (75 MHz, MeOD):  = 200.3, 167.2, 164.8, 149.2, 146.7, 135.2, 132.3, 
122.0, 120.9, 116.4, 112.2, 112.0, 107.5, 80.6, 56.4, 45.5 ppm. FT-IR:  (cm-1) = 539, 735, 
794, 819, 856, 1024, 1109, 1157, 1212, 1238, 1268, 1449, 1467, 1517, 1576, 1598, 1651, 
2844, 2938, 2966, 3062, 3345. ESI-MS: m/z (%) = 301.1 (100) [M+H]
+
. HR-MS: calcd. 
for C17H17O5 [M+H]
+
 301.1071; found 301.1069. 
 
3-(4-Hydroxy-3-methoxyphenyl)-2,3,4,5-tetrahydrobenzo[b]oxepin-8-ol (16c) 
8-(Benzyloxy)-3-(4-(benzyloxy)-3-methoxyphenyl)benzo[b]oxepin-5(2H)-one 2c (0.16 
g, 0.23 mmol) was dissolved in EtOAc/MeOH (2:1, 30 mL) and Pd/C (38 mg) was added. 
The reaction mixture was placed in an autoclave under 5 bar H2 pressure and stirred for 6 
hours. The mixture was filtered through celite and the solvent removed under reduced 
pressure. The crude product was purified by flash chromatography on a Biotage® 
 solera™ flash purification system (PE/DCM/ACN 4:1:1, Rf 0.3). 3-(4-Hydroxy-3-
methoxyphenyl)-2,3,4,5-tetrahydrobenzo[b]oxepin-8-ol 16c was isolated in 90 % yield (85 
mg, 0.3 mmol). 
1
H NMR (300 MHz, MeOD):  = 6.95 (d, J = 7.8 Hz, 1H, H-6), 6.76 (d, J 
= 1.2 Hz, 1H, H-2´), 6.71 (d, J = 8.1 Hz, 1H, H-5´), 6.62 (d, J = 8.1 Hz, 1H, H-6´), 6.47 – 
6.39 (m, 2H, overlapping signals H-7 and H-9), 4.24 (dd, J = 11.9, 2.2 Hz, 1H, H-2A), 
3.80 (s, 3H, OCH3), 3.59 (dd, J = 11.8, 10.6 Hz, 1H, H-2B),3.11 – 2.99 (m, 1H, H-3), 2.85 
(t, J = 12.8 Hz, 1H, H-5B), 2.70 (dd, J = 13.8, 5.6 Hz, 1H, H-5A), 2.12 – 2.01 (m, 2H, H-
4A), 1.68 (dd, J = 23.9, 11.9 Hz, 1H, H-4B) ppm. 
13
C NMR (75 MHz, MeOD):  = 162.2 
(C-10), 157.9 (C-8), 149.0 (C-3´), 146.2 (C-4´), 135.9 (C-1´), 131.7 (C-6), 127.7 (C-11), 
120.9 (C-6´), 116.3 (C-5´), 112.2 (C-2´), 111.5 (C-7), 109.1 (C-9), 79.3 (C-2), 56.4 
(OCH3), 50.5 (C-3), 35.6 (C-4), 33.3 (C-5) ppm. FT-IR:  (cm
-1
) = 734, 1023, 1112, 1150, 
1228, 1267, 1515, 1614, 2853, 2927, 3029, 3383. ESI-MS: m/z (%) = 123.1 (15), 137.1 
(22), 149.1 (100), 176.0 (26), 286.1 (24) [M]
+•
. HR-MS: calcd. for C17H18O4 [M]
+•
 
286.1205; found 286.1204. 
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7-Hydroxy-3-(4-hydroxy-3-methoxyphenyl)-8-methoxy-3,4-
dihydrobenzo[b]oxepin-5(2H)-one (11d) 
7-(Benzyloxy)-3-(4-(benzyloxy)-3-methoxyphenyl)-8-methoxybenzo[b]oxepin-5(2H)-
one 2d (0.10 g, 0.20 mmol) was dissolved in EtOAc/MeOH (2:1, 30 mL) and Pd/C (10 
mg) was added. The reaction mixture was placed in an autoclave under 5 bar H2 pressure 
and stirred for 10 hours. The mixture was filtered through celite and the solvent removed 
under reduced pressure. The crude product was purified by flash chromatography on a 
Biotage®  solera™ flash purification system (PE/EtOAc 2:1, Rf 0.22). 7-Hydroxy-3-(4-
hydroxy-3-methoxyphenyl)-8-methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one 11d was 
isolated in 65 % yield (42 mg, 0.13 mmol). 
1
H NMR (300 MHz, CDCl3):  = 7.38 (s, 1H), 
6.87 (d, J = 8.1 Hz, 2H), 6.87 (d, J = 1.8 Hz, 1H), 6.82 (dd, J = 8.2, 1.8 Hz, 1H), 6.62 (s, 
1H), 5.60 (s, 1H), 5.45 (s, 1H), 4.35 (dd, J = 12.1, 6.5 Hz, 1H), 4.26 (dd, J = 12.1, 6.5 Hz, 
1H), 3.93 (s, 3H), 3.89 (s, 3H), 3.48 (p, J = 6.5 Hz, 1H), 3.19 (dd, J = 12.6, 8.2 Hz, 1H), 
3.09 (dd, J = 12.6, 6.4 Hz, 1H) ppm. 
13
C NMR (101 MHz, MeOD):  = 200.4, 159.8, 
154.6, 149.2, 146.7, 143.6, 135.1, 122.2, 121.0, 116.4, 114.5, 112.0, 104.8, 80.8, 56.6, 
56.4, 45.3 ppm. FT-IR:  (cm-1) = 827, 1031, 1151, 1208, 1270, 1362, 1443, 1504, 1613, 
1656, 2953, 3418. ESI-MS: m/z (%) = 331.1 (100) [M+H]
+
. HR-MS: calcd. for C18H19O6 
[M+H]
+
 331.1176; found 331.1178. 
 
3-(4-Hydroxyphenyl)-2,3-dihydrobenzo[b]oxepin-8-ol (1a) 
8-Hydroxy-3-(4-hydroxyphenyl)-3,4-dihydrobenzo[b]oxepin-5(2H)-one 11a (30 mg, 
0.21 mmol) was dissolved in EtOH (15 mL). The solution was cooled to 0 °C before 
NaBH4 (31 mg, 0.55 mmol) was added. The reaction mixture was stirred for 3 hour at 0 °C 
and additional 20 hours at room temperature. The progress of the reaction was monitored 
by TLC. After the consumption of the substrate the reaction was quenched by addition of 
1 N HCl (2 mL) while cooling with an ice-water bath and stirring over night. EtOH was 
removed under reduced pressure before the rest of the reaction solution was extracted with 
Et2O (4×10 mL). The combined organic phases were dried with MgSO4 and the solvent 
was removed under reduced pressure. The crude product was purified by flash 
chromatography on a Biotage®  solera™ flash purification system (PE/EtOAc 2:1, Rf 
0.24). 3-(4-Hydroxyphenyl)-2,3-dihydrobenzo[b]oxepin-8-ol 1a was obtained as white 
solid in 46 % yield (13 mg, 0.051 mmol). 
1
H NMR (600 MHz, MeOD):  = 7.10 – 7.03 (m, 
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3H), 6.76 – 6.71 (m, 2H), 6.48 (dd, J = 8.4, 2.5 Hz, 1H), 6.41 – 6.34 (m, 2H), 5.78 (dd, J = 
11.8, 4.1 Hz, 1H), 4.23 (ddd, J = 11.7, 3.2, 0.8 Hz, 1H), 4.07 (dd, J = 11.6, 6.7 Hz, 1H), 
3.88 – 3.82 (m, 1H) ppm. 13C NMR (151 MHz, MeOD):  = 161.7, 158.8, 157.4, 134.8, 
133.5, 131.1, 130.4, 128.9, 120.0, 116.2, 111.0, 107.3, 76.4, 50.7 ppm. FT-IR:  (cm-1) = 
732, 820, 1115, 1161, 1248, 1511, 1611, 2923, 2957, 3066, 3376. ESI-MS: m/z (%) = 
107.1 (49), 147.1 (100), 239.1 (24), 254.1 (41) [M]
+•
. HR-MS: calcd. for C16H14O3 [M]
+•
 
254.0943; found 254.0943. (Ref.
2
) 
 
3-(4-Hydroxyphenyl)-8-methoxy-2,3-dihydrobenzo[b]oxepin-7-ol (1b) 
7-Hydroxy-3-(4-hydroxyphenyl)-8-methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one 11b 
(0.11 g, 0.36 mmol) was dissolved in EtOH (15 mL) and NaBH4 (0.07 g, 1.8 mmol) was 
added. The reaction mixture was stirred for 24 hours at room temperature before aqueous 
NaOH (5 %, 15 mL) was added. Ater stirring for an additional hour, the mixture was 
extracted with EtOAc (3×20 mL), the combined organic phases were dried with MgSO4 
and the solvent was removed under reduced pressure. The crude product was purified by 
flash chromatography (DCM/ACN/PE 1:1:1.5, Rf 0.44). 3-(4-Hydroxyphenyl)-8-methoxy-
2,3-dihydrobenzo[b]oxepin-7-ol 1b was obtained in 42 % yield (44 mg, 0.15 mmol). 
1
H NMR (300 MHz, MeOD):  = 7.07 – 7.01 (m, 2H), 6.74 – 6.69 (m, 2H), 6.66 (s, 1H), 
6.52 (s, 1H), 6.28 (dd, J = 12.0, 1.9 Hz, 1H), 5.81 (dd, J = 11.8, 4.1 Hz, 1H), 4.19 (dd, J = 
11.5, 3.1 Hz, 1H), 4.03 (dd, J = 11.6, 6.6 Hz, 1H), 3.87 – 3.82 (m, 1H), 3.80 (s, 3H) ppm. 
13
C NMR (75 MHz, MeOD):  = 157.4, 154.3, 148.7, 142.5, 133.5, 132.6, 130.5, 128.6, 
120.3, 119.1, 116.2, 104.7, 76.7, 56.4, 51.0 ppm. APCI-MS: m/z (%) = 191.0 (20), 285.0 
(100) [M+H]
+
. EI-MS: m/z (%) = 177.1 (100), 284.1 (27) [M]
+•
. HR-MS: calcd. for 
C17H16O4 [M]
+•
 284.1049; found 284.1048. (Ref.
2
) 
 
3-(4-Hydroxy-3-methoxyphenyl)-2,3-dihydrobenzo[b]oxepin-8-ol (1c) 
8-Hydroxy-3-(4-hydroxy-3-methoxyphenyl)-3,4-dihydrobenzo[b]oxepin-5(2H)-one 11c 
(63 mg, 0.21 mmol) was dissolved in EtOH (15 mL). The solution was cooled to 0 °C 
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before NaBH4 (40 mg, 1.05 mmol) was added. The reaction mixture was stirred for 2 hour 
at 0 °C and additional 20 hours at room temperature. The progress of the reaction was 
monitored by TLC. After the consumption of the substrate, the reaction was quenched by 
the addition of 1 N HCl (3 mL) while cooling with an ice-water bath. EtOH was removed 
under reduced pressure before the rest of the reaction solution was extracted with Et2O 
(4×10 mL). The combined organic phases were dried with MgSO4 and the solvent was 
removed under reduced pressure. The crude product was purified by flash chromatography 
on Biotage®  solera™ flash purification system (PE/EtOAc 2:1, Rf 0.2). 3-(4-Hydroxy-3-
methoxyphenyl)-8-methoxy-2,3-dihydrobenzo[b]oxepin-7-ol 1c was obtained in 15 % 
yield (9 mg, 0.014 mmol). The unconverted substrate 8-hydroxy-3-(4-hydroxy-3-
methoxyphenyl)-3,4-dihydrobenzo[b]oxepin-5(2H)-one 11c (25 mg, 0.08 mmol) could be 
reisolated and reused; the corrected yield of 1c is 24 %. 
1
H NMR (600 MHz, MeOD):  = 
7.05 (d, J = 8.4 Hz, 1H, H-6), 6.79 (d, J = 1.9 Hz, 1H, H-2´), 6.73 (d, J = 8.1 Hz, 1H, H-
5´), 6.67 (dd, J = 8.1, 1.9 Hz, 1H, H-6´), 6.45 (dd, J = 8.4, 2.5 Hz, 1H, H-7), 6.36 (dd, J = 
11.8, 1.9 Hz, 1H, H-5), 6.34 (d, J = 2.5 Hz, 1H, H-9), 5.77 (dd, J = 11.8, 4.0 Hz, 1H, H-4), 
4.22 (ddd, J = 11.7, 3.2, 0.6 Hz, 1H, H-2), 4.07 (dd, J = 11.6, 6.7 Hz, 1H, H-2), 3.84 (m, 
1H, H-3), 3.79 (s, 3H, OCH3) ppm. 
13
C NMR (151 MHz, MeOD):  = 161.7 (C-11), 158.8 
(C-8), 148.9 (C-3´), 146.5 (C-4´), 134.9 (C-6), 134.3 (C-1´), 131.0 (C-4), 129.0 (C-5), 
121.9 (C-6´), 120.0 (C-10), 116.2 (C-5´), 113.1 (C-2´), 111.1 (C-7), 107.3 (C-9), 76.4 (C-
2), 56.3 (C-OMe), 51.1 (C-3) ppm. FT-IR:  (cm-1) = 540, 736, 819, 854, 1023, 1110, 
1158, 1236, 1268, 1517, 1598, 1651, 2841, 2939, 2964, 3065, 3374. ESI-MS: m/z (%) = 
161.1 (52), 182.5 (66), 284.1 (17) [M]
+•
, 285.1 (100) [M+H]
+
. HR-MS: calcd. for 
C17H17O4 [M+H]
+
 285.1121; found 285.1120. 
 
3-(4-Hydroxy-3-methoxyphenyl)-8-methoxy-2,3-dihydrobenzo[b]oxepin-7-ol (1d) 
7-Hydroxy-3-(4-hydroxy-3-methoxyphenyl)-8-methoxy-3,4-dihydrobenzo[b]oxepin-
5(2H)-one 11d (56 mg, 0.17 mmol) was dissolved in EtOH (15 mL). The solution was 
cooled to 0 °C before NaBH4 (32 mg, 0.85 mmol) was added. The reaction mixture was 
stirred for 1 hour at 0 °C and additional 6 hours at room temperature. The progress of the 
reaction was monitored by TLC. After the consumption of the substrate the reaction was 
quenched by the addition of 1 N HCl (3 mL) while cooling with an ice-water bath. EtOH 
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was removed under reduced pressure before the rest of the reaction solution was extracted 
with Et2O (4 × 10 mL). The combined organic phases were dried with MgSO4 and the 
solvent was removed under reduced pressure. The crude product was purified by flash 
chromatography on a Biotage®  solera™ flash purification system (PE/EtOAc 2:1, Rf 0.3). 
3-(4-Hydroxy-3-methoxyphenyl)-8-methoxy-2,3-dihydrobenzo[b]oxepin-7-ol 1d was 
obtained in 37 % yield (20 mg, 0.063 mmol). 
1
H NMR (600 MHz, CDCl3):  = 6.87 (d, J = 
8.0 Hz, 1H, H-5´), 6.78 (s, 1H, H-6), 6.75 (dd, J = 8.0, 1.9 Hz, 1H, H-6´), 6.73 (d, J = 1.9 
Hz, 1H, H-2´), 6.54 (s, 1H, H-9), 6.33 (dd, J = 11.9, 1.9 Hz, 1H, H-5), 5.89 (dd, J = 11.8, 
4.1 Hz, 1H, H-4), 5.54 (s, 0.5H, OH), 5.25 (s, 0.5H, OH), 4.26 (dd, J = 11.7, 3.3 Hz, 1H, 
H-2), 4.13 (dd, J = 11.7, 6.6 Hz, 1H, H-2), 3.91 – 3.87 (m, 1H, H-3), 3.85 (s, 6H, OCH3) 
ppm. 
13
C NMR (151 MHz, CDCl3):  = 153.0 (C-11), 146.5 (C-3´), 146.4, 146.0 (C-8), 
145.9, 144.6 (C-4´), 144.5, 140.6 (C-7), 140.5, 133.0 (C-1´), 131.4 (C-4), 127.8 (C-5), 
121.1 (C-6´), 119.1 (C-10), 117.0 (C-6), 116.9, 114.3 (C-5´), 114.3, 110.8 (C-2´), 103.2 
(C-9), 75.5 (C-2), 56.0 (C-OMe), 55.9 (C-OMe), 49.9 (C-3) ppm. FT-IR:  (cm-1) = 736, 
776, 816, 843, 876, 1030, 1123, 1167, 1203, 1260, 1430, 1444, 1507, 1612, 2846, 2938, 
2963, 3008, 3425. EI-MS: m/z (%) = 177.1 (100), 314.2 (18) [M]
+•
. HR-MS: calcd. for 
C16H14O3 [M]
+•
 314.1154; found 314.1150.  
 
Ethyl 4-(4-(benzyloxy)-3-methoxyphenoxy)butanoate (17) 
4-(Benzyloxy)-3-methoxyphenol 4b (4.60 g, 20.0 mmol) and ethyl-4-bromo-butyrate 
(3.0 mL, 20 mmol) were dissolved in dry acetone (150 mL). Anhydrous K2CO3 (8.14 g, 60 
mmol) and KI (0.16 g, 1.0 mmol) were added in one portion. This slurry was heated to 60 
°C for 24 hours. K2CO3 was filtered off and washed with EtOAc (50 mL). The organic 
phase was washed with 1 N HCl (20 mL) and the aqueous phase was extracted with EtOAc 
(3×50 mL). The combined organic phases were dried with MgSO4 and the solvent was 
removed under reduced pressure. The crude product was purified by flash chromatography 
on a Biotage®  solera™ flash purification system (PE/EtOAc 4:1). Ethyl 4-(4-
(benzyloxy)-3-methoxyphenoxy)butanoate 17 was isolated as yellow oil in 65 % yield 
(4.52 g, 13.1 mmol). 
1
H NMR (300 MHz, CDCl3):  = 7.46 – 7.40 (m, 2H), 7.40 – 7.28 (m, 
3H), 6.78 (d, J = 8.7 Hz, 1H), 6.52 (t, J = 2.3 Hz, 1H), 6.32 (dd, J = 8.7, 2.8 Hz, 1H), 5.07 
(s, 2H), 4.15 (q, J = 7.1 Hz, 2H), 3.94 (t, J = 6.1 Hz, 2H), 3.86 (s, 3H), 2.51 (t, J = 7.3 Hz, 
2H), 2.14 – 2.02 (m, 2H), 1.26 (t, J = 7.1 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3):  = 
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173.3, 154.1, 150.9, 142.5, 137.5, 128.7, 128.5, 128.2, 127.8, 127.6, 127.5, 115.7, 103.9, 
101.0, 72.1, 67.1, 60.5, 55.9, 30.8, 24.7, 14.3 ppm. FT-IR:  (cm-1) = 696, 736, 791, 834, 
1025, 1196, 1450, 1508, 1730, 2939, 3029. ESI-MS: m/z (%) = 345.2 (100) [M+H]
+
, 362.2 
(19) [M+NH4]
+
, 367.2 (25) [M+Na]
+
. HR-MS: calcd. for C20H24O5 [M+H]
+
 345.1697; 
found 345.1705. 
 
4-(4-(Benzyloxy)-3-methoxyphenoxy)butanoic acid (18) 
Ethyl 4-(4-(benzyloxy)-3-methoxyphenoxy)butanoate 17 (4.50 g, 13.0 mmol) was 
dissolved in THF/H2O (3:1, 130 mL) and cooled with an ice-water-bath before LiOH (3.13 
g, 130 mmol) was added. This slurry was stirred at 60 °C for 20 hours. Afterwards the 
reaction mixture was acidified with 1 N HCl to about pH 2 and extracted with EtOAc 
(3×100 mL). The combined organic phases were dried with MgSO4 and the solvent was 
removed under reduced pressure. 4-(4-(Benzyloxy)-3-methoxyphenoxy)butanoic acid 18 
was obtained as white crystalline solid in 98 % yield (4.03 g, 12.7 mmol). Mp 111 – 113 
°C. 
1
H NMR (300 MHz, CDCl3):  = 7.46 – 7.28 (m, 6H), 6.78 (d, J = 8.8 Hz, 1H), 6.52 
(d, J = 2.8 Hz, 1H), 6.31 (dd, J = 8.7, 2.8 Hz, 1H), 5.08 (s, 2H), 3.96 (t, J = 6.1 Hz, 2H), 
3.86 (s, J = 8.3 Hz, 4H), 2.58 (t, J = 7.3 Hz, 2H), 2.14 – 2.03 (m, 2H) ppm. 13C NMR (75 
MHz, CDCl3):  = 179.2, 154.0, 150.9, 142.5, 137.5, 128.7, 128.5, 128.3, 127.8, 127.7, 
127.5, 115.6, 103.9, 101.0, 72.1, 66.9, 55.9, 30.5, 24.4 ppm. FT-IR:  (cm-1) = 729, 1027, 
1207, 1447, 1515, 1695, 1739, 2889, 2948, 2970, 3032. ESI-MS: m/z (%) = 317.1 (100) 
[M+H]
+
, 334.2 (11) [M+NH4]
+
, 655.3 (12) [2M+Na]
+
. HR-MS: calcd. for C18H20O5 
[M+H]
+
 317.1384; found 317.1390. 
 
7-(Benzyloxy)-8-methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one (19) 
4-(4-(Benzyloxy)-3-methoxyphenoxy)butanoic acid 18 (0.32 g, 1.0 mmol) was 
dissolved in dry dichloromethane (10 mL). The solution was cooled with an ice-water-bath 
before pyridine (80 L, 0.50 mmol) and cyanuric chloride (0.30 g, 1.6 mmol) were added. 
The reaction mixture was stirred at 0 °C for 0.5 hours, the cooling bath was then removed 
and the mixture stirred for additional 4 hours at room temperature. After cooling to -60 °C, 
AlCl3 (0.16 g, 1.2 mmol) was added in three portions. The mixture was allowed to warm 
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slowly up to 0 °C over a period of 3 hours, before the cooling bath was removed. The 
reaction mixture was stirred at room temperature for 2 days and then quenched by addition 
of H2O (5 mL). The aqueous phase was extracted with dichloromethane (3×20 mL). The 
combined organic phases were dried with MgSO4 and the solvent was removed under 
reduced pressure. The crude product was purified by flash chromatography on a Biotage® 
 solera™ flash purification system (PE/EtOAc 2:1, Rf 0.3). 7-(Benzyloxy)-8-methoxy-3,4-
dihydrobenzo[b]oxepin-5(2H)-one 19 was obtained as colorless oil in 15 % yield (45 mg, 
0.15 mmol). 
1
H NMR (300 MHz, CDCl3):  = 7.49 – 7.29 (m, 6H), 6.59 (s, 1H), 5.12 (s, 
2H), 4.21 (t, J = 6.8 Hz, 2H), 3.90 (s, 3H), 2.86 (t, J = 6.9 Hz, 2H), 2.16 (quint, J = 6.8 Hz, 
2H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 199.1, 158.4, 154.5, 144.2, 136.7, 128.6, 128.0, 
127.6, 120.9, 112.6, 104.2, 73.1, 71.2, 56.2, 40.5, 26.0 ppm. FT-IR:  (cm-1) = 697, 746, 
1148, 1198, 1262, 1381, 1444, 1504, 1606, 1664, 1732, 2927, 2959, 3028. APCI-MS: m/z 
(%) = 299.1 (100) [M+H]
+
. HR-MS: calcd. for C18H19O4 [M+H]
+
 299.1278; found 
299.1279. 
 
7-Hydroxy-8-methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one (20) 
7-(Benzyloxy)-8-methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one 19 (62 mg, 0.21 
mmol) was dissolved in EtOAc (10 mL) and Pd/C (15 mg) was added. The reaction 
mixture was placed in an autoclave under 5 bar H2 pressure and stirred for 5 hours. The 
mixture was filtered through celite and the solvent removed under reduced pressure. The 
crude product was purified by flash chromatography on a Biotage®  solera™ flash 
purification system (PE/EtOAc 2:1, Rf 0.12). 7-Hydroxy-8-methoxy-3,4-
dihydrobenzo[b]oxepin-5(2H)-one 20 was isolated in 64 % yield (28 mg, 0.13 mmol). 
1
H 
NMR (300 MHz, MeOD):  = 7.14 (s, J = 4.5 Hz, 1H), 6.64 (s, J = 10.3 Hz, 1H), 4.14 (t, J 
= 6.9 Hz, 2H), 3.87 (s, J = 4.1 Hz, 3H), 2.82 – 2.72 (m, 2H), 2.15 – 2.03 (m, 2H) ppm. 13C 
NMR (75 MHz, MeOD):  = 201.9, 158.4, 154.6, 143.7, 122.9, 114.6, 105.3, 73.7, 56.6, 
41.3, 26.7 ppm. FT-IR:  (cm-1) = 885, 937, 1056, 1143, 1264, 1443, 1501, 1614, 1662, 
2883, 2954, 3402. EI-MS: m/z (%) = 123.1 (38), 166.1 (47), 177.1 (27), 193.1 (11), 208.1 
(100) [M]
+•
. HR-MS: calcd. for C11H12O4 [M]
+•
 208.0736; found 208.0734. 
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8-methoxy-2,3-dihydrobenzo[b]oxepin-7-ol (1e) 
7-Hydroxy-8-methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one 20 (27 mg, 0.13 mmol) 
was dissolved in EtOH (4 mL). The solution was cooled to 0 °C before NaBH4 (25 mg, 
0.65 mmol) was added. The reaction mixture was stirred for 5 hour at 0 °C and additional 3 
hours at room temperature. The progress of the reaction was monitored by TLC. After the 
consumption of the substrate the reaction was quenched by the addition of 1 N HCl (1 mL) 
while cooling with an ice-water bath. EtOH was removed under reduced pressure before 
the rest of the reaction solution was extracted with Et2O (4 × 10 mL). The combined 
organic phases were dried with MgSO4 and the solvent was removed under reduced 
pressure. The crude product was purified by flash chromatography on a Biotage® 
 solera™ flash purification system (PE/EtOAc 2:1, Rf 0.34). 8-methoxy-2,3-
dihydrobenzo[b]oxepin-7-ol 1e was obtained in 36 % yield (9.0 mg, 0.047 mmol). 
1
H 
NMR (600 MHz, CDCl3):  = 6.70 (s, 1H, H-6), 6.52 (s, 1H, H-9), 6.18 (dt, J = 11.8, 1.7 
Hz, 1H, H-5), 5.84 (dt, J = 11.7, 4.5 Hz, 1H, H-4), 5.19 (s, 0.8H, OH), 4.20 (t, J = 4.9 Hz, 
1H, H-2), 3.85 (s, J = 5.6 Hz, 2H, OCH3), 2.64 (ddd, J = 9.8, 4.7, 1.9 Hz, 1H, H-3) ppm. 
13
C NMR (151 MHz, CDCl3):  = 152.7 (C-10), 145.8 (C-8), 140.4 (C-7), 128.3 (C-4), 
128.0 (C-5), 119.5 (C-11), 117.0 (C-6), 103.1 (C-9), 69.9 (C-2), 56.0 (OCH3), 34.4 (C-3) 
ppm. FT-IR:  (cm-1) = 800, 872, 1023, 1168, 1201, 1258, 1444, 1506, 1624, 2935, 3013, 
3428. EI-MS: m/z (%) = 105.1 (13) [PhCO]
+
, 162.1 (11), 177.1 (50), 192.1 (100) [M]
+•
. 
HR-MS: calcd. for C11H12O3 [M]
+•
 192.0786; found 192.0785. 
 
N-(3-Methoxyphenyl)-4-methylbenzenesulfonamide (21) 
m-Anisidine (1.12 mL, 10.0 mmol) was dissolved in dry THF (15 mL). NEt3 (1.66 mL, 
12.0 mmol) and tosylchloride (1.90 g, 10.0 mmol) were added and the solution was stirred 
at room temperature for 28 hours. The reaction was quenched by adding water (5 mL). The 
aqueous phase was extracted with EtOAc (3×10 mL) and the combined organic phases 
were dried with MgSO4. The solvent was removed under reduced pressure to obtain N-(3-
methoxyphenyl)-4-methylbenzenesulfonamide 21 in 100 % yield (2.8 g, 10 mmol). 
1
H NMR (300 MHz, CDCl3):  = 7.70 (d, J = 8.2 Hz, 2H), 7.22 (d, J = 8.1 Hz, 2H), 7.10 (t, 
J = 8.1 Hz, 1H), 6.71 (t, J = 2.2 Hz, 1H), 6.66 – 6.59 (m, 2H), 3.73 (d, J = 3.6 Hz, 3H), 
2.37 (s, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 160.3, 143.9, 137.8, 136.0, 130.0, 
129.7, 127.3, 113.3, 110.8, 106.8, 55.3, 21.6 ppm. (Ref.
51
) 
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4-(4-Ethoxy-1-(N-(3-methoxyphenyl)-4-methylphenyl-
sulfonamido)-4-oxobut-2-en-2-yl)phenyl benzoate (22) 
N-(3-Methoxyphenyl)-4-methylbenzenesulfonamide 21 (2.27 g, 8.20 mmol) was 
dissolved in acetone (50 mL) and cooled with ice-water-bath before 4-(1-bromo-4-ethoxy-
4-oxobut-2-en-2-yl)phenyl benzoate 5a (3.18 g, 8.20 mmol) and anhydrous K2CO3 (2.27 g, 
16.4 mmol) were added. This slurry was stirred at 0 °C for 0.5 hours and afterwards heated 
to 50 °C for 40 hours. K2CO3 was filtered off and washed with EtOAc (50 mL). The 
organic phase was washed with 1 N HCl (10 mL) and water (10 mL). The aqueous phase 
was extracted with EtOAc (20 mL). The combined organic phases were dried with MgSO4 
and the solvent was removed under reduced pressure. The crude product was recrystallized 
from EtOAc. 4-(4-Ethoxy-1-(N-(3-methoxyphenyl)-4-methylphenylsulfonamido)-4-
oxobut-2-en-2-yl)phenyl benzoate 22 was obtained as colorless crystals in 61 % yield (2.93 
g, 5.00 mmol). 
1
H NMR (300 MHz, CDCl3):  = 8.27 – 8.18 (m, 2H), 7.70 – 7.63 (m, 1H), 
7.58 – 7.50 (m, 2H), 7.50 – 7.43 (m, 4H), 7.29 – 7.21 (m, 4H), 7.01 (t, J = 8.1 Hz, 1H), 
6.73 (ddd, J = 8.3, 2.5, 0.7 Hz, 1H), 6.29 (ddd, J = 7.9, 1.8, 0.8 Hz, 1H), 6.22 (t, J = 2.2 
Hz, 1H), 5.97 (s, 1H), 5.41 (d, J = 0.8 Hz, 2H), 4.10 (q, J = 7.1 Hz, 2H), 3.58 (s, 3H), 2.43 
(s, 3H), 1.23 (t, J = 7.1 Hz, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 165.8, 164.9, 159.4, 
152.9, 151.8, 143.6, 139.2, 135.7, 134.5, 133.7, 130.2, 129.5, 129.4, 128.8, 128.7, 127.9, 
121.7, 121.2, 120.6, 114.7, 113.8, 60.3, 55.2, 47.0, 21.6, 14.2 ppm. FT-IR:  (cm-1) = 536, 
579, 707, 816, 1053, 1154, 1248, 1348, 1599, 1705, 1737, 2937, 2972, 3004, 3065. ESI-
MS: m/z (%) = 586.2 (91) [M+H]
+
, 603.2 (81) [M+NH4]
+
, 608.2 (41) [M+Na]
+
, 
1193.4(100) [2M+Na]
+
. HR-MS: calcd. for C33H32NO7S [M+H]
+
 586.1894; found 
586.1899. 
 
(Benzyl 3-(4-(benzyloxy)phenyl)-4-(N-(3-methoxyphenyl)-4-
methylphenylsulfonamido)but-2-enoate (23) 
4-(4-Ethoxy-1-(N-(3-methoxyphenyl)-4-methylphenylsulfonamido)-4-oxobut-2-en-2-
yl)phenyl benzoate 22 (0.77 g, 1.32 mmol) was dissolved in THF/H2O (4:1, 30 mL) and 
cooled with an ice-water-bath before LiOH (0.32 g, 13 mmol) was added. This slurry was 
stirred at 0 °C for 1 hour and heated to 55 °C for 44 hours. The completion of the reaction 
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was monitored by TLC. Afterwards the reaction mixture was acidified with 1 N HCl to pH 
1 - 2 and extracted with EtOAc (3×50 mL). The combined organic phases were dried with 
MgSO4 and the solvent was removed under reduced pressure. The residue was used 
without further purification in the subsequent reaction and dissolved in acetone (10 mL). 
Benzyl bromide (0.77 mL, 6.5 mmol), K2CO3 (0.36 g, 2.6 mmol) and KI (20 mg, 
0.13 mmol) were added to the stirring solution before heating was initiated. The reaction 
mixture was heated to 60 °C for 40 h. After K2CO3 was filtered off and acidified with 
1 N HCl, the mixture was extracted with dichloromethane (3×40 mL). The combined 
organic phases were dried with MgSO4. The crude product was purified by flash 
chromatography on a Biotage®  solera™ flash purification system (PE/EtOAc 4:1, Rf 0.3). 
(Benzyl 3-(4-(benzyloxy)phenyl)-4-(N-(3-methoxyphenyl)-4-methylphenylsulfonamido)-
but-2-enoate 23 was obtained as yellow oil in 29 % yield (0.24 g, 0.38 mmol). 
1
H NMR 
(300 MHz, CDCl3):  = 7.51 – 7.23 (m, 20H), 7.00 – 6.92 (m, 3H), 6.71 (dd, J = 8.2, 2.4 
Hz, 1H), 6.24 (d, J = 7.7 Hz, 1H), 6.19 (t, J = 2.1 Hz, 1H), 5.97 (s, 1H), 5.40 (s, 2H), 5.11 
(s, 2H), 5.07 (s, J = 5.0 Hz, 2H), 3.50 (s, 3H), 2.44 (s, J = 5.9 Hz, 3H) ppm. 
13
C NMR (75 
MHz, CDCl3):  = 165.8, 159.9, 159.2, 153.9, 143.6, 139.1, 136.7, 135.8, 134.6, 130.4, 
129.5, 129.1, 128.8, 128.7, 128.6, 128.2, 128.1, 128.0, 127.9, 127.6, 127.0, 120.8, 118.9, 
114.6, 113.8, 70.1, 65.9, 55.1, 46.7, 21.6 ppm. ESI-MS: m/z (%) =634.2 (100) [M+H]
+
, 
656.2 (33) [M+Na]
+
, 1289.4 (63) [2M+Na]
+
. HR-MS: calcd. for C38H36NO6S [M+H]
+
 
634.2258; found 634.2256. 
 
3-(4-(Benzyloxy)phenyl)-4-(N-(3-methoxyphenyl)-4-
methylphenylsulfonamido)but-2-enoic acid (24) 
 (Benzyl 3-(4-(benzyloxy)phenyl)-4-(N-(3-methoxyphenyl)-4-methylphenyl-
sulfonamide)but-2-enoate 23 (0.23 g, 0.36 mmol) was dissolved in THF/H2O (4:1, 12 mL) 
and cooled with an ice-water-bath before LiOH (43 mg, 1.8 mmol) was added. This slurry 
was stirred at 0 °C for 1 hour and additional 30 hours at 60 °C. Afterwards the reaction 
mixture was acidified with 1 N HCl to pH 1 - 2 and extracted with EtOAc (3×10 mL). The 
combined organic phases were dried with MgSO4 and the solvent was removed under 
reduced pressure. The residue was recrystallized from MeOH/dichloromethane (4:1, 
2.5 mL). 3-(4-(Benzyloxy)phenyl)-4-(N-(3-methoxyphenyl)-4-methylphenylsulfon-
amido)but-2-enoic acid 24 was obtained as white crystalline solid in 23 % yield (44 mg, 
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0.08 mmol). 
1
H NMR (300 MHz, CDCl3):  = 7.50 – 7.34 (m, 9H), 7.24 (d, J = 8.2 Hz, 
2H), 7.03 – 6.95 (m, 3H), 6.72 (dd, J = 8.0, 2.2 Hz, 1H), 6.27 – 6.19 (m, 1H), 6.16 (t, J = 
2.2 Hz, 1H), 5.94 (d, 2H), 5.36 (s, 2H), 5.13 (s, 2H), 3.51 (s, 3H), 2.42 (s, 3H) ppm. 
13
C NMR (75 MHz, CDCl3):  = 170.0, 160.2, 159.3, 156.5, 143.7, 139.2, 136.6, 134.4, 
130.2, 129.4, 129.2, 128.9, 128.7, 128.2, 127.9, 127.6, 120.8, 117.8, 114.7, 114.6, 113.9, 
70.1, 55.1, 46.9, 21.6 ppm. ESI-MS: m/z (%) = 544.2 (100) [M+H]
+
, 561.2 (20) 
[M+NH4]
+
. HR-MS: calcd. for C31H30NO6S [M+H]
+
 544.1788; found 544.1791. 
 
 
4-(4-(Benzyloxy)phenyl)-1-(3-methoxyphenyl)-1H-pyrrol-2(5H)-one (27) 
3-(4-(Benzyloxy)phenyl)-4-(N-(3-methoxyphenyl)-4-methylphenylsulfonamido)but-2-
enoic acid 24 (26 mg, 0.05 mmol) was dissolved in dry dichloroethane (1 mL). The 
solution was cooled with an ice-water-bath before pyridine (4 L, 0.05 mmol) and 
cyanuric chloride (13 mg, 0.08 mmol) were added. The reaction mixture was stirred at 0 °C 
for 0.5 hours, the cooling bath was then removed and the mixture stirred for additional 3 
hours at room temperature. After cooling to -30 °C, InCl3 (11 mg, 0.05 mmol) was added 
in three portions. The mixture was allowed to warm slowly up to 0 °C over a period of 2 
hours and was stirred additional 10 hours at room temperature before the reaction was 
quenched by adding H2O (0.5 mL). The aqueous phase was extracted with Et2O (3×2 mL). 
The combined organic phases were dried with MgSO4 and the solvent was removed under 
reduced pressure. The crude product was purified by flash chromatography on a Biotage® 
 solera™ flash purification system (PE/EtOAc 2:1, Rf 0.3). 4-(4-(Benzyloxy)phenyl)-1-(3-
methoxyphenyl)-1H-pyrrol-2(5H)-one 27 was obtained in 28 % yield (5 mg, 0.013 mmol) 
(when AlCl3 was used as Lewis acid, 4-(4-(Benzyloxy)phenyl)-1-(3-methoxyphenyl)-1H-
pyrrol-2(5H)-one 27 was obtained in 87 % yield (12 mg, 0.032 mmol) from 3-(4-
(Benzyloxy)phenyl)-4-(N-(3-methoxyphenyl)-4-methylphenylsulfonamido)but-2-enoic 
acid 24 (20 mg, 0.037 mmol)). 
1
H NMR (600 MHz, CDCl3):  = 7.55 (t, J = 2.1 Hz, 1H), 
7.53 – 7.50 (m, 2H), 7.46 – 7.42 (m, 2H), 7.42 – 7.39 (m, 2H), 7.37 – 7.33 (m, 1H), 7.29 (t, 
J = 7.9 Hz, 1H), 7.27 (t, J = 1.5 Hz, 1H), 7.06 – 7.02 (m, 2H), 6.69 (ddd, J = 7.8, 2.3, 1.3 
Hz, 1H), 6.39 (s, 1H), 5.13 (s, 2H), 4.74 (d, J = 0.9 Hz, 2H), 3.85 (s, 3H) ppm. 
13
C NMR 
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(151 MHz, CDCl3):  = 170.9, 160.8, 160.4, 153.3, 140.8, 136.5, 129.9, 128.9, 128.4, 
127.7, 127.6, 124.4, 119.5, 115.6, 110.7, 109.6, 104.8, 70.3, 55.5, 53.0 ppm. FT-IR:  (cm-
1
) = 695, 765, 823, 1034, 1178, 1252, 1382, 1514, 1604, 1674, 2924, 3036. EI-MS: m/z 
(%) = 91.1 (100) [C7H7]
+
, 280.2 (7) [M-C7H7]
+
, 371.2 (11) [M]
+•
. HR-MS: calcd. for 
C24H21NO3 [M]
+•
 371.1521; found 371.1524. 
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3.5.2 Pharmacological testing 
Cytotoxicity 
The influence of ruscozepine B 1b on the viability of HMEC-1 cells was determined 
after 24 hours of incubation using an MTT assay according to Mosman
52
 (modified, n = 3 
in sextuplicates).  
 
ICAM-1 
Confluent grown human microvascular endothelial cells (HMEC-1)
53
 were pretreated 
either with ruscozepine B 1b, parthenolide (Calbiochem, purity ≥ 97 %, 5 µM, positive 
control), or medium (ECGM, endothelial cell growth medium (Provitro) + 10 % FCS, + 
antibiotics, + supplements) as a negative control in 24-well plates. Thirty minutes later, 
10 ng/mL TNF- (Sigma-Aldrich) were added to stimulate the ICAM-1 expression. After 
24 hours of incubation (New Brunswick Scientific, 37 °C, 5 % CO2), cells were washed 
with PBS, removed from the plate with trypsin/EDTA and fixed with formalin. After 
incubating with a FITC-labelled mouse antibody against ICAM-1 (Biozol) for 20 min, the 
fluorescence intensity was measured by FACS analysis (Becton Dickinson Facscalibur™). 
ICAM-1 expression of cells treated with TNF-α only was set as 100 %.  
 
ORAC-Fluorescein assay 
The ORAC-Fl assay was performed according to Davalos et al. 
42
 and Vogel et al. 
43
 in 
96-well plates with fluorescein (final concentration 300 nM) as fluorescent probe and 75 
mM phosphate buffer (pH 7.4) for all dilution steps and as reaction milieu. The antioxidant 
(compounds 1a-e, 16a/c or Trolox, 20 µL) was incubated in different concentrations 
(compounds 1a-e, 16a/c 1.0-5.0 μM; Trolox, 1-8 μM) together with a fluorescein solution 
(120 μL) at 37 °C for 15 min. The reaction was started by the addition of 60 μL of AAPH 
(2,2′-azobis(2-methylpropionamide) dihydrochloride; final concentration, 12 mM), 
yielding a final volume of 200 μL. After the addition of AAPH, the fluorescence was 
recorded every minute in a Tecan 96-plate reader (λex = 485 nm, λem = 536 nm, 37 °C) for 
300 min. Samples were measured at five different concentrations (1.0-5.0 μM). Eight 
Synthesis of novel natural products isolated from butchers broom 
 
108 
calibration curves using 1-8 μM Trolox as antioxidant were also carried out in each assay. 
Controls were measured without antioxidant as well as without AAPH and antioxidant. 
ORAC values were expressed as Trolox equivalents (mean±SD) by using the standard 
curve calculated for each assay. The regression coefficient between AUC and antioxidant 
concentration was calculated for all samples (r
2
 > 0.93). Further positive control 
measurements were performed with xanthohumol. 
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4 Summary 
The first part of this dissertation (chapter 1 and 2) deals with the deoxygenation of 
alcohols. Chapter 1 reviews catalytic deoxygenation methods currently used in organic 
synthesis. Recent examples are used to demonstrate the different deoxygenation strategies 
employing either a two-step procedure or the direct deoxygenation of alcohols. For the 
commonly used two-step procedures the alcohols are transferred into a corresponding ester 
or ether that can be cleaved reductively by common palladium, nickel or rhodium catalysts. 
The direct deoxygenation is the preferred method; while the catalyst activates the C-O 
bond a conversion into an appropriate leaving group is not necessary. Lewis acids are 
commonly used for this activation and silanes are typically used as reducing agents. 
Chapter 2 reports the deoxygenation of benzylic alcohols with hydriodic acid in a 
biphasic media. This method, using boiling hydriodic acid and red phosphorous for the 
deoxygenation of gluconic acid to hydrocarbons, was reported the first time by Killiani 
140 years ago. We reinvestigated this method by using hydriodic acid in toluene to 
separate the organic molecules from the harsh acidic conditions in the aqueous phase and 
allow milder reaction conditions. With this method benzylic and -carbonyl alcohols are 
deoxygenated successfully. Even catalytic amounts of hydriodic acid are sufficient for the 
deoxygenation when excess of red phosphorous is used as terminal reducing agent. 
In chapter 3 we describe the synthesis of the natural products ruscozepine A and B 
isolated from Ruscus aculeatus L. and analogous compounds. An existing synthetic 
pathway for the basic benzoxepine structure was improved for the synthesis of the 
ruscozepines. Especially a mild procedure for the intramolecular Friedel-Crafts acylation is 
applied, because typically used procedures were not favorable. Unfortunately the 
developed synthesis was not applicable for the synthesis of an analogous benzazepine. 
Pharmacological testing revealed a high antioxidant activity by an ORAC-fluoresceine 
assay, while no anti-inflammatory activity was observed in an ICAM-1 expression 
inhibition assay. 
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5 Zusammenfassung 
Der erste Teil dieser Dissertation (Kapitel 1 und 2) befasst sich mit der Deoxygenierung 
von Alkoholen. Im ersten Kapitel sind katalytische Deoxygenierungsmethoden 
zusammengefasst, die derzeit Anwendung in der organischen Chemie finden. Anhand 
aktueller Beispiele werden die unterschiedlichen Strategien zur Deoxygenierung von 
Alkoholen aufgezeigt, die entweder auf einer zweistufigen oder direkten Methode beruhen. 
Bei den häufig genutzten zweistufigen Methoden werden die Alkohole erst in einen 
entsprechenden Ester oder Ether umgewandelt um dann reduktiv mit Hilfe eines 
Palladium, Nickel oder Rhodium Katalysators gespalten zu werden. Die direkten 
Deoxygenierungen sind die bevorzugten Methoden; da hierbei ein Katalysator die C-O 
Bindung aktiviert, ist keine Umwandlung in eine geeignete Abgangsgruppe notwendig. Für 
gewöhnlich werden Lewis Säuren für diese Aktivierung genutzt, wobei Silane als typische 
Reduktionsmittel eingesetzt werden. 
Kapitel 2 berichtet über die Deoxygenierung von Benzylalkoholen mit Iodwasserstoff-
säure in einem zweiphasigen Medium. Über die Verwendung von Iodwasserstoffsäure zur 
Deoxygenierung von Alkoholen berichtete erstmals Killiani vor 140 Jahren, um 
Gluconsäure in kochender Iodwasserstoffsäure mit rotem Phosphor zu den entsprechenden 
Kohlenwasserstoffen zu deoxygenieren. Wir griffen diese Methode wieder auf indem wir 
Iodwasserstoffsäure in Toluol nutzten um organische Moleküle von der starken 
Mineralsäure in der wässrigen Phase zu separieren um somit mildere Reaktions-
bedingungen zu erhalten. Unter diesen Bedingungen können Benzyl- und -Carbonyl-
alkohole erfolgreich deoxygeniert werden. Wird roter Phosphor im Überschuss eingesetzt, 
sind sogar katalytische Mengen von Iodwasserstoffsäure hinreichend um Benzylalkohole 
zu deoxygenieren. 
In Kapitel 3 wird die Synthese der Naturstoffe Ruscozepin A und B, isoliert aus dem 
stechenden Mäusedorn (Ruscus aculeatus L.), und analogen Substanzen beschrieben. Für 
die Synthese der Ruscozepine wurde ein bekannter Syntheseweg für die Benzoxepin-
grundstruktur verbessert und auf analoge Substanzen übertragen. Besonders die 
Anwendung einer milden Variante der Friedel-Crafts Acylierung war essentiell, da 
etablierte Methoden dieser Reaktion nicht zum gewünschten Ergebnis führten. Allerdings 
konnte die dabei etablierte Syntheseroute nicht auf die Synthese eines analogen 
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Benzazepins angewandt werden. Die Pharmakologische Testung dieser Substanzen 
offenbarte ein hohes antioxidatives Potential in einem ORAC-Fluorescein Assay, während 
keine entzündungshemmenden Eigenschaften in einem ICAM-1 Expression Inhibitions 
Assay beobachtet werden konnten. 
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6 Appendix 
6.1 Abbreviations 
[BMIM][BF4] 1-Butyl-3-methyl-
imidazolium-
tetrafluorborate 
[BSO3BIM] 1-(4-Butylsulfonic  
[NTf2] acid)-3-
(n-butyl)imidazolium-
bis(trifluormethyl-
sulfonyl)imide 
[EMIM][NTf2] 1-Ethyl-3-
methylimidazoliumbis(t
rifluormethylsulfonyl)i
mid 
°C Degree Celsius 
µL Micro liter 
µM Micro molar 
µW Micro watt 
13
C NMR Carbon NMR 
1
H NMR Proton NMR 
1-OL 1-Octanol 
Å Angstrom (10
-10
 meters) 
AAPH 2,2´-Azobis-(2-
methylpropionamide)-
dihydrochloride 
ACN Acetonitrile 
APCI Atmospheric-pressure 
chemical ionization 
BzCl Benzoyl chloride 
C(sp
2
) Carbon in sp
2
 
hybridization 
C(sp
3
) Carbon in sp
3
 
hybridization 
Ca(NTf2)2 Calcium(II) 
bis(trifluoromethanesulf
onimide) 
calcd. Calculated 
Cbz Carboxybenzyl 
CDCl3 Deuterated chloroform 
CI Chemical ionization 
C‒O Carbon oxygen bond 
cod 1,5-Cyclooctadiene 
cot 1,3,5-Cyclooctatriene 
CVI Chronic venous 
insufficiency 
DBPB 2,2-Di-
tertbutylperoxybutane  
DBPO Dibenzoyl peroxide 
DCE 1,2-Dichloroethane 
DCM Dichloromethane 
DMAP 4-Dimethylamino-
pyridine 
DMF Dimethylformamide 
DMSO Dimethyl sulfoxide 
DMSO-d6 Deuterated dimethyl 
sulfoxide 
DOE 1,1-Dioctylether 
dppf (1,3-Bis(diphenyl-
phosphino)ferrocene) 
dppp (1,3-Bis(diphenyl-
phosphino)propane) 
e
-
 Electron 
ECGM Endothelial cell growth 
medium 
EDTA Ethylenediamine-
tetraacetic acid 
EE Ethoxyethyl 
EI Electron impact 
ionization 
eq. Equivalent 
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ES Electrospray 
ESI Electrospray ionization 
Et2O Diethyl ether 
Et3SiH Triethylsilane 
EtOAc Ethyl acetate 
EtOH Ethanol 
eV Electron volts 
F/mol Farad per mol  
FACS Fluorescence-activated 
cell sorting 
FITC Fluorescein 
isothiocyanate 
FCS Fetal calf serum 
FT-IR Fourier transform 
infrared spectroscopy 
h Hour 
H
+
 Proton 
HDO Hydrodeoxygenation 
HI Hydriodic acid 
HMEC-1 Human microvascular 
endothelial cells 
HR-MS High resolution mass 
spectrometry 
ICAM-1 Intercellular adhesion 
molecule 
LAH Lithium aluminium 
hydride 
LiAlH4 Lithium aluminium 
hydride 
LiBHEt3 Lithium 
triethylborohydride 
LPS Lipopolysaccharide 
M Molar concentration 
mA/cm
2
 Milli ampere per square 
centimeter (electric 
current density) 
mean±SD Reference range 
(standard deviation) 
MeNO2 Nitromethane 
MeOD Deuterated methanol, 
MeOH-d4 
MeOH Methanol 
MgSO4 Magnesium sulfate 
MHz Mega hertz 
min Minute 
mL Milli liter 
mm Milli meter 
mmol Milli mole 
Mo(CO)6 Molybdenum 
hexacarbonyl 
mol% Mole percent 
MOM Methoxymethyl 
Mp Melting point 
MS Mass spectrometry 
Ms Mesylate 
MSA Methanesulfonic acid 
MTT 3-(4,5-Dimethylthiazol-
2-yl)-2,5-diphenyl-
tetrazolium bromide 
N Normal concentration 
NBS N-Bromosuccinimide 
n-BuLi n-Butyl lithium 
Nf Nafion 
NF-B Nuclear factor kappa-
light-chain-enhancer of 
activated B-cells 
Ni(cod)2 Bis(1,5-
cyclooctadiene)nickel 
Ni/Cg Nickel on graphite 
nm Nano meter 
NMR Nuclear magnetic 
resonance 
ORAC Oxygen radical 
absorbance capacity 
PCy3 Tricyclohexylphosphine 
Pd/C Palladium on charcoal 
PE petroleum ether 
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PPA Polyphosphoric acid 
PPh3 Triphenylphosphine 
ppm Parts per million 
Pred Red phosphorous 
pTSA para-Toluenesulfonic 
acid 
Rf Retention factor 
RhCl(PPh3)3 Wilkinson catalyst 
ROS Reactive oxygen 
species 
Ru/C Ruthenium on charcoal 
sat. Saturated 
SCE Saturated calomel 
electrode 
SET Single electron 
transfere 
TBDMS tert-Butyldimethylsilyl 
TBST Tri-tert-
butoxysilanethiol 
TEAC Trolox equivalent 
antioxidant capacity 
TEMPO (2,2,6,6-Tetramethyl-
piperidin-1-yl)oxyl 
Tf Triflate 
TFE 2,2,2-Trifluoroethanol 
THF Tetrahydrofuran 
THFA 4-(2-Tetrahydrofuryl)-
2-butanol 
TLC Thin layer 
chromatography 
TMSCl Trimethylsilyl chloride 
TNF- Tumor necrosis factor 
alpha 
Trolox 6-Hydroxy-2,5,7,8-
tetramethylchroman-2-
carboxylic acid 
Ts Tosyl 
UV Ultra violet 
V Volt 
Vis Visible light 
wt.-% Weight percent 
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6.2 Copies of selected NMR – Spectra 
4-(1-Bromo-4-ethoxy-4-oxobut-2-en-2-yl)phenyl benzoate (5a) 
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4-(1-(4-(Benzyloxy)-3-methoxyphenoxy)-4-ethoxy-4-oxobut-2-en-2-yl)phenyl benzoate (3b) 
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4-(3-(Benzyloxy)phenoxy)-3-(4-(benzyloxy)phenyl)but-2-enoic acid (10a) 
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4-(4-(Benzyloxy)-3-methoxyphenoxy)-3-(4-(benzyloxy)phenyl)but-2-enoic acid (10b) 
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3-(4-(Benzyloxy)-3-methoxyphenyl)-4-(3-(benzyloxy)phenoxy)but-2-enoic acid (10c) 
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3-(4-(Benzyloxy)-3-methoxyphenyl)-4-(3-(benzyloxy)-4-methoxyphenoxy)but-2-enoic acid 
(10d) 
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8-(Benzyloxy)-3-(4-(benzyloxy)phenyl)benzo[b]oxepin-5(2H)-one (2a) 
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7-(Benzyloxy)-3-(4-hydroxyphenyl)-8-methoxybenzo[b]oxepin-5(2H)-one (2b) 
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8-(Benzyloxy)-3-(4-(benzyloxy)-3-methoxyphenyl)benzo[b]oxepin-5(2H)-one (2c) 
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7-(Benzyloxy)-3-(4-(benzyloxy)-3-methoxyphenyl)-8-methoxybenzo[b]oxepin-5(2H)-one 
(2d) 
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3-(4-Hydroxyphenyl)-2,3,4,5-tetrahydrobenzo[b]oxepin-8-ol (16a) 
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129 
7-Hydroxy-3-(4-hydroxyphenyl)-8-methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one (11b) 
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3-(4-Hydroxy-3-methoxyphenyl)-2,3,4,5-tetrahydrobenzo[b]oxepin-8-ol (16c) 
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3-(4-Hydroxyphenyl)-2,3-dihydrobenzo[b]oxepin-8-ol (1a) 
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3-(4-Hydroxyphenyl)-8-methoxy-2,3-dihydrobenzo[b]oxepin-7-ol (1b) 
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3-(4-Hydroxy-3-methoxyphenyl)-2,3-dihydrobenzo[b]oxepin-8-ol (1c) 
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3-(4-Hydroxy-3-methoxyphenyl)-8-methoxy-2,3-dihydrobenzo[b]oxepin-7-ol (1d) 
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4-(4-(Benzyloxy)-3-methoxyphenoxy)butanoic acid (18) 
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7-(Benzyloxy)-8-methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one (19) 
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7-Hydroxy-8-methoxy-3,4-dihydrobenzo[b]oxepin-5(2H)-one (20) 
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8-methoxy-2,3-dihydrobenzo[b]oxepin-7-ol (1e) 
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3-(4-(Benzyloxy)phenyl)-4-(N-(3-methoxyphenyl)-4-methylphenylsulfonamido)but-2-enoic 
acid (24) 
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4-(4-(Benzyloxy)phenyl)-1-(3-methoxyphenyl)-1H-pyrrol-2(5H)-one (27) 
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